
<html lang="en"     class="pb-page"  data-request-id="c558001a-3146-47db-843c-5cd1fddc0dd7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.0c01835;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-1;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors" /></meta><meta name="dc.Creator" content="Ehesan U.  Sharif" /></meta><meta name="dc.Creator" content="Jaroslaw  Kalisiak" /></meta><meta name="dc.Creator" content="Kenneth V.  Lawson" /></meta><meta name="dc.Creator" content="Dillon H.  Miles" /></meta><meta name="dc.Creator" content="Eric  Newcomb" /></meta><meta name="dc.Creator" content="Erick A.  Lindsey" /></meta><meta name="dc.Creator" content="Brandon R.  Rosen" /></meta><meta name="dc.Creator" content="Laurent P. P.  Debien" /></meta><meta name="dc.Creator" content="Ada  Chen" /></meta><meta name="dc.Creator" content="Xiaoning  Zhao" /></meta><meta name="dc.Creator" content="Stephen W.  Young" /></meta><meta name="dc.Creator" content="Nigel P.  Walker" /></meta><meta name="dc.Creator" content="Norbert  Sträter" /></meta><meta name="dc.Creator" content="Emma R.  Scaletti" /></meta><meta name="dc.Creator" content="Lixia  Jin" /></meta><meta name="dc.Creator" content="Guifen  Xu" /></meta><meta name="dc.Creator" content="Manmohan R.  Leleti" /></meta><meta name="dc.Creator" content="Jay P.  Powers" /></meta><meta name="dc.Description" content="Solid tumors are often associated with high levels of extracellular ATP. Ectonucleotidases catalyze the sequential hydrolysis of ATP to adenosine, which potently suppresses T-cell and NK-cell funct..." /></meta><meta name="Description" content="Solid tumors are often associated with high levels of extracellular ATP. Ectonucleotidases catalyze the sequential hydrolysis of ATP to adenosine, which potently suppresses T-cell and NK-cell funct..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 5, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01835" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01835" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01835" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01835" /></link>
        
    
    

<title>Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01835" /></meta><meta property="og:title" content="Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0014.jpeg" /></meta><meta property="og:description" content="Solid tumors are often associated with high levels of extracellular ATP. Ectonucleotidases catalyze the sequential hydrolysis of ATP to adenosine, which potently suppresses T-cell and NK-cell functions via the adenosine receptors (A2a and A2b). The ectonucleotidase CD73 catalyzes the conversion of AMP to adenosine. Thus, increased CD73 enzymatic activity in the tumor microenvironment is a potential mechanism for tumor immune evasion and has been associated with poor prognosis in the clinic. CD73 inhibition is anticipated to restore immune function by skirting this major mechanism of adenosine generation. We have developed a series of potent and selective methylenephosphonic acid CD73 inhibitors via a structure-based design. Key binding interactions of the known inhibitor adenosine-5′-(α,β-methylene)diphosphate (AMPCP) with hCD73 provided the foundation for our early designs. The structure–activity relationship study guided by this structure-based design led to the discovery of 4a, which exhibits excellent potency against CD73, exquisite selectivity against related ectonucleotidases, and a favorable pharmacokinetic profile." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01835"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01835">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01835&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01835&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01835&amp;href=/doi/10.1021/acs.jmedchem.0c01835" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 845-860</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01793" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01883" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Ehesan U. Sharif</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ehesan U. Sharif</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Arcus Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#7a1f09121b08131c3a1b08190f0918131554191517"><span class="__cf_email__" data-cfemail="d2b7a1bab3a0bbb492b3a0b1a7a1b0bbbdfcb1bdbf">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ehesan+U.++Sharif">Ehesan U. Sharif</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2605-6745" title="Orcid link">http://orcid.org/0000-0002-2605-6745</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jaroslaw Kalisiak</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jaroslaw Kalisiak</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Arcus Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jaroslaw++Kalisiak">Jaroslaw Kalisiak</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kenneth V. Lawson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kenneth V. Lawson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Arcus Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth+V.++Lawson">Kenneth V. Lawson</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5094-6337" title="Orcid link">http://orcid.org/0000-0001-5094-6337</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dillon H. Miles</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dillon H. Miles</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Arcus Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dillon+H.++Miles">Dillon H. Miles</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eric Newcomb</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eric Newcomb</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Arcus Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Newcomb">Eric Newcomb</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Erick A. Lindsey</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Erick A. Lindsey</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Arcus Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Erick+A.++Lindsey">Erick A. Lindsey</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Brandon R. Rosen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brandon R. Rosen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Arcus Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brandon+R.++Rosen">Brandon R. Rosen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0790-6433" title="Orcid link">http://orcid.org/0000-0002-0790-6433</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laurent P. P. Debien</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laurent P. P. Debien</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Arcus Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laurent+P.+P.++Debien">Laurent P. P. Debien</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ada Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ada Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Arcus Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ada++Chen">Ada Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiaoning Zhao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaoning Zhao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Arcus Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoning++Zhao">Xiaoning Zhao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stephen W. Young</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephen W. Young</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Arcus Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+W.++Young">Stephen W. Young</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nigel P. Walker</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nigel P. Walker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Arcus Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nigel+P.++Walker">Nigel P. Walker</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Norbert Sträter</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Norbert Sträter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Bioanalytical Chemistry, Center for Biotechnology and Biomedicine, Leipzig University, Deutscher Platz 5, D-04103 Leipzig, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Norbert++Str%C3%A4ter">Norbert Sträter</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2001-0500" title="Orcid link">http://orcid.org/0000-0002-2001-0500</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Emma R. Scaletti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Emma R. Scaletti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Bioanalytical Chemistry, Center for Biotechnology and Biomedicine, Leipzig University, Deutscher Platz 5, D-04103 Leipzig, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Emma+R.++Scaletti">Emma R. Scaletti</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lixia Jin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lixia Jin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Arcus Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lixia++Jin">Lixia Jin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Guifen Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Guifen Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Arcus Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Guifen++Xu">Guifen Xu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Manmohan R. Leleti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Manmohan R. Leleti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Arcus Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Manmohan+R.++Leleti">Manmohan R. Leleti</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Jay P. Powers</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jay P. Powers</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Arcus Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jay+P.++Powers">Jay P. Powers</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01835&amp;href=/doi/10.1021%2Facs.jmedchem.0c01835" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 845–860</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 5, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 October 2020</li><li><span class="item_label"><b>Published</b> online</span>5 January 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 January 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01835" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01835</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D845%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DEhesan%2BU.%2BSharif%252C%2BJaroslaw%2BKalisiak%252C%2BKenneth%2BV.%2BLawson%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D1%26contentID%3Dacs.jmedchem.0c01835%26title%3DDiscovery%2Bof%2BPotent%2Band%2BSelective%2BMethylenephosphonic%2BAcid%2BCD73%2BInhibitors%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D860%26publicationDate%3DJanuary%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01835"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1450</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">2</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01835" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ehesan&quot;,&quot;last_name&quot;:&quot;U. Sharif&quot;},{&quot;first_name&quot;:&quot;Jaroslaw&quot;,&quot;last_name&quot;:&quot;Kalisiak&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;V. Lawson&quot;},{&quot;first_name&quot;:&quot;Dillon&quot;,&quot;last_name&quot;:&quot;H. Miles&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Newcomb&quot;},{&quot;first_name&quot;:&quot;Erick&quot;,&quot;last_name&quot;:&quot;A. Lindsey&quot;},{&quot;first_name&quot;:&quot;Brandon&quot;,&quot;last_name&quot;:&quot;R. Rosen&quot;},{&quot;first_name&quot;:&quot;Laurent&quot;,&quot;last_name&quot;:&quot;P. P. Debien&quot;},{&quot;first_name&quot;:&quot;Ada&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Xiaoning&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;W. Young&quot;},{&quot;first_name&quot;:&quot;Nigel&quot;,&quot;last_name&quot;:&quot;P. Walker&quot;},{&quot;first_name&quot;:&quot;Norbert&quot;,&quot;last_name&quot;:&quot;Sträter&quot;},{&quot;first_name&quot;:&quot;Emma&quot;,&quot;last_name&quot;:&quot;R. Scaletti&quot;},{&quot;first_name&quot;:&quot;Lixia&quot;,&quot;last_name&quot;:&quot;Jin&quot;},{&quot;first_name&quot;:&quot;Guifen&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Manmohan&quot;,&quot;last_name&quot;:&quot;R. Leleti&quot;},{&quot;first_name&quot;:&quot;Jay&quot;,&quot;last_name&quot;:&quot;P. Powers&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;845-860&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01835&quot;},&quot;abstract&quot;:&quot;Solid tumors are often associated with high levels of extracellular ATP. Ectonucleotidases catalyze the sequential hydrolysis of ATP to adenosine, which potently suppresses T-cell and NK-cell functions via the adenosine receptors (A2a and A2b). The ectonucleotidase CD73 catalyzes the conversion of AMP to adenosine. Thus, increased CD73 enzymatic activity in the tumor microenvironment is a potential mechanism for tumor immune evasion and has been associated with poor prognosis in the clinic. CD73 inhibition is anticipated to restore immune function by skirting this major mechanism of adenosine generation. We have developed a series of potent and selective methylenephosphonic acid CD73 inhibitors via a structure-based design. Key binding interactions of the known inhibitor adenosine-5′-(α,β-methylene)diphosphate (AMPCP) with hCD73 provided the foundation for our early designs. The structure–activity relationship study guided by this structure-based design led to the discovery of 4a, which exhibits excellent pot&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01835&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01835" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01835&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01835" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01835&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01835" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01835&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01835&amp;href=/doi/10.1021/acs.jmedchem.0c01835" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01835" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01835" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01835%26sid%3Dliteratum%253Aachs%26pmid%3D33399453%26genre%3Darticle%26aulast%3DSharif%26date%3D2021%26atitle%3DDiscovery%2Bof%2BPotent%2Band%2BSelective%2BMethylenephosphonic%2BAcid%2BCD73%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D1%26spage%3D845%26epage%3D860%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292161" title="Modification">Modification</a>,</li><li><a href="/action/doSearch?ConceptID=291592" title="Adenine">Adenine</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292317" title="Ethyl groups">Ethyl groups</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/jmcmar.2021.64.issue-1/20210114/jmcmar.2021.64.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/medium/jm0c01835_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01835&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Solid tumors are often associated with high levels of extracellular ATP. Ectonucleotidases catalyze the sequential hydrolysis of ATP to adenosine, which potently suppresses T-cell and NK-cell functions via the adenosine receptors (A<sub>2a</sub> and A<sub>2b</sub>). The ectonucleotidase CD73 catalyzes the conversion of AMP to adenosine. Thus, increased CD73 enzymatic activity in the tumor microenvironment is a potential mechanism for tumor immune evasion and has been associated with poor prognosis in the clinic. CD73 inhibition is anticipated to restore immune function by skirting this major mechanism of adenosine generation. We have developed a series of potent and selective methylenephosphonic acid CD73 inhibitors via a structure-based design. Key binding interactions of the known inhibitor adenosine-5′-(α,β-methylene)diphosphate (AMPCP) with hCD73 provided the foundation for our early designs. The structure–activity relationship study guided by this structure-based design led to the discovery of <b>4a</b>, which exhibits excellent potency against CD73, exquisite selectivity against related ectonucleotidases, and a favorable pharmacokinetic profile.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45888" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45888" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">5′-Ribonucleotide phosphohydrolase, also known as cluster of differentiation 73 (CD73), is a Zn-binding GPI-anchored extracellular protein that functions as a noncovalent homodimer with two structural domains connected by a small hinge region.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> CD73 has high affinity for adenosine monophosphate (AMP) and catalyzes the conversion of AMP to adenosine.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Numerous studies have demonstrated that CD73 is upregulated by hypoxia within the tumor microenvironment.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> High concentrations of CD73 within the tumor microenvironment contribute substantially to elevated levels of adenosine, which results in immune suppression by activating the adenosine receptors (A<sub>2a</sub> and A<sub>2b</sub>) on infiltrating lymphocytes.</div><div class="NLM_p last">CD73 represents a novel therapeutic target for cancer immunology, and several efforts have been undertaken to leverage the role it plays in the development of anticancer therapeutics.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> For example, anti-CD73 antibody therapy has been shown to inhibit tumor growth and metastasis in animal models.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Müller and co-workers have reported derivatives of α-β-methylene-ADP (AMPCP), one of the earlier metabolically stable, potent, and selective CD73 inhibitors known.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Similarly, in industrial settings, several efforts have been directed toward the discovery of CD73 inhibitors in recent years.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> Despite these efforts, no CD73 inhibitors are currently approved for clinical use. Therefore, the development of new CD73 inhibitors continues to be vitally important.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36637" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36637" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We started our investigation based on the known CD73 inhibitor AMPCP. The crystal structure of AMPCP bound to human CD73 (hCD73) was disclosed by Sträter et al. in 2012 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4H2I">4H2I</a>).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Our initial lead scaffold was designed by investigation of key binding interactions of this known inhibitor with hCD73, i.e., coordination of the phosphonomethyl-phosphonic acid with di-zinc, hydrogen-bonding interaction between <i>syn</i>-diol of ribose with Asp-506 and Asn-390 and the hydrophobic π–π stacking between adenine and Phe-500 and Phe-417 shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/medium/jm0c01835_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Key Interactions of AMPCP with hCD73</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01835&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Early structure–activity relationship (SAR) studies on APMCP were reported by Müller et al., where substitution at the C6 and C8 positions and the methylene bridging the two phosphonic acid units of AMPCP were investigated.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Their study found that substitution of the C6 amine with a benzyl group led to analog PSB-12379 (<i>K</i><sub>i</sub> = 2.2 nM) with substantially improved potency relative to AMPCP (<i>K</i><sub>i</sub> = 88.4 nM). While the results were encouraging, their reported SAR was limited to the aforementioned modifications.</div><div class="NLM_p">During the course of our early investigations, in a parallel program also targeting CD73 using bisphosphonic acids, it was discovered that introduction of a chlorine atom at the C2 position of PSB-12379 led to a 14-fold improvement in potency (IC<sub>50</sub> = 0.4 nM for <b>1</b>, <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).<a onclick="showRef(event, 'cit7a cit7b cit7c'); return false;" href="javascript:void(0);" class="ref cit7a cit7b cit7c">(7a−c)</a> Similar beneficial effects of C2 chlorine substitution have been reported subsequentially by Müller et al.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Our early discovery led us to focus our SAR on <b>1</b>. In general, bisphosphonates are poorly absorbed from the gastrointestinal tract; thus, they suffer from poor oral bioavailability. To alleviate the potential liability arising from bisphosphonic acid, we embarked on this simultaneous SAR study by replacing the bisphosphonic acid moiety of <b>1</b>.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/medium/jm0c01835_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. SAR Study of AMPCP-Based CD73 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01835&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our initial effort to replace the bisphosphonic acid moiety in <b>1</b> with malonic acid led to a significant drop in potency (<b>1a</b>, IC<sub>50</sub> = 1 μM), presumably due to the loss of interaction with di-zinc (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). When this malonic acid was replaced with phosphonoacetic acid <b>1b</b>, an improvement in potency was observed (IC<sub>50</sub> = 110 nM). However, the ability of the phosphonic acid moiety to engage in the binding interaction with di-zinc was realized to a greater extent when the steric congestion around it was removed. Thus, replacing the phosphonoacetic acid with a methylenephosphonic acid (<b>1c</b>) led to adequate interaction with di-zinc and further improvement in potency (IC<sub>50</sub> = 58 nM). The position of the phosphonic acid also played a key role in the observed potency. For example, if the phosphonic acid moiety was extended by an ethylene (<b>1d</b>) or a propylene (<b>1e</b>) linker, complete loss of potency was observed. This SAR interrogation resulted in successful replacement of the bisphosphonic acid <b>1</b> with methylenephosphonic acid <b>1c</b>. Additionally, methylenephosphonic acid analogs offered us the prospect for developing prodrugs to improve oral bioavailability because contrary to earlier experience with bisphosphonic acids, successful development of prodrugs for monophosphonic acids have been reported.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Replacement of Bisphosphonic Acid Residue</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/medium/jm0c01835_0009.gif" alt="" id="fx1" /></img><div></div></div><div class="NLM_p">To improve the potency of the methylenephosphonic acid analog <b>1c</b>, we carried out a systematic SAR analysis of the adenine core, which began with modification at the C6 position (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> A wide variety of benzylamines and phenethylamines were tolerated at the C6 position. Substitution of the phenyl ring in the phenethylamine moiety with electron-donating or electron-withdrawing groups did not significantly affect the potency (<b>2a–2c</b>). Similar observations were made with substitution of the benzylamine (<b>1c</b> vs <b>2f</b>). In contrast, the stereochemistry at the benzylic position appeared to be important for the observed potency. For example, (<i>S</i>)-(−)-α-methylbenzylamine as a C6 substituent (<b>2d</b>) exhibited higher potency than its enantiomer (<b>2e</b>) (IC<sub>50</sub> = 65 nM for <b>2d</b> vs IC<sub>50</sub> = 156 nM for <b>2e</b>). Heteroaromatic amine substituents like 2-picolylamine <b>2h</b>, <i>N</i>-methylpyrazole-4-methylamine <b>2i</b>, and 4-methyltriazole-3-methylamine <b>2j</b> showed decreased potency. C6-amine substituents containing an aliphatic group (<b>2k</b>) or carbocyclic groups (<b>2l–2o</b>) were also investigated. The most potent analog <b>2n</b> was obtained when cyclopentylamine was introduced at the C6 position (IC<sub>50</sub> = 26 nM). Compounds containing a cyclic secondary amine at the C6 position, such as pyrrolidine (<b>2p</b>) or morpholine (<b>2r</b>), were found to be less potent. Similarly, C6 amines that contain a heterocyclic substituent as in the case of (<i>R</i>)-3-aminotetrahydrofuran (<b>2q</b>) did not improve the potency (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Modification of C6 Position</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/medium/jm0c01835_0010.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p">To better understand the binding interactions of methylenephosphonic acid analog <b>2n</b> with hCD73, we obtained an X-ray cocrystal structure of <b>2n</b> bound to hCD73 (PDB: 6YE1). The X-ray structure revealed that the methylene phosphonate interacts extensively with the di-zinc, as was observed in the case of AMPCP. Similarly, other polar interactions of the ribose moiety and hydrophobic interactions of the adenine base are also maintained (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D). From the overlaid cocrystal structures of AMPCP and <b>2n</b>, it can be seen that the terminal phosphonates superimpose well but the ribose and the adenine rings of <b>2n</b> are shifted 1–1.5 Å relative to AMPCP (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A,B). This shift of the adenine base toward the di-zinc center indicates that when <b>2n</b> is bound to CD73, the N- and C-terminal domains of CD73 move closer together to accommodate the shorter phosphate linker. Further study of the X-ray cocrystal structure revealed a narrow hydrophobic pocket around the C2 chlorine atom (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C). This presented us with an opportunity to evaluate C2 modifications to improve the binding affinity and boost the potency.</div><figure id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/medium/jm0c01835_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Superposition of AMPCP (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4H2I">4H2I</a>) in gray with <b>2n</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YE1">6YE1</a>) in yellow. (B) Lateral view of superposition of AMPCP and <b>2n</b>. (C) X-ray structure of <b>2n</b> bound to CD73, represented by a water-accessible surface in gray for selected residues within 10 Å of the ligand, reveals a narrow hydrophobic pocket around the C2 chlorine. (D) Molecular interactions of <b>2n</b> in the cocrystal structure with hCD73.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01835&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Replacing the C2 chlorine with a phenyl group (<b>3a</b>) led to a decrease in potency, presumably due to the conformational constraints induced by the biaryl system, which might not be accommodated in the nucleotide binding site of the enzyme. As expected, this effect was particularly severe for the <i>o-</i>tolyl group (<b>3b</b>), which showed a > 130-fold loss in potency (IC<sub>50</sub> = 3.5 μM for <b>3b</b> vs IC<sub>50</sub> = 26 nM for <b>2n</b>). The conformational strain imposed by the biaryl rings could be relieved by a methylene-ether bridge (<b>3c</b> and <b>3d</b>). In the case of <b>3d</b>, a boost in potency was observed when the C2 chlorine was replaced with a phenoxy methyl ether (IC<sub>50</sub> = 13 nM). Unsurprisingly, when the C2 chlorine was replaced with pyrrolidine-3-methyl ether, complete loss of activity was observed (<b>3e</b>, IC<sub>50</sub> > 10 μM, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) presumably because of the negative interaction between the polar pyrrolidine and the hydrophobic pocket around the C2 position. Taking into account the potency, synthetic tractability, and physiochemical properties of the C2-modified analogs, we concluded that the C2-chlorine substituent (<b>2n</b>) was optimal.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Modification of C2 Position</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/medium/jm0c01835_0011.gif" alt="" id="fx3" /></img><div></div></div><div class="NLM_p">Next, we focused on the modification of the adenine base by changing its electron distribution to modulate hydrophobic interactions arising from the π–π stacking of Phe-500 and Phe-417 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D). When adenine base <b>2n</b> (IC<sub>50</sub> = 26 nM) was replaced with pyrazolopyrimidine <b>4a</b>, a 10-fold improvement in potency (IC<sub>50</sub> = 2.6 nM) was observed (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Similarly, introduction of pyrazolopyridine (<b>4b</b>) led to a fivefold improvement in potency (IC<sub>50</sub> = 4.5 nM). However, replacing the adenine base with imidazolopyridine (<b>4c</b>) did not improve potency (IC<sub>50</sub> = 33 nM) (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/medium/jm0c01835_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) X-ray structure of <b>4a</b> cocrystallized with hCD73 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YE2">6YE2</a>) showing molecular interactions. (B) Overlay of X-ray crystals of <b>2n</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YE1">6YE1</a>) in green and <b>4a</b> in yellow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01835&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Modification of the Purine Base</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/medium/jm0c01835_0012.gif" alt="" id="fx4" /></img><div></div></div><div class="NLM_p">It is worth noting that heterocyclic core modifications <b>4a</b> and <b>4b</b>, which incorporate a nitrogen atom at the 8-position, both led to a significant boost in potency. To further understand how these modifications influence the protein-binding interactions that improve potency, we obtained an X-ray cocrystal of <b>4a</b> with hCD73 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YE2">6YE2</a>). <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A shows key ligand interactions. In comparison to the adenine base in <b>2n</b>, the position of the pyrazolopyrimidine base in <b>4a</b> shifted 0.8 Å away from the N-terminal domain of CD73. This shift can be visualized clearly from the crystal structure overlay of <b>2n</b> with <b>4a</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). These two compounds differ only in the position of the nitrogen atom at the 7- and 8-positions, and the close alignment of the protein atoms of both CD73 domains indicates an almost identical relative domain orientation. Repositioning of the nitrogen atom affects electron distribution of the nucleobase, which presumably influences the hydrophobic stacking interactions of <b>4a</b>, resulting in the observed shift. The shifting of the pyrazolopyrimidine away from the phosphonate residue also indicates that the C2 chlorine is being extended deeper into the narrow hydrophobic pocket compared to <b>2n</b>. The potentially stronger interaction established due to this conformational orientation might have contributed toward the improvement in potency.</div><div class="NLM_p">Compound <b>4a</b> was characterized further against related targets and evaluated for off-target selectivity (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). It was found to exhibit excellent potency against soluble hCD73 (IC<sub>50</sub> = 0.86 nM) and soluble mouse CD73 (mCD73; IC<sub>50</sub> = 3.0 nM), CHO cells overexpressing hCD73 (IC<sub>50</sub> = 2.6 nM) or mCD73 (IC<sub>50</sub> = 13 nM), and the human ovary cancer cell line SKOV-3 (IC<sub>50</sub> = 0.55 nM). It exhibits excellent selectivity (IC<sub>50</sub> > 10 000 nM) against CD39, A<sub>2a</sub>R, and NTPDase2, 3, and 8. Furthermore, compound <b>4a</b> was also found to be stable when cultured with human, dog, rat, or mouse hepatocytes (see the SI) and exhibited low clearance in rats (CL = 0.13 L/h/kg).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Potency and Selectivity of <b>4a</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="2" align="center">potency</th><th class="rowsep1 colsep0" colspan="2" align="center">selectivity</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">target</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">target</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hCD73-CHO</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">CD39</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hCD73 (soluble)</td><td class="colsep0 rowsep0" align="left">0.86</td><td class="colsep0 rowsep0" align="left">A<sub>2a</sub>R</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mCD73-CHO</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">hNTPDase-2</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mCD73 (soluble)</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">hNTPDase-3</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SKOV-3</td><td class="colsep0 rowsep0" align="left">0.55</td><td class="colsep0 rowsep0" align="left">hNTPDase-8</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr></tbody></table></div></div><div class="NLM_p">During our earlier investigation of C6 substituents on the adenine series (<i>vide supra</i>), we found that introduction of α-(<i>S</i>)-methylbenzylamine at the C6 position (<b>2d</b>) led to decreased clearance, albeit with some loss in potency compared to the corresponding cyclopentylamine (<b>2n</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). Based on this observation, we decided to re-evaluate C6 substitutions on the most potent analogs, <b>4a</b> in the pyrazolopyrimidine series and <b>4b</b> in the pyrazolopyridine series, to further decrease clearance in rats. The observed trend in potency and clearance of the pyrazolopyrimidine series was similar to that of the adenine series. When cyclopentylamine in <b>4a</b> was replaced with α-(<i>S</i>)-methylbenzylamine (<b>5a</b>), it resulted in an 11-fold loss in potency but a 39-fold decrease in systemic clearance. To improve potency while maintaining low clearance, fluoro-substituted α-(<i>S</i>)-methylbenzylamines were explored. The loss in potency due to introduction of α-(<i>S</i>)-methylbenzylamine was substantially reclaimed with 2<i>-</i>fluoro- and 4<i>-</i>fluoro-α-(<i>S</i>)-methylbenzylamines <b>5b</b> (IC<sub>50</sub> = 7.6 nM) and <b>5d</b> (IC<sub>50</sub> = 12 nM), respectively. Contrary to this, 3<i>-</i>fluoro-α-(<i>S</i>)-methylbenzylamine (<b>5c</b>) had a deleterious effect on potency (IC<sub>50</sub> = 39 nM). A similar trend in potencies was also reflected in the pyrazolopyridine series when the C6 cyclopentylamine of <b>4b</b> was replaced with the above-mentioned fluoro-benzyl amines (<b>5e–5h</b>). The positive effect of fluorine incorporation on rat pharmacokinetic (PK) was demonstrated with <b>5d</b> in the pyrazolopyrimidine series and with <b>5h</b> in the pyrozolopyridine series. Both <b>5d</b> and <b>5h</b> exhibited remarkably low clearance and improved half-life (CL = 0.020 and 0.018 L/h/kg; <i>T</i><sub>1/2</sub> = 4.5 and 4.0 h, respectively).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Further Improvements in Rat PK</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/medium/jm0c01835_0013.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> measured in hCD73-CHO cells.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">PK experiments were performed on male SD rats at IV dose of 0.25 or 0.5 mg/kg using 31.6% dimethylacetamide (DMA) + 36.8% ethanol + 31.6% poly(ethylene glycol) (PEG) as the vehicle; N/D, not determined.</p></div></div><div></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Chemistry</h3><div class="NLM_p">The bisphosphonic acid replacement analogs (<b>1a</b>–<b>e</b>) were synthesized according to <a class="ref internalNav" href="#sch3a" aria-label="Scheme 3a">Scheme 3a</a>. Introduction of the malonate and phosphonoacetate at the C5′ hydroxyl group of commercially available 2,6-dichloro-9-[2,3-<i>O</i>-(1-methylethylidene)-β-<span class="smallcaps smallerCapital">d</span>-ribofuranosyl]-9<i>H</i>-purine <b>6</b> was carried out via rhodium catalysis using dimethyl 2-diazomalonate and ethyl 2-diazo-2-(diethoxyphosphoryl)acetate in refluxing toluene to obtain <b>7</b> and <b>8</b>, respectively.<a onclick="showRef(event, 'cit7d'); return false;" href="javascript:void(0);" class="ref cit7d">(7d)</a> The benzylamine was then introduced at the C6 position via a S<sub>N</sub>Ar reaction to obtain <b>9</b> and <b>10</b>, respectively. Hydrolysis of the ethyl phosphate and removal of the acetonide were carried out with TMS-Br and a successive aqueous quench. Saponification of dimethylmalonate <b>11</b> and phosphonoethylacetate <b>12</b> with LiOH gave <b>1a</b> and <b>1b</b>, respectively. Monophosphonic acid derivatives (<b>1c–e</b>) were synthesized using a four-step sequence (steps e–h) shown in <a class="ref internalNav" href="#sch3a" aria-label="Scheme 3a">Scheme 3a</a>. The first step in the synthesis involves a S<sub>N</sub>Ar reaction between commercially available 2,6-dichloropurine riboside triacetate <b>13</b> and benzylamine in ethanol in the presence of triethylamine. The crude reaction mixture was then subjected to global acetate deprotection using methanolic ammonia to obtain <b>14</b>. Next, the 2,3-<i>syn-</i>diol was protected as acetonide <b>15</b>. At this stage, alkyl phosphonates were introduced at the C5′ hydroxyl of the ribose unit using diethyl <i>p</i>-toluenesulfonyloxy methylphosphonate, diethyl 2-bromoethylphosphonate, and diethyl 2-bromopropylphosphonate in the presence of NaH in <i>N</i>,<i>N</i>-dimethylformamide (DMF) to obtain phosphonates <b>16</b>, <b>17</b>, and <b>18</b>, respectively. As before, hydrolysis of ethylphosphonates and concomitant acetonide removal were achieved with TBS-Br and a successive aqueous quench to yield <b>1c</b>–<b>e</b>. The above-mentioned four-step sequence (<a class="ref internalNav" href="#sch3a" aria-label="Scheme 3a">Scheme 3a</a>, steps e–h) was also used for the synthesis of all C6-modified analogs (<b>2a</b>–<b>2r</b>) shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. Similar synthesis of 5′-methylphosphonate nucleosides has been reported previously.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><figure id="sch3a" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3a</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/medium/jm0c01835_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3a. Replacement of Bisphosphonic Acid<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01835&amp;id=sch3a"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Rh<sub>2</sub>(OAc)<sub>4</sub>, dimethyl 2-diazomalonate for <b>7</b> or ethyl 2-diazo-2-(diethoxyphosphoryl)acetate for <b>8</b>, toluene, reflux, yield = 60% for <b>7</b> and 64% for <b>8</b>; (b) benzylamine, Et<sub>3</sub>N, EtOH, room temperature (rt), yield = quantitative; (c) TMS-Br, CH<sub>3</sub>CN, rt and then H<sub>2</sub>O, yield = 38% for <b>11</b> and 23% for <b>12</b>; (d) LiOH, tetrahydrofuran (THF)/H<sub>2</sub>O, rt, yield = 89% for <b>1a</b>, 15% for <b>1b</b>; (e) benzylamine, Et<sub>3</sub>N, EtOH, rt and then 7 N NH<sub>3</sub> in MeOH, yield = 55%; (f) 2,2-dimethoxypropane, <i>p-</i>TSA, acetone, rt; (g) diethyl <i>p</i>-toluenesulfonyloxy methylphosphonate for <b>1c</b> or diethyl 2-bromoethylphosphonate for <b>1d</b> or diethyl 2-bromopropylphosphonate for <b>1e</b>, NaH, DMF, 0 °C–rt; (h) TMS-Br, CH<sub>3</sub>CN, rt and then H<sub>2</sub>O, yield = 20% for <b>1c</b>, 6% for <b>1d</b>, 23% for <b>1e</b> (three steps).</p></p></figure><div class="NLM_p">Variation of the C2 position was carried out according to <a class="ref internalNav" href="#sch3b" aria-label="Scheme 3b">Scheme 3b</a>. Following Steps e–g in <a class="ref internalNav" href="#sch3a" aria-label="Scheme 3a">Scheme 3a</a>, commercially available 2,6-dichloropurine riboside triacetate <b>13</b> was converted to <b>19</b>, which was used for various C2 modifications. Introduction of a phenyl or <i>o-</i>tolyl substituent (<b>3a</b> and <b>3b</b>, respectively) was achieved via Suzuki coupling of <b>19</b> with the corresponding arylboronic acids followed by hydrolysis of the ethylphosphonate using TMS-Br and a successive aqueous quench. For the synthesis of the methylene-ether substituents, intermediate <b>19</b> was first coupled with cinnamylboronic acid to obtain <b>20</b>. Oxidative cleavage of <b>20</b> furnished aldehyde <b>21</b>, which was further reduced to carbinol <b>22</b>.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The carbinol <b>22</b> was then treated with thionyl chloride to obtain <b>23</b>, which was used for the synthesis of various methylene-ether analogs. Methoxymethyl ether <b>3c</b> and phenoxymethylether <b>3d</b> were synthesized via S<sub>N</sub>2 displacement of the chlorine atom of <b>23</b> by methanol and phenol, respectively, in the presence of potassium carbonate followed by hydrolysis of the phosphonate ester. For the synthesis of compound <b>3e</b>, commercially available <i>N</i>-Boc-3-pyrrolidinol was used in the presence of sodium hydride in <i>N</i>,<i>N-</i>dimethylformamide. Removal of the Boc group and the hydrolysis of the ethylphosphonate were carried out in one-pot using TMS-Br.</div><figure id="sch3b" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3b</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/medium/jm0c01835_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0006.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3b. Synthesis of C2-Modified Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01835&amp;id=sch3b"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) two steps: (1) phenylboronic acid or tolylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>3</sub>CO<sub>3</sub>, THF/H<sub>2</sub>O, reflux; (2) TMS-Br, CH<sub>3</sub>CN, rt and then H<sub>2</sub>O, yields = 20% for <b>3a</b> and 10% for <b>3b</b>; (b) cinnamylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>3</sub>CO<sub>3</sub>, THF/H<sub>2</sub>O, reflux; (c) K<sub>2</sub>OsO<sub>4</sub>·<sub>2</sub>H<sub>2</sub>O, NaIO<sub>4</sub>, 2,6-lutidine, THF, H<sub>2</sub>O, rt; (d) NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, yield = 60% (three steps); (e) SOCl<sub>2</sub>, pyridine, CH<sub>3</sub>CN, 0 °C, yield = 40%; (f) two steps: (1) K<sub>2</sub>CO<sub>3</sub>, MeOH or phenol, rt–40 °C; (2) TMS-Br, CH<sub>3</sub>CN, rt and then H<sub>2</sub>O, yields = 13% for <b>3c</b> and 37% for <b>3d</b>; (g) <i>N</i>-Boc-3-pyrrolidinol, NaH, DMF; (h) TMS-Br, CH<sub>3</sub>CN, rt and then H<sub>2</sub>O, yield = 15% (two steps).</p></p></figure><div class="NLM_p">Synthesis of analogs with modifications to the central core was carried out according to <a class="ref internalNav" href="#sch3c" aria-label="Scheme 3c">Scheme 3c</a>. <i>N-</i>Glycosylation of commercially available central cores pyrazolopyrmidine <b>25</b> and pyrazolopyridine <b>26</b> with ribose tetraacetate were carried out using bis(trimethylsilyl)amine (HMDS) and trimethylsilyl trifluoromethanesulfonate (TMSOTf) to obtain <b>27</b> and <b>28</b>, respectively. Similar to the synthesis of <b>1c</b>, cyclopentylamine was introduced at the C6 position of pyrazolopyrimidine <b>27</b> at room temperature in methanol in the presence of triethylamine. Successive removal of the acetate groups with methanolic ammonia gave compounds <b>29</b>. <i>Syn</i>-diol of <b>29</b> was then protected as acetonide <b>30</b>. The methylphosphate moiety was then introduced at C5′ hydroxyl to obtain <b>31</b>. Finally, global deprotection of <b>31</b> gave <b>4a</b>. This four-step sequence (steps b–e) was also used for the synthesis of analogs <b>5a</b>–<b>d</b>. An alternative approach was adopted for the synthesis of the pyrazolopyridine-derived analog <b>4b</b>, in which cyclopentylamine was introduced at the C6 position at the end of the sequence. The glycosylated product <b>28</b> was first converted to acetonide <b>32</b>, followed by introduction of the phosphate residue at C5′ to obtain <b>33</b>. Contrary to the pyrazolopyrimidine <b>27</b>, installation of C6 amines on pyrazolopyridine <b>33</b> required elevated temperature (refluxing ethanol). As before, hydrolysis of the ethylphosphonate and removal of acetonide were carried out in one-pot using TMS-Br to obtain analogs <b>4b</b>. Analogs <b>5e</b>–<b>h</b> were synthesized in a similar fashion to <b>4b</b>. Glycosylation of imidazolopyridine <b>34</b> was achieved using <i>N</i>,<i>O</i>-bis(trimethylsilyl)acetamide (BSA) and TMSOTf. Similar to pyrazolopyridine core <b>33</b>, installation of the C6 cyclopentylamine on imidazolopyridine <b>35</b> was achieved at elevated temperature using refluxing dioxane to obtain <b>36</b>. Analogous to the synthesis of <b>4a</b>, compound <b>36</b> was then subjected to steps k–m to furnish <b>4c</b>.</div><figure id="sch3c" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3c</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/medium/jm0c01835_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0007.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3c. Synthesis of Analogs with Modified Purine Base<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01835&amp;id=sch3c"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HMDS, (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, reflux and then β-<span class="smallcaps smallerCapital">d</span>-ribofuranose 1,2,3,5-tetraacetate, TMSOTf, CH<sub>3</sub>CN, rt, yield = 25% for <b>27</b> and 32% for <b>28</b>; (b) cyclopentylamine, Et<sub>3</sub>N, MeOH, rt and then 7 N NH<sub>3</sub> in MeOH; (c) 2,2-dimethoxypropane, <i>p-</i>TSA, acetone, rt; (d) NaHMDS, diethyl <i>p</i>-toluenesulfonyloxy methylphosphonate THF, 0 °C–rt; yield = 73% (three steps); (e) TMS-Br, CH<sub>3</sub>CN, rt and then MeOH/HCl, yield = 93%; (f) two steps: (1) 7 N NH<sub>3</sub> in MeOH, rt; (2) 2,2-dimethoxypropane, <i>p</i>-TSA, acetone, rt, yield = 80%; (g) diethyl <i>p</i>-toluenesulfonyloxy methylphosphonate, LiHMDS, THF, −78 °C–rt, yield = 59%; (h) two steps: (1) cyclopentylamine, Et<sub>3</sub>N, EtOH, reflux; (2) TMS-Br, CH<sub>3</sub>CN, rt and then H<sub>2</sub>O, yield = 48%; (i) BSA, CH<sub>3</sub>CN, reflux then β-<span class="smallcaps smallerCapital">d</span>-ribofuranose 1,2,3,5-tetraacetate, TMSOTf, CH<sub>3</sub>CN, reflux; (j) cyclopentylamine, dioxane, reflux, yield = 40%, two steps; (k) 2,2-dimethoxypropane, <i>p-</i>TSA, acetone, rt, yield = 78%; (l) NaHMDS, diethyl <i>p</i>-toluenesulfonyloxy methylphosphonate THF, 0 °C–rt; yield = 62%; (m) TMS-Br, CH<sub>3</sub>CN, rt and then H<sub>2</sub>O, yield = 15%.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55131" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55131" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A series of methylenephosphonic acid analogs were synthesized in a systematic SAR study of CD73 inhibitors. Our structure-based design relied on information from the X-ray cocrystal structures of hCD73 with the known inhibitor AMPCP as well as our early lead methylenephosphonic acid <b>2n</b>. We have demonstrated that the bisphosphonic acid moiety can be successfully replaced with a methylenephosphonic acid on nucleoside-derived CD73 inhibitors. With additional modifications of the adenine base, improved potency and selectivity can be achieved. Our structure-guided approach led to systematic investigation of the C2 position to take advantage of a hydrophobic pocket and nucleobase modification to influence π–π stacking to boost potency. Similarly, we demonstrated that introduction of 4<i>-</i>fluoro-α-(<i>S</i>)-methylbenzylamine at C6 led to a remarkable improvement in rat PK properties. In combination with the results from our additional SAR studies on CD73 inhibitors in a related program,<a onclick="showRef(event, 'cit7c'); return false;" href="javascript:void(0);" class="ref cit7c">(7c)</a> currently in human clinical trials, this study describes progress toward understanding the molecular requirements for nucleotide-like small-molecule CD73 inhibitors and the discovery of several promising candidates against this promising therapeutic target.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45657" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45657" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Chemistry</h3><div class="NLM_p">All reactions were performed using a Teflon-coated magnetic stir bar at the indicated temperature and were conducted under an inert atmosphere when stated. All chemicals were used as received. Reactions were monitored by TLC (silica gel 60 with fluorescence F254, visualized with a short-wave/long-wave UV lamp) and/or liquid chromatography–mass spectrometry (LCMS, Agilent 1100 series LCMS with UV detection at 254 nm using a binary solvent system [0.1% trifluoroacetic acid (TFA) in MeCN/0.1% TFA in H<sub>2</sub>O] using either of the following columns: Agilent Eclipse Plus C18 [3.5 μm, 4.6 mm i.d. × 100 mm] or Aeris Widepore C4 [3.6 μm, 2.1 mm i.d. × 50 mm]). Flash chromatography was conducted on silica gel using an automated system (CombiFlash RF+ manufactured by Teledyne ISCO), with detection wavelengths of 254 and 280 nm. Reverse-phase preparative high-performance liquid chromatography (HPLC) was conducted on an Agilent 1260 Infinity series HPLC. Samples were eluted using a binary solvent system (0.1% TFA in MeCN/0.1% TFA in H<sub>2</sub>O) with gradient elution on a Gemini C18 110 Å column (21.2 mm i.d. × 250 mm) with detection at 254 nm. Final compounds obtained through preparative HPLC were concentrated through lyophilization. All reported yields are isolated yields. All assayed compounds were purified to ≥95% purity as determined by LCMS (Agilent 1100 series LCMS with UV detection at 254 nm using a binary solvent system [0.1% TFA in MeCN/0.1% TFA in H<sub>2</sub>O] using either of the following columns: Agilent Eclipse Plus C18 column [3.5 μm, 4.6 mm i.d. × 100 mm] or Aeris Widepore C4 column [3.6 μm, 2.1 mm i.d. × 50 mm]). <sup>1</sup>H NMR spectra were recorded on a Varian 400 MHz NMR spectrometer equipped with an Oxford AS400 magnet. Chemical shifts (δ) are reported as parts per million (ppm) relative to residual undeuterated solvent as an internal reference. The abbreviations s, br. s, d, t, q, dd, dt, ddd, and m stand for singlet, broad singlet, doublet, triplet, quartet, doublet of doublets, doublet of triplets, doublet of doublet of doublets, and multiplet, respectively.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 2-{[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-[6-(Benzylamino)-2-chloro-9<i>H</i>-purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy}propanedioic Acid (<b>1a</b>)</h4><div class="NLM_p">A mixture of 2,6-dichloro-9-[2,3-<i>O</i>-(1-methylethylidene)-β-<span class="smallcaps smallerCapital">d</span>-ribofuranosyl]-9<i>H</i>-purine <b>6</b> (1.05 g, 2.9 mmol), dimethyl 2-diazomalonate (648 mg, 4.1 mmol), and Rh<sub>2</sub>(OAc)<sub>4</sub> (128 mg, 0.29 mmol) in toluene (50 mL) was stirred at 100 °C overnight. After cooling to rt, the solvent was evaporated from the reaction mixture and the crude material was purified by column chromatography to obtain <b>7</b> as a yellow oil in 60% yield (850 mg). ESI MS [M + H]<sup>+</sup> for C<sub>18</sub>H<sub>20</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>0</sub>, calcd 491.1, found 490.8.</div><div class="NLM_p">A mixture of <b>7</b> (420 mg, 0.86 mmol), benzylamine (98 μL, 0.9 mmol), and triethylamine (125 μL, 0.9 mmol) in EtOH (5 mL) was stirred at rt overnight. The solvent was evaporated from the reaction mixture, and the crude product <b>9</b> was used in the next step without purification. ESI MS [M + H]<sup>+</sup> for C<sub>25</sub>H<sub>29</sub>ClN<sub>5</sub>O<sub>8</sub>, calcd 562.2, found 562.2.</div><div class="NLM_p">The crude product <b>9</b> was dissolved in anhydrous CH<sub>3</sub>CN (10 mL). TMS-Br (1.0 mL) was added, and the reaction was stirred at rt overnight. Then, it was quenched with H<sub>2</sub>O (2 mL) and stirred at rt for 4 h or until LCMS analysis showed complete cleavage of the acetonide protecting group. The reaction mixture was evaporated and purified by reverse-phase HPLC (C18 column, 0–30% gradient of acetonitrile and water with 0.1% TFA) to give the product <b>11</b> as a white solid in 38% yield (210 mg) over two steps: ESI MS [M + H]<sup>+</sup> for C<sub>22</sub>H<sub>24</sub>ClN<sub>5</sub>O<sub>8</sub>, calcd 522.1, found 522.2.</div><div class="NLM_p last">Compound <b>11</b> (170 mg, 0.27 mmol) was dissolved in 4 mL of a 1:1 mixture of THF and H<sub>2</sub>O. To this mixture was added LiOH·H<sub>2</sub>O (46 mg, 1.1 mmol) and was stirred overnight at rt and then neutralized with AcOH. The solvent was evaporated from the reaction mixture, and the crude material was purified by reverse-phase HPLC (C18 column, 0–30% gradient of acetonitrile and water with 0.1% TFA) to give the product <b>1a</b> as a white solid in 89% yield (145 mg) over two steps: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.92 (t, <i>J</i> = 6.2 Hz, 1H), 8.57 (s, 1H), 7.40–7.17 (m, 5H), 5.87 (d, <i>J</i> = 6.3 Hz, 1H), 4.65 (t, <i>J</i> = 5.5 Hz, 1H), 4.59 (d, <i>J</i> = 9.4 Hz, 2H), 4.17 (dd, <i>J</i> = 4.8, 2.7 Hz, 1H), 4.10 (q, <i>J</i> = 3.0 Hz, 1H), 3.76 (dd, <i>J</i> = 10.4, 3.1 Hz, 1H), 3.65 (dd, <i>J</i> = 10.6, 3.3 Hz, 1H). ESI MS [M + H]<sup>+</sup> for C<sub>20</sub>H<sub>20</sub>ClN<sub>5</sub>O<sub>8</sub>, calcd 494.1, found 494.1.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 2-{[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-[6-(Benzylamino)-2-chloro-9<i>H</i>-purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy}-2-phosphonoacetic Acid (<b>1b</b>)</h4><div class="NLM_p last">Compound <b>1b</b> was synthesized in a similar fashion to example <b>1a</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.93 (dt, <i>J</i> = 12.6, 6.4 Hz, 1H), 8.61 (d, <i>J</i> = 7.2 Hz, 1H), 7.43–7.17 (m, 5H), 5.86 (d, <i>J</i> = 6.5 Hz, 1H), 4.74–4.53 (m, 2H), 4.19 (dd, <i>J</i> = 18.5, 4.2 Hz, 2H), 4.08 (q, <i>J</i> = 3.2 Hz, 1H), 3.85–3.60 (m, 2H). ESI MS [M + H]<sup>+</sup> for C<sub>19</sub>H<sub>21</sub>ClN<sub>5</sub>O<sub>9</sub>P, calcd 530.1, found 530.1.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-[6-(Benzylamino)-2-chloro-9<i>H</i>-purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy}methyl) Phosphonic Acid (<b>1c</b>)</h4><div class="NLM_p">A mixture of 2,6-dichloro-9-(2,3,5-tri-<i>O</i>-acetyl-β-<span class="smallcaps smallerCapital">d</span>-ribofuranosyl)purine <b>6</b> (29 g, 65 mmol), benzylamine (28.4 mL, 260 mmol), and triethylamine (9 mL, 165 mmol) in EtOH (200 mL) was stirred at rt for overnight. Then, 7 M NH<sub>3</sub> in MeOH (50 mL) was added to the above reaction and was stirred at rt for 24 h. The solvent was evaporated, and the mixture was reconstituted in 400 mL of EtOAc and 300 mL of H<sub>2</sub>O. Layers were separated, and the aqueous layer was extracted with EtOAc (2 × 300 mL). The combined organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated, and purified by silica gel chromatography give <b>14</b> as a white solid in 55% yield (14 g). ESI MS [M + H]<sup>+</sup> for C<sub>17</sub>H<sub>19</sub>ClN<sub>5</sub>O<sub>4</sub>, calcd 392.1, found 392.1.</div><div class="NLM_p">Compound <b>14</b> (5.6 g, 14.3 mmol) was dissolved in acetone (100 mL) and 2,2-dimethoxypropane (30 mL). To this mixture was added <i>p</i>-TsOH·H<sub>2</sub>O (3.4 g, 17.9 mmol). The reaction mixture was stirred at rt overnight, diluted with brine (100 mL), and carefully quenched with saturated NaHCO<sub>3</sub> (200 mL). After extraction with EtOAc (2 × 200 mL), combined organics were dried over MgSO<sub>4</sub> and evaporated to give the crude product <b>15</b> (6.1 g), which was used in the next step without purification. ESI MS [M + H]<sup>+</sup> for C<sub>20</sub>H<sub>22</sub>ClN<sub>5</sub>O<sub>4</sub>, calcd 432.1, found 432.1.</div><div class="NLM_p">A sample of the crude product <b>15</b> (431.5 mg, 1 mmol) was dissolved in anhydrous DMF (5 mL) and cooled to 0 °C; then, 60% NaH (60 mg, 1.5 mmol) was added and the reaction mixture was stirred at 0 °C for 1 h. Diethyl <i>p</i>-toluenesulfonyloxy methylphosphonate (386 mg, 1.2 mmol, 1.2 equiv) was added, and the reaction was slowly warmed up to rt and stirred overnight. H<sub>2</sub>O (20 mL) was added to dilute the reaction mixture and extracted with MTBE (2 × 10 mL). The combined organics were dried over MgSO<sub>4</sub>, filtered, and evaporated to give crude product <b>16</b>, which was used in the next step without purification. ESI MS [M + H]<sup>+</sup> for C<sub>25</sub>H<sub>33</sub>ClN<sub>5</sub>O<sub>7</sub>P, calcd 582.2, found 582.1.</div><div class="NLM_p last">All of the crude product <b>16</b> was dissolved in anhydrous CH<sub>3</sub>CN (5 mL), TMS-Br (0.5 mL) was added, and the reaction was stirred at rt overnight. It was quenched with H<sub>2</sub>O (1 mL) and stirred at rt for 4 h or until LCMS analysis showed complete cleavage of the acetonide protecting group. The reaction mixture was evaporated and purified by reverse-phase HPLC (C18 column, 0–30% gradient of acetonitrile and water with 0.1% TFA) to give the product <b>1c</b> as a white solid in 20% yield (123 mg) over three steps: %: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.93 (t, <i>J</i> = 6.2 Hz, 1H), 8.44 (s, 1H), 7.37–7.22 (m, 5H), 5.85 (d, <i>J</i> = 6.0 Hz, 1H), 4.68–4.61 (m, 2H), 4.54 (t, <i>J</i> = 5.5 Hz, 1H), 4.15–4.09 (m, 1H), 4.05 (q, <i>J</i> = 3.8 Hz, 1H), 3.77–3.65 (m, 2H), 3.61 (d, <i>J</i> = 8.9 Hz, 2H). ESI MS [M + H]<sup>+</sup> for C<sub>18</sub>H<sub>22</sub>ClN<sub>5</sub>O<sub>7</sub>P, calcd 486.1, found 486.2.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (2-{[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-[6-(Benzylamino)-2-chloro-9<i>H</i>-purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy}ethyl)phosphonic Acid (<b>1d</b>)</h4><div class="NLM_p last">Compound <b>1d</b> was synthesized in a similar fashion to example <b>1c</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.46 (d, <i>J</i> = 29.8 Hz, 1H), 7.31 (m, 6H), 5.87 (d, <i>J</i> = 5.8 Hz, 1H), 5.71–5.41 (m, 1H), 4.97 (d, <i>J</i> = 12.7 Hz, 1H), 4.65–3.25 (m, 7H), 2.13–1.84 (m, 2H). ESI MS [M + H]<sup>+</sup> for C<sub>19</sub>H<sub>23</sub>ClN<sub>5</sub>O<sub>7</sub>P, calcd 500.1, found 500.1.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (3-{[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-[6-(Benzylamino)-2-chloro-9<i>H</i>-purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy}propyl)phophonic Acid (<b>1e</b>)</h4><div class="NLM_p last">Compound <b>1e</b> was synthesized in a similar fashion to example <b>1c</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.39 (d, <i>J</i> = 32.3 Hz, 1H), 7.34–7.05 (m, 5H), 5.80 (d, <i>J</i> = 6.1 Hz, 1H), 5.48 (q, <i>J</i> = 16.6 Hz, 1H), 5.02–4.71 (m, 1H), 4.55–4.36 (m, 1H), 4.18–3.93 (m, 2H), 3.88 (q, <i>J</i> = 3.8 Hz, 1H), 3.70–3.22 (m, 3H), 1.88–1.39 (m, 4H). ESI MS [M + H]<sup>+</sup> for C<sub>20</sub>H<sub>25</sub>ClN<sub>5</sub>O<sub>7</sub>P, calcd 514.1, found 514.1.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-{2-Chloro-6-[(2-phenylethyl)amino]-9<i>H</i>-purin-9-yl}-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>2a</b>)</h4><div class="NLM_p last">Compound <b>2a</b> was synthesized in a similar fashion to example <b>1c</b> as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.50–8.33 (m, 2H), 7.33–7.17 (m, 5H), 5.84 (d, <i>J</i> = 6.1 Hz, 1H), 4.54 (t, <i>J</i> = 5.5 Hz, 1H), 4.12 (dd, <i>J</i> = 4.9, 3.2 Hz, 1H), 4.05 (q, <i>J</i> = 3.7 Hz, 1H), 3.79–3.57 (m, 6H), 2.92 (t, <i>J</i> = 7.4 Hz, 2H). ESI MS [M + H]<sup>+</sup> for C<sub>19</sub>H<sub>24</sub>ClN<sub>5</sub>O<sub>7</sub>P, calcd 500.1, found 500.2.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(2-Chloro-6-{[2-(2-methoxyphenyl)ethyl]amino}-9<i>H</i>-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]metoxy}methyl)phosphonic Acid (<b>2b</b>)</h4><div class="NLM_p last">Compound <b>2b</b> was synthesized in a similar fashion to example <b>1c</b> as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.46–8.33 (m, 2H), 7.22–7.11 (m, 2H), 6.96 (d, <i>J</i> = 8.2 Hz, 1H), 6.84 (t, <i>J</i> = 7.4 Hz, 1H), 5.84 (d, <i>J</i> = 6.1 Hz, 1H), 4.57–4.51 (m, 1H), 4.12 (dd, <i>J</i> = 4.9, 3.2 Hz, 1H), 4.05 (q, <i>J</i> = 3.7 Hz, 1H), 3.82–3.56 (m, 9H), 2.89 (t, <i>J</i> = 7.3 Hz, 2H). ESI MS [M + H]<sup>+</sup> for C<sub>20</sub>H<sub>26</sub>ClN<sub>5</sub>O<sub>8</sub>P, calcd 530.1, found 530.2.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(2-Chloro-6-{[2-(2-fluorophenyl)ethyl]amino}-9<i>H</i>-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>2c</b>)</h4><div class="NLM_p last">Compound <b>2c</b> was synthesized in a similar fashion to example <b>1c</b> as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.54–8.39 (m, 2H), 7.33–7.07 (m, 5H), 5.84 (d, <i>J</i> = 6.1 Hz, 1H), 4.57–4.52 (m, 1H), 4.12 (dd, <i>J</i> = 4.9, 3.2 Hz, 1H), 4.05 (q, <i>J</i> = 3.8 Hz, 1H), 3.77–3.57 (m, 6H), 2.96 (t, <i>J</i> = 7.2 Hz, 2H). ESI MS [M + H]<sup>+</sup> for C<sub>19</sub>H<sub>23</sub>ClFN<sub>5</sub>O<sub>7</sub>P, calcd 518.1, found 518.2.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(2-Chloro-6-{[(1<i>S</i>)-1-phenylethyl]amino}-9<i>H</i>-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>2d</b>)</h4><div class="NLM_p last">Compound <b>2d</b> was synthesized in a similar fashion to example <b>1c</b> as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.89 (d, <i>J</i> = 8.4 Hz, 1H), 8.45 (s, 1H), 7.43 (d, <i>J</i> = 7.5 Hz, 2H), 7.31 (t, <i>J</i> = 7.6 Hz, 2H), 7.21 (t, <i>J</i> = 7.3 Hz, 1H), 5.84 (d, <i>J</i> = 6.0 Hz, 1H), 5.41 (p, <i>J</i> = 7.6 Hz, 1H), 4.51 (t, <i>J</i> = 5.4 Hz, 1H), 4.15–4.08 (m, 1H), 4.07–4.01 (m, 1H), 3.78–3.65 (m, 2H), 3.61 (d, <i>J</i> = 9.0 Hz, 2H), 1.54 (d, <i>J</i> = 7.0 Hz, 3H). ESI MS [M + H]<sup>+</sup> for C<sub>19</sub>H<sub>24</sub>ClN<sub>5</sub>O<sub>7</sub>P, calcd 500.1, found 500.2.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(2-Chloro-6-{[(1<i>R</i>)-1-phenylethyl]amino}-9<i>H</i>-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>2e</b>)</h4><div class="NLM_p last">Compound <b>2e</b> was synthesized in a similar fashion to example <b>1c</b> as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.89 (d, <i>J</i> = 8.4 Hz, 1H), 8.46 (s, 1H), 7.44 (d, <i>J</i> = 7.4 Hz, 2H), 7.31 (t, <i>J</i> = 7.6 Hz, 2H), 7.21 (t, <i>J</i> = 7.2 Hz, 1H), 5.84 (d, <i>J</i> = 6.1 Hz, 1H), 5.41 (p, <i>J</i> = 7.6 Hz, 1H), 4.54 (t, <i>J</i> = 5.5 Hz, 1H), 4.15–4.07 (m, 1H), 4.07–4.01 (m, 1H), 3.77–3.65 (m, 2H), 3.61 (dd, <i>J</i> = 8.9, 1.8 Hz, 2H), 1.54 (d, <i>J</i> = 6.9 Hz, 3H). ESI MS [M + H]<sup>+</sup> for C<sub>19</sub>H<sub>24</sub>ClN<sub>5</sub>O<sub>7</sub>P, calcd 500.1, found 500.2.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(2-Chloro-6-{[(2-chlorophenyl)methyl]amino}-9<i>H</i>-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>2f</b>)</h4><div class="NLM_p last">Compound <b>2f</b> was synthesized in a similar fashion to example <b>1c</b> as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.97–8.90 (m, 1H), 8.49 (s, 1H), 7.50–7.43 (m, 1H), 7.33–7.25 (m, 3H), 5.87 (d, <i>J</i> = 6.0 Hz, 1H), 4.75–4.67 (m, 2H), 4.56 (t, <i>J</i> = 5.5 Hz, 1H), 4.16–4.02 (m, 2H), 3.78–3.65 (m, 2H), 3.62 (d, <i>J</i> = 8.9 Hz, 2H). ESI MS [M + H]<sup>+</sup> for C<sub>18</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>7</sub>P, calcd 520.1, found 520.1.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(2-Chloro-6-{[(2-chlorophenyl)methyl](methyl)amino}-9<i>H</i>-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>2g</b>)</h4><div class="NLM_p last">Compound <b>2g</b> was synthesized in a similar fashion to example <b>1c</b> as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.56–8.33 (m, 1H), 7.54–7.48 (m, 1H), 7.36–7.27 (m, 2H), 7.23–7.08 (m, 1H), 5.88 (d, <i>J</i> = 6.1 Hz, 1H), 5.63 (s, 1H), 5.00 (s, 1H), 4.54 (s, 1H), 4.15–4.01 (m, 2H), 3.78–3.55 (m, 5H), 3.17 (s, 2H). ESI MS [M + H]<sup>+</sup> for C<sub>19</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>7</sub>P, calcd 534.1, found 534.1</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-{2-Chloro-6-[(pyridin-2-ylmethyl)amino]-9<i>H</i>-purin-9-yl}-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>2h</b>)</h4><div class="NLM_p last">Compound <b>2h</b> was synthesized in a similar fashion to example <b>1c</b> as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.05 (t, <i>J</i> = 6.2 Hz, 1H), 8.82–8.78 (m, 1H), 8.72–8.68 (m, 1H), 8.49 (s, 1H), 8.26 (d, <i>J</i> = 8.1 Hz, 1H), 7.83–7.76 (m, 1H), 5.86 (d, <i>J</i> = 6.1 Hz, 1H), 4.78 (d, <i>J</i> = 6.0 Hz, 2H), 4.54 (dd, <i>J</i> = 6.1, 4.9 Hz, 1H), 4.12 (dd, <i>J</i> = 4.9, 3.2 Hz, 1H), 4.05 (q, <i>J</i> = 3.7 Hz, 1H), 3.77–3.66 (m, 2H), 3.61 (dd, <i>J</i> = 8.9, 1.5 Hz, 2H). ESI MS [M + H]<sup>+</sup> for C<sub>17</sub>H<sub>21</sub>ClN<sub>6</sub>O<sub>7</sub>P, calcd 487.1, found 487.1.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(2-Chloro-6-{[(1-methyl-1<i>H</i>-pyrazol-4-yl)methyl]amino}-9<i>H</i>-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>2i</b>)</h4><div class="NLM_p last">Compound <b>2i</b> was synthesized in a similar fashion to example <b>1c</b> as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.72 (t, <i>J</i> = 6.1 Hz, 1H), 8.43 (s, 1H), 7.58 (s, 1H), 7.38 (s, 1H), 5.84 (d, <i>J</i> = 6.0 Hz, 1H), 4.54 (t, <i>J</i> = 5.5 Hz, 1H), 4.48–4.43 (m, 2H), 4.12 (dd, <i>J</i> = 4.9, 3.3 Hz, 1H), 4.05 (q, <i>J</i> = 3.7 Hz, 1H), 3.76 (s, 3H), 3.75–3.65 (m, 2H), 3.62 (d, <i>J</i> = 8.9 Hz, 2H). ESI MS [M + H]<sup>+</sup> for C<sub>16</sub>H<sub>22</sub>ClN<sub>7</sub>O<sub>7</sub>P, calcd 490.1, found 490.2.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(2-Chloro-6-{[(4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl]amino}-9<i>H</i>-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>2j</b>)</h4><div class="NLM_p last">Compound <b>2j</b> was synthesized in a similar fashion to example <b>1c</b> as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.12–8.99 (m, 2H), 8.51 (s, 1H), 5.86 (d, <i>J</i> = 6.1 Hz, 1H), 4.87 (s, 2H), 4.54 (t, <i>J</i> = 5.5 Hz, 1H), 4.12 (dd, <i>J</i> = 4.9, 3.2 Hz, 1H), 4.06 (q, <i>J</i> = 3.7 Hz, 1H), 3.86 (s, 3H), 3.77–3.65 (m, 2H), 3.61 (dd, <i>J</i> = 8.9, 1.6 Hz, 2H). ESI MS [M + H]<sup>+</sup> for C<sub>15</sub>H<sub>21</sub>ClN<sub>8</sub>O<sub>7</sub>P, calcd 491.1, found 491.2.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-{2-Chloro-6-[(propan-2-yl)amino]-9<i>H</i>-purin-9-yl}-3,4-dihydroxyoxolan-2-yl]methoxy}methyl) Phosphonic Acid (<b>2k</b>)</h4><div class="NLM_p last">Compound <b>2k</b> was synthesized in a similar fashion to example <b>1c</b> as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.67 (s, 1H), 8.21–8.09 (m, 1H), 5.79 (d, <i>J</i> = 7.1 Hz, 1H), 4.23 (dd, <i>J</i> = 4.8, 1.9 Hz, 1H), 4.02 (s, 1H), 3.66–3.50 (m, 3H), 3.42–3.19 (m, 3H), 1.21 (dd, <i>J</i> = 6.5, 2.1 Hz, 6H). ESI MS [M + H]<sup>+</sup> for C<sub>14</sub>H<sub>22</sub>ClN<sub>5</sub>O<sub>7</sub>P, calcd 438.1, found 438.1.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-[2-Chloro-6-(cyclopropylamino)-9<i>H</i>-purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>2l</b>)</h4><div class="NLM_p last">Compound <b>2l</b> was synthesized in a similar fashion to example <b>1c</b> as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.53 (s, 1H), 8.42 (s, 1H), 5.85 (d, <i>J</i> = 6.0 Hz, 1H), 4.54 (t, <i>J</i> = 5.5 Hz, 1H), 4.12 (dd, <i>J</i> = 4.9, 3.2 Hz, 1H), 4.05 (q, <i>J</i> = 3.7 Hz, 1H), 3.77–3.65 (m, 2H), 3.61 (dd, <i>J</i> = 8.9, 1.4 Hz, 2H), 2.97 (s, 1H), 0.84–0.56 (m, 4H). ESI MS [M + H]<sup>+</sup> for C<sub>14</sub>H<sub>20</sub>ClN<sub>5</sub>O<sub>7</sub>P, calcd 436.1, found 436.1.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-[2-Chloro-6-(cyclobutylamino)-9<i>H</i>-purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>2m</b>)</h4><div class="NLM_p last">Compound <b>2m</b> was synthesized in a similar fashion to example <b>1c</b> as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.67 (d, <i>J</i> = 7.7 Hz, 1H), 8.43 (s, 1H), 5.84 (d, <i>J</i> = 5.9 Hz, 1H), 4.61 (q, <i>J</i> = 8.1 Hz, 1H), 4.56–4.50 (m, 1H), 4.15–4.09 (m, 1H), 4.05 (q, <i>J</i> = 3.7 Hz, 1H), 3.78–3.65 (m, 2H), 3.61 (d, <i>J</i> = 8.8 Hz, 2H), 2.35–2.00 (m, 4H), 1.74–1.61 (m, 2H). ESI MS [M + H]<sup>+</sup> for C<sub>15</sub>H<sub>22</sub>ClN<sub>5</sub>O<sub>7</sub>P, calcd 450.1, found 450.1.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-[2-Chloro-6-(cyclopentylamino)-9<i>H</i>-purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>2n</b>)</h4><div class="NLM_p last">Compound <b>2n</b> was synthesized in a similar fashion to example <b>1c</b> as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ 8.41 (s, 1H), 8.39–8.26 (m, 1H), 5.84 (d, <i>J</i> = 5.9 Hz, 1H), 4.53 (t, <i>J</i> = 5.5 Hz, 1H), 4.48–4.35 (m, 1H), 4.12 (dd, <i>J</i> = 4.9, 3.3 Hz, 1H), 4.05 (q, <i>J</i> = 3.8 Hz, 1H), 3.79–3.65 (m, 2H), 3.62 (d, <i>J</i> = 8.9 Hz, 2H), 2.05–1.85 (m, 2H), 1.78–1.44 (m, 6H). ESI MS [M + H]<sup>+</sup> for C<sub>16</sub>H<sub>24</sub>ClN<sub>5</sub>O<sub>7</sub>P, calcd 464.1, found 464.2.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-{2-Chloro-6-[(cyclopentylmethyl)amino]-9<i>H</i>-purin-9-yl}-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>2o</b>)</h4><div class="NLM_p last">Compound <b>2o</b> was synthesized in a similar fashion to example <b>1c</b> as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.45 (t, <i>J</i> = 2.4 Hz, 1H), 8.41 (s, 1H), 5.84 (d, <i>J</i> = 6.0 Hz, 1H), 4.61–4.47 (m, 1H), 4.12 (t, <i>J</i> = 4.1 Hz, 1H), 4.04 (d, <i>J</i> = 3.7 Hz, 1H), 3.85–3.51 (m, 5H), 3.36 (m, 1H), 2.38–2.13 (m, 1H), 1.77–1.39 (m, 6H), 1.34–1.12 (m, 2H). ESI MS [M + H] for C<sub>17</sub>H<sub>25</sub>ClN<sub>5</sub>O<sub>7</sub>P, calcd 478.1, found 478.2.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-[2-Chloro-6-(pyrrolidin-1-yl)-9<i>H</i>-purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>2p</b>)</h4><div class="NLM_p last">Compound <b>2p</b> was synthesized in a similar fashion to example <b>1c</b> as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.41 (s, 1H), 5.86 (d, <i>J</i> = 6.1 Hz, 1H), 4.53 (dd, <i>J</i> = 6.2, 4.9 Hz, 1H), 4.11 (dd, <i>J</i> = 4.9, 3.2 Hz, 1H), 4.09–4.00 (m, 3H), 3.76–3.65 (m, 2H), 3.65–3.56 (m, 4H), 2.05–1.86 (m, 4H). ESI MS [M + H]<sup>+</sup> for C<sub>15</sub>H<sub>22</sub>ClN<sub>5</sub>O<sub>7</sub>P, calcd 450.1, found 450.2.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(2-Chloro-6-{[(3<i>R</i>)-oxolan-3-yl]amino}-9<i>H</i>-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>2q</b>)</h4><div class="NLM_p last">Compound <b>2q</b> was synthesized in a similar fashion to example <b>1c</b> as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.63–8.51 (m, 1H), 8.45 (s, 1H), 5.86 (d, <i>J</i> = 6.0 Hz, 1H), 4.63 (s, 1H), 4.57–4.51 (m, 1H), 4.12 (dd, <i>J</i> = 4.9, 3.3 Hz, 1H), 4.05 (q, <i>J</i> = 3.7 Hz, 1H), 3.96–3.83 (m, 2H), 3.79–3.66 (m, 3H), 3.62 (d, <i>J</i> = 8.9 Hz, 3H), 2.29–1.83 (m, 2H). ESI MS [M + H]<sup>+</sup> for C<sub>15</sub>H<sub>22</sub>ClN<sub>5</sub>O<sub>8</sub>P, calcd 466.1, found 466.1.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-[2-Chloro-6-(morpholin-4-yl)-9<i>H</i>-purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>2r</b>)</h4><div class="NLM_p last">Compound <b>2r</b> was synthesized in a similar fashion to example <b>1c</b> as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.77 (s, 1H), 5.82 (d, <i>J</i> = 7.5 Hz, 1H), 5.14 (dd, <i>J</i> = 7.5, 4.7 Hz, 1H), 4.27–4.21 (m, 1H), 4.05–4.00 (m, 1H), 3.78–3.66 (m, 4H), 3.61–3.48 (m, 2H), 3.35 (dd, <i>J</i> = 12.1, 7.6 Hz, 1H), 3.27–3.15 (m, 1H). ESI MS [M + H]<sup>+</sup> for C<sub>15</sub>H<sub>22</sub>ClN<sub>5</sub>O<sub>8</sub>P, calcd 466.1, found 466.1.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-[6-(Cyclopentylamino)-2-phenyl-9<i>H</i>-purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>3a</b>)</h4><div class="NLM_p">A mixture of 2,6-dichloro-9-(2,3,5-tri-<i>O</i>-acetyl-β-<span class="smallcaps smallerCapital">d</span>-ribofuranosyl)purine <b>13</b> (13.5 g, 30 mmol), cyclopentylamine (3.2 mL, 33 mmol), and triethylamine (4.6 mL, 33 mmol) in MeOH (60 mL) was stirred at rt overnight. Then, 7 M NH<sub>3</sub> in MeOH (20 mL) was added to the above reaction and stirred at rt for 1 day. The reaction mixture was evaporated, the crude product was redissolved in acetone (100 mL), and 2,2-dimethoxypropane (40 mL) and p-TsOH·H<sub>2</sub>O (7.1 g, 37.5 mmol) were added. The reaction mixture was stirred at rt overnight, diluted with brine (100 mL), and carefully quenched with saturated NaHCO<sub>3</sub> (200 mL). After extraction with EtOAc (2 × 200 mL), combined organics were dried over MgSO<sub>4</sub>, filtered, and evaporated to give crude acetonide (12.2 g), which was used in the next step without purification. A sample of the crude product (410 mg, 1 mmol) was dissolved in anhydrous DMF (5 mL) and cooled to 0 °C; then, 60% NaH (60 mg, 1.5 mmol) was added and the reaction mixture was stirred at 0 °C for 1 h. Diethyl <i>p</i>-toluenesulfonyloxy methylphosphonate (386 mg, 1.2 mmol, 1.2 equiv) was added, and the reaction was slowly warmed up to rt and stirred overnight. It was diluted with H<sub>2</sub>O (20 mL) and extracted with MTBE (2 × 10 mL); combined organics were dried over MgSO<sub>4</sub>, filtered, and evaporated to give the crude product <b>19</b>, which was used in the next step without purification. ESI MS [M + H]<sup>+</sup> for C<sub>23</sub>H<sub>36</sub>ClN<sub>5</sub>O<sub>7</sub>P, calcd 560.2, found 560.1.</div><div class="NLM_p">In a glass vial, compound <b>19</b> (250 mg, 0.45 mmol), phenylboronic acid (82 mg, 0.67 mmol), and sodium carbonate (142 mg, 3.75 mmol) were suspended in 3:1 THF/H<sub>2</sub>O (3 mL). This mixture was degassed by N<sub>2</sub> sparge for 10 min. Subsequently, Pd(PPh<sub>3</sub>)<sub>4</sub> (52 mg, 0.045 mmol) was added, and the resulting mixture was degassed for an additional 5 min and then sealed and heated to 80 °C overnight. After cooling to room temperature, the reaction was diluted with EtOAc and washed with water and brine. The organics were dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to obtain the crude product. ESI MS [M + H]<sup>+</sup> for C<sub>29</sub>H<sub>40</sub>N<sub>5</sub>O<sub>7</sub>P, calcd 602.3, found 602.4.</div><div class="NLM_p last">The crude product obtained above was dissolved in anhydrous CH<sub>3</sub>CN (2.5 mL), TMS-Br (0.25 mL) was added, and the reaction was stirred at rt overnight. It was quenched with H<sub>2</sub>O (0.25 mL) and stirred at rt for 4 h or until LCMS analysis showed complete cleavage of the acetonide protecting group. The reaction mixture was evaporated and purified by reverse-phase HPLC (C18 column, 0–30% gradient of acetonitrile and water with 0.1% TFA) to give the product <b>3a</b> as a white solid in 20% yield (46 mg). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.44–8.37 (m, 3H), 7.55–7.41 (m, 4H), 6.03 (d, <i>J</i> = 6.0 Hz, 1H), 4.73 (t, <i>J</i> = 5.6 Hz, 1H), 4.27–4.17 (m, 1H), 4.08 (app. q, <i>J</i> = 4.0 Hz, 1H), 3.89–3.74 (m, 1H), 3.70 (dd, <i>J</i> = 10.6, 4.8 Hz, 1H), 3.61 (d, <i>J</i> = 8.8 Hz, 2H), 3.52 (dd, <i>J</i> = 8.5, 3.6 Hz, 1H), 2.10–1.98 (m, 3H), 1.80–1.54 (m, 5H). ESI MS [M – H]<sup>−</sup> for C<sub>22</sub>H<sub>28</sub>N<sub>5</sub>O<sub>7</sub>P, calcd 504.2, found 504.3.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-[6-(Cyclopentylamino)-2-(2-methyl phenyl)-9<i>H</i>-purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>3b</b>)</h4><div class="NLM_p last">Compound <b>3b</b> was synthesized in a similar fashion to example <b>3a</b> as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.49 (s, 1H), 7.55–7.09 (m, 4H), 5.97 (d, <i>J</i> = 5.8 Hz, 1H), 4.64 (t, <i>J</i> = 5.4 Hz, 1H), 4.32–4.08 (m, 1H), 4.05 (app. q, <i>J</i> = 3.9 Hz, 1H), 3.75 (dd, <i>J</i> = 10.7, 3.6 Hz, 1H), 3.68 (dd, <i>J</i> = 10.7, 4.6 Hz, 1H), 3.60 (dd, <i>J</i> = 8.9, 1.9 Hz, 2H), 1.97 (br. s, 3H), 1.80–1.45 (m, 8H). ESI MS [M – H]<sup>−</sup> for C<sub>23</sub>H<sub>30</sub>N<sub>5</sub>O<sub>7</sub>P, calcd 518.2, found 518.2.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-[6-(Cyclopentylamino)-2-(methoxymethyl)-9<i>H</i>-purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>3c</b>)</h4><div class="NLM_p">In a round-bottom flask, compound <b>19</b> (1.5 g, 2.68 mmol), phenylvinylboronic acid (595 mg, 4.02 mmol), and sodium carbonate (845 mg, 8.04 mmol) were suspended in 3:1 THF/H<sub>2</sub>O (15 mL). This mixture was degassed by N<sub>2</sub> sparge for 10 min. Subsequently, Pd(PPh<sub>3</sub>)<sub>4</sub> (310 mg, 0.27 mmol) was added, and the resulting mixture was degassed for an additional 5 min and then heated to reflux overnight. After cooling to rt, the reaction was diluted with EtOAc and washed with water and brine. The organics were dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to obtain the crude product <b>20</b> (1.89 g), which was used directly in the following step without purification. ESI MS [M + H]<sup>+</sup> for C<sub>31</sub>H<sub>42</sub>N<sub>5</sub>O<sub>7</sub>P, calcd 628.3, found 628.4.</div><div class="NLM_p">To a suspension of the crude product <b>20</b> (1.62 g), sodium periodate (3.31 g, 15.48 mmol), and 2,6-lutidine (601 μL, 5.16 mmol) in 2:1 THF/H<sub>2</sub>O (28 mL) was added potassium osmate dihydrate (24 mg, 0.065 mmol). The resulting thick suspension was stirred overnight at room temperature and then partitioned between EtOAc and water. The organics were washed sequentially with water and brine, dried over MgSO<sub>4</sub>, and concentrated under reduced pressure to obtain the crude product <b>7</b>, which was used directly in the following step without purification. ESI MS [M + H]<sup>+</sup> for C<sub>24</sub>H<sub>36</sub>N<sub>5</sub>O<sub>8</sub>P, calcd 554.2, found 554.3.</div><div class="NLM_p">To a solution of the crude compound <b>21</b> (471 mg) in dichloroethane (5.7 mL) was added sodium triacetoxyborohydride (216 mg, 1.02 mmol) in a single portion. The reaction was stirred at room temperature overnight and then partitioned between EtOAc and water. The organics were washed with brine, dried over MgSO<sub>4</sub>, and concentrated under reduced pressure. The title compound <b>22</b> (285 mg, 60% for three steps) was obtained following column chromatography (SiO<sub>2</sub>, 0–15% gradient of MeOH and CH<sub>2</sub>Cl<sub>2</sub>). ESI MS [M + H]<sup>+</sup> for C<sub>24</sub>H<sub>38</sub>N<sub>5</sub>O<sub>8</sub>P, calcd 556.3, found 556.3.</div><div class="NLM_p">To a solution of compound <b>22</b> (285 mg, 0.51 mmol) in acetonitrile (5 mL) at 0 °C were added pyridine (125 μL, 1.54 mmol) followed by thionyl chloride (56 μL, 0.77 mmol). The reaction was kept at 0 °C for 1 h. Subsequently, saturated NaHCO<sub>3</sub> (aq) was added slowly until gas evolution ceased. The reaction was diluted with EtOAc and washed with sat. NaHCO<sub>3</sub>, water, and brine. The organics were dried over MgSO<sub>4</sub> and concentrated under reduced pressure. The title compound <b>23</b> (115 mg, 40%) was obtained following column chromatography (SiO<sub>2</sub>, 0–10% gradient of MeOH and CH<sub>2</sub>Cl<sub>2</sub>). ESI MS [M + H]<sup>+</sup> for C<sub>24</sub>H<sub>37</sub>ClN<sub>5</sub>O<sub>7</sub>P, calcd 574.2, found 574.3.</div><div class="NLM_p">To a flask charged with compound <b>23</b> (115 mg, 0.20 mmol) in methanol (5 ml) was added potassium carbonate (138 mg, 1.0 mmol). The resulting suspension was stirred overnight at room temperature, diluted with EtOAc, and washed with water and brine. The organics were dried over MgSO<sub>4</sub> and concentrated under reduced pressure. The crude mixture (35 mg) so obtained comprised the desired product as well as an inconsequential mixture of methyl-phosphonates resulting from transesterification. ESI MS [M + H]<sup>+</sup> for C<sub>25</sub>H<sub>40</sub>N<sub>5</sub>O<sub>8</sub>P, calcd 570.3, found 570.3.</div><div class="NLM_p last">The crude product obtained above (35 mg) was dissolved in anhydrous CH<sub>3</sub>CN (2.5 mL), TMS-Br (0.25 mL) was added, and the reaction was stirred at rt for 1.5 h. It was quenched with H<sub>2</sub>O (0.25 mL) and stirred at rt for 1 h or until LCMS analysis showed complete cleavage of the acetonide protecting group. The reaction mixture was evaporated and purified by reverse-phase HPLC (C18 column, 0–30% gradient of acetonitrile and water with 0.1% TFA) to give the product <b>3c</b> as a white solid in 13% yield (12 mg), two steps: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.48 (br. s, 1H), 5.94 (d, <i>J</i> = 6.2 Hz, 1H), 4.61 (t, <i>J</i> = 5.6 Hz, 1H), 4.42 (s, 3H), 4.15 (dd, <i>J</i> = 4.9, 3.1 Hz, 1H), 4.05 (t, <i>J</i> = 3.8 Hz, 1H), 3.82–3.65 (m, 2H), 3.61 (d, <i>J</i> = 8.9 Hz, 2H), 3.39 (d, <i>J</i> = 1.3 Hz, 3H), 1.97 (br. s, 2H), 1.82–1.65 (m, 2H), 1.58 (br. s, 4H). ESI MS [M – H]<sup>−</sup> for C<sub>18</sub>H<sub>28</sub>N<sub>5</sub>O<sub>8</sub>P, calcd 472.2, found 472.3.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-[6-(Cyclopentylamino)-2-(phenoxy methyl)-9<i>H</i>-purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>3d</b>)</h4><div class="NLM_p last">Compound <b>3d</b> was synthesized in a similar fashion to example <b>3c</b> as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.33 (s, 1H), 7.30–7.12 (m, 3H), 6.93 (d, <i>J</i> = 7.8 Hz, 2H), 6.84 (t, <i>J</i> = 7.3 Hz, 1H), 5.84 (d, <i>J</i> = 5.9 Hz, 1H), 4.99 (s, 3H), 4.53 (dd, <i>J</i> = 6.1, 5.0 Hz, 1H), 4.07 (dd, <i>J</i> = 5.0, 3.4 Hz, 1H), 3.95 (q, <i>J</i> = 3.9 Hz, 1H), 3.65 (dd, <i>J</i> = 10.7, 3.7 Hz, 1H), 3.59–3.49 (m, 3H), 1.81 (s, 3H), 1.63 (br. s, 3H), 1.46 (br. s, 5H). ESI MS [M + H]<sup>+</sup> for C<sub>23</sub>H<sub>30</sub>N<sub>5</sub>O<sub>8</sub>P, calcd 536.2, found 536.3.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-[6-(Cyclopentylamino)-2-[(pyrrolidin-3-yloxy)methyl]-9<i>H</i>-purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>3e</b>)</h4><div class="NLM_p">To a vial containing 1-boc-3-hydroxypyrrolidine (107 mg, 0.57 mmol) in DMF (1.5 mL) was added sodium hydride (60 wt % oil dispersion, 23 mg, 0.57 mmol). After 2 min, compound <b>23</b> (65 mg, 0.11 mmol) in DMF (500 μL) was added and the reaction was stirred overnight at rt. The reaction was quenched with water, diluted with EtOAc, and washed with water and brine. The organics were dried over MgSO<sub>4</sub> and concentrated under reduced pressure. The crude product <b>24</b> was used directly in the following step without further purification. ESI MS [M + H]<sup>+</sup> for C<sub>33</sub>H<sub>53</sub>N<sub>6</sub>O<sub>10</sub>P, calcd 724.4, found 725.4.</div><div class="NLM_p last">All of the crude product <b>24</b> was dissolved in anhydrous CH<sub>3</sub>CN (3.0 mL), TMS-Br (0.3 mL) was added, and the reaction was stirred at rt for 1.5 h. It was quenched with H<sub>2</sub>O (0.3 mL) and stirred at rt for 4 h or until LCMS analysis showed complete cleavage of the acetonide and BOC protecting groups. The reaction mixture was evaporated and purified by reverse-phase HPLC (C18 column, 0–30% gradient of acetonitrile and water with 0.1% TFA) to give the product <b>3e</b> as a white solid in 15% yield (9 mg, two steps): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.00 (s, 1H), 8.82 (s, 1H), 5.91 (d, <i>J</i> = 6.1 Hz, 1H), 4.62 (t, <i>J</i> = 5.6 Hz, 1H), 4.54–4.41 (m, 4H), 4.16 (t, <i>J</i> = 4.1 Hz, 1H), 4.04 (q, <i>J</i> = 4.0 Hz, 1H), 3.78–3.67 (m, 2H), 3.61 (d, <i>J</i> = 8.8 Hz, 2H), 3.40–3.13 (m, 5H), 2.20–2.09 (m, 1H), 2.04–1.88 (m, 4H), 1.66–1.47 (m, 4H). ESI MS [M – H]<sup>−</sup> for C<sub>21</sub>H<sub>33</sub>N<sub>6</sub>O<sub>8</sub>P, calcd 527.2, found 527.4.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-[6-Chloro-4-(cyclopentylamino)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>4a</b>)</h4><div class="NLM_p">The mixture of 4,6-dichloro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine <b>25</b> (47.7 g, 252.4 mmol) and (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub> (300 mg) in HMDS (200 mL) was stirred under reflux for 5 h and then concentrated under a vacuum to give a dark-brown oil that was immediately used in the next step. The crude TMS-protected heterocycle was dissolved in anhydrous CH<sub>3</sub>CN (500 mL), and 1,2,3,5-tetraacetate-β-<span class="smallcaps smallerCapital">d</span>-ribofuranose (88.3 g, 277.6 mmol) was added. The reaction mixture was stirred at rt until all starting materials dissolved, and then, TfO-TMS (68.3 mL, 378.6 mmol) was added dropwise. It was stirred at rt overnight, concentrated under a vacuum to ∼50% of the original volume, and then carefully quenched with saturated NaHCO<sub>3</sub> (1 L) and extracted with EtOAc (3 × 500 mL). Combined organics were dried over MgSO<sub>4</sub>, filtered, and evaporated to give a dark-brown oil that was purified by column chromatography (SiO<sub>2</sub>, hexane/EtOAc, 100–40%) to give <b>27</b> (yellow oil, 28.5 g, 25%). ESI MS [M + Na]<sup>+</sup> for C<sub>16</sub>H<sub>16</sub>Cl<sub>2</sub>N<sub>4</sub>NaO<sub>7</sub>, calcd 469.0, found 469.0.</div><div class="NLM_p">Compound <b>27</b> (22 g, 49.3 mmol) was dissolved in MeOH (100 mL) and cooled to 0 °C. Cyclopentylamine (5.1 g, 51.8 mmol) and triethylamine (7.2 mL, 51.8 mmol) were added, and the reaction mixture was stirred at 0 °C for 15 min and then at rt for 4 h. Then, 7 M NH<sub>3</sub> in MeOH (60 mL) was added and the reaction was stirred at rt for 1 day. The reaction mixture was evaporated, and the crude product <b>29</b> was used in the next step without purification. ESI MS [M + H]<sup>+</sup> for C<sub>15</sub>H<sub>21</sub>ClN<sub>5</sub>O<sub>4</sub>, calcd 370.1, found 370.2.</div><div class="NLM_p">The crude product <b>29</b> (10.5 g, 28.4 mmol) was dissolved in acetone (50 mL), and 2,2-dimethoxypropane (50 mL) and <i>p</i>-TsOH·H<sub>2</sub>O (6.7 g, 35.5 mmol) were added. The reaction mixture was stirred at rt overnight, diluted with brine (100 mL), and carefully quenched with saturated NaHCO<sub>3</sub> (100 mL). After extraction with EtOAc (2 × 100 mL), combined organics were dried over MgSO<sub>4</sub>, filtered, and evaporated to give the crude product <b>30</b> (6.2 g), which was used in the next step without purification. ESI MS [M + H]<sup>+</sup> for C<sub>18</sub>H<sub>25</sub>ClN<sub>5</sub>O<sub>4</sub>, calcd 410.2, found 410.2.</div><div class="NLM_p">The crude compound <b>30</b> (3.2 g, 7.8 mmol) in anhydrous THF (50 mL) was cooled to 0 °C, and 1 M NaHMDS in THF (12.4 mL, 12.4 mmol) was added dropwise. The reaction mixture was stirred at 0 °C for 1 h; then, (diethoxyphosphoryl)methyl trifluoromethanesulfonate (3.4 g, 12.4 mmol) was added. The cooling bath was removed, and the reaction was stirred at rt overnight. It was quenched with a saturated solution of NH<sub>4</sub>Cl (50 mL) and diluted with MTBE (100 mL). The organic layer was separated, dried over MgSO<sub>4</sub>, filtered, and evaporated. The crude product was purified by column chromatography (SiO<sub>2</sub>, Hex → Hex:EtOAc, 2:8) to give compound <b>31</b> as a white foamy solid (3.2 g, 73%). ESI MS [M + H]<sup>+</sup> for C<sub>23</sub>H<sub>36</sub>ClN<sub>5</sub>O<sub>7</sub>P, calcd 560.2, found 560.3.</div><div class="NLM_p last">Product <b>31</b> (3.2 g, 5.7 mmol) was dissolved in anhydrous CH<sub>3</sub>CN (30 mL), TMS-Br (1.6 mL) was added, and the reaction was stirred at rt overnight. The solvent was evaporated to obtain a white foamy solid. To a portion of the white solid (250 mg) were added 4 mL of MeOH and 2 mL of 1 N HCl. The reaction mixture was stirred for 8 h at rt, after which the solvent was evaporated and purified by reverse-phase HPLC (C18 column, 0–30% gradient of acetonitrile and water with 0.1% TFA) to give the product <b>4a</b> as a white solid in 93% yield (267 mg): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) 8.71 (d, <i>J</i> = 7.2 Hz, 1H), 8.25 (s, 1H), 6.00 (d, <i>J</i> = 3.9 Hz, 1H), 4.51–4.37 (m, 2H), 4.19 (t, <i>J</i> = 5.2 Hz, 1H), 4.07–3.98 (m, 1H), 3.71 (dd, <i>J</i> = 10.7, 4.0 Hz, 1H), 3.59–3.48 (m, 3H), 2.06–1.93 (m, 3H), 1.79–1.47 (m, 5H). ESI MS [M + H]<sup>+</sup> for C<sub>16</sub>H<sub>24</sub>ClN<sub>5</sub>O<sub>7</sub>P, calcd 464.1, found 464.2.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-Chloro-4-{[(1<i>S</i>)-1-phenylethyl]amino}-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>5a</b>)</h4><div class="NLM_p last">Compound <b>5a</b> was synthesized in a similar fashion to example <b>4a</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.49 (s, 1H), 7.55–7.09 (m, 4H), 5.97 (d, <i>J</i> = 5.8 Hz, 1H), 4.64 (t, <i>J</i> = 5.4 Hz, 1H), 4.32–4.08 (m, 1H), 4.05 (app. q, <i>J</i> = 3.9 Hz, 1H), 3.75 (dd, <i>J</i> = 10.7, 3.6 Hz, 1H), 3.68 (dd, <i>J</i> = 10.7, 4.6 Hz, 1H), 3.60 (dd, <i>J</i> = 8.9, 1.9 Hz, 2H), 1.97 (br. s, 3H), 1.80–1.45 (m, 8H). ESI MS [M – H]<sup>−</sup> for C<sub>19</sub>H<sub>23</sub>ClN<sub>5</sub>O<sub>7</sub>P, calcd 498.1, found 498.3.</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-Chloro-4-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>5b</b>)</h4><div class="NLM_p last">Compound <b>5b</b> was synthesized in a similar fashion to example <b>4a</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.21 (t, <i>J</i> = 6.6 Hz, 1H), 8.32 (dt, <i>J</i> = 4.7, 1.0 Hz, 1H), 7.43 (t, <i>J</i> = 7.8 Hz, 1H), 7.36–7.23 (m, 1H), 7.22–7.12 (m, 2H), 6.03–5.92 (m, 1H), 5.58 (q, <i>J</i> = 7.0 Hz, 1H), 4.44 (t, <i>J</i> = 4.5 Hz, 1H), 4.16 (d, <i>J</i> = 5.6 Hz, 1H), 4.05–3.93 (m, 1H), 3.69 (dd, <i>J</i> = 10.8, 4.0 Hz, 1H), 3.52 (t, <i>J</i> = 8.2 Hz, 2H), 1.53 (d, <i>J</i> = 6.9 Hz, 3H). ESI MS [M + H]<sup>+</sup> for C<sub>19</sub>H<sub>22</sub>ClFN<sub>5</sub>O<sub>7</sub>P, calcd 518.1, found 518.1.</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-Chloro-4-{[(1<i>S</i>)-1-(3-fluorophenyl)ethyl]amino}-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>5c</b>)</h4><div class="NLM_p last">Compound <b>5c</b> was synthesized in a similar fashion to example <b>4a</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.16 (d, <i>J</i> = 7.8 Hz, 1H), 8.35–8.21 (m, 1H), 7.50–7.28 (m, 1H), 7.22 (d, <i>J</i> = 8.7 Hz, 2H), 7.07 (t, <i>J</i> = 8.7 Hz, 1H), 5.99 (d, <i>J</i> = 4.1 Hz, 1H), 5.41 (t, <i>J</i> = 7.2 Hz, 1H), 4.44 (t, <i>J</i> = 4.4 Hz, 1H), 4.17 (t, <i>J</i> = 5.1 Hz, 1H), 3.99 (s, 1H), 3.69 (dd, <i>J</i> = 10.7, 3.9 Hz, 1H), 3.51 (d, <i>J</i> = 8.7 Hz, 2H), 1.53 (d, <i>J</i> = 6.8 Hz, 3H). ESI MS [M + H]<sup>+</sup> for C<sub>19</sub>H<sub>22</sub>ClFN<sub>5</sub>O<sub>7</sub>P, calcd 518.1, found 518.1.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-Chloro-4-{[(1<i>S</i>)-1-(4-fluorophenyl)ethyl]amino}-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>5d</b>)</h4><div class="NLM_p last">Compound <b>5d</b> was synthesized in a similar fashion to example <b>4a</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.14 (d, <i>J</i> = 7.8 Hz, 1H), 8.29 (s, 1H), 7.42 (t, <i>J</i> = 6.8 Hz, 2H), 7.22–7.05 (m, 2H), 5.98 (d, <i>J</i> = 4.1 Hz, 1H), 5.48–5.31 (m, 1H), 4.44 (t, <i>J</i> = 4.6 Hz, 1H), 4.17 (t, <i>J</i> = 5.1 Hz, 1H), 3.99 (d, <i>J</i> = 5.9 Hz, 1H), 3.69 (dd, <i>J</i> = 10.9, 4.0 Hz, 1H), 3.51 (d, <i>J</i> = 8.6 Hz, 2H), 1.57–1.48 (m, 3H). ESI MS [M + H]<sup>+</sup> for C<sub>19</sub>H<sub>22</sub>ClFN<sub>5</sub>O<sub>7</sub>P, calcd 518.1, found 518.1</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-[6-Chloro-4-(cyclopentylamino)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridin-1-yl]-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>4b</b>)</h4><div class="NLM_p">A mixture of 4,6-dichloro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine <b>26</b> (9.5 g, 50.5 mmol) and (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub> (100 mg) in HMDS (50 mL) was stirred under reflux for 5 h and then concentrated under a vacuum to give a dark-brown oil that was immediately used in the next step. The crude TMS-protected heterocycle was dissolved in anhydrous CH<sub>3</sub>CN (100 mL), and 1,2,3,5-tetraacetate-β-<span class="smallcaps smallerCapital">d</span>-ribofuranose (17.6 g, 55.5 mmol) was added. The reaction mixture was stirred at rt until all starting materials dissolved; then, TfO-TMS (13.7 mL, 75.7 mmol) was added dropwise. It was stirred at rt overnight, concentrated under a vacuum to ∼50% of the original volume, and then carefully quenched with saturated NaHCO<sub>3</sub> (300 mL) and extracted with EtOAc (3 × 100 mL). Combined organics were dried over MgSO<sub>4</sub>, filtered, and evaporated to give a dark-brown oil that was purified by column chromatography (SiO<sub>2</sub>, hexane/EtOAc, 100–40%) to give <b>28</b> (yellow oil, 7.2 g, 32%). ESI MS [M + Na]<sup>+</sup> for C<sub>17</sub>H<sub>17</sub>Cl<sub>2</sub>N<sub>3</sub>NaO<sub>7</sub>, calcd 468.0, found 468.0.</div><div class="NLM_p">Compound <b>28</b> (3.1 g, 6.9 mmol) was dissolved in MeOH (10 mL) and cooled to 0 °C. Then, 7 M NH<sub>3</sub> in MeOH (5 mL) was added and the reaction was stirred at rt for 1 day. The reaction mixture was evaporated, the crude material was redissolved in acetone (10 mL), and 2,2-dimethoxypropane (10 mL) and <i>p</i>-TsOH·H<sub>2</sub>O (1.63 g, 8.6 mmol) were added. The reaction mixture was stirred at rt overnight, diluted with brine (20 mL), and carefully quenched with saturated NaHCO<sub>3</sub> (30 mL). After extraction with EtOAc (2 × 50 mL), combined organics were dried over MgSO<sub>4</sub>, filtered, and evaporated. The crude material was purified by column chromatography (SiO<sub>2</sub>, hexane/EtOAc, 1:1) to give <b>32</b> (white solid, 2.0 g, 80%, overall). ESI MS [M + H]<sup>+</sup> for C<sub>14</sub>H<sub>16</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>4</sub>, calcd 360.1, found 360.1.</div><div class="NLM_p">A solution of compound <b>32</b> (2.7 g, 7.5 mmol) in anhydrous THF (20 mL) was cooled to 0 °C, and 1 M LiHMDS in THF (9.0 mL, 9.0 mmol) was added dropwise. The reaction mixture was stirred at −78 °C for 1 h; then, (diethoxyphosphoryl)methyl trifluoromethanesulfonate (2.4 g, 9.0 mmol) was added. The cooling bath was removed, and the reaction was stirred at rt overnight. It was quenched with a saturated solution of NH<sub>4</sub>Cl (6.0 mL) and diluted with MTBE (20 mL). The organic layer was separated, dried over MgSO<sub>4</sub>, filtered, and evaporated. The crude product was purified by column chromatography (SiO<sub>2</sub>, Hex → Hex:EtOAc, 2:8) to give compound <b>33</b> as a white foamy solid (2.0 g, 59%). ESI MS [M + H]<sup>+</sup> for C<sub>19</sub>H<sub>27</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>7</sub>P, calcd 510.1, found 510.0.</div><div class="NLM_p last">In a glass vial, compound <b>33</b> (400 mg, 0.78 mmol) was dissolved in EtOH (1.0 mL). To this solution were added cyclopentylamine (115 μL, 1.17 mmol) and triethylamine (163 μL, 1.17 mmol). The reaction mixture was heated to reflux in the sealed vial for 16 h. Volatiles were removed under reduced pressure, and the crude mass was redissolved in anhydrous CH<sub>3</sub>CN (5.0 mL), followed by addition of TMS-Br (0.5 mL). The reaction mixture was stirred at rt overnight before quenching with H<sub>2</sub>O (1 mL) and stirring for an additional 4 h at rt or until LCMS analysis showed complete cleavage of the acetonide protecting group. The reaction mixture was evaporated and purified by reverse-phase HPLC (C18 column, 0–30% gradient of acetonitrile and water with 0.1% TFA) to give the product <b>4b</b> as a white solid (200 mg; 48%): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ 8.26 (s, 1H), 7.65 (d, <i>J</i> = 6.7 Hz, 1H), 6.22 (s, 1H), 6.06 (d, <i>J</i> = 3.9 Hz, 1H), 4.47 (t, <i>J</i> = 4.5 Hz, 1H), 4.17 (t, <i>J</i> = 5.2 Hz, 1H), 4.02–3.92 (m, 2H), 3.69 (dd, <i>J</i> = 10.9, 3.9 Hz, 1H), 3.50 (d, <i>J</i> = 8.6 Hz, 3H), 2.06–1.88 (m, 2H), 1.75–1.47 (m, 6H). ESI MS [M + H]<sup>+</sup> for C<sub>17</sub>H<sub>25</sub>ClN<sub>4</sub>O<sub>7</sub>P, calcd 463.1, found 463.2.</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-Chloro-4-{[(1<i>S</i>)-1-phenylethyl]amino}-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>5e</b>)</h4><div class="NLM_p last">Compound <b>5e</b> was synthesized in a similar fashion to example <b>4b</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.37 (s, 1H), 8.19 (d, <i>J</i> = 7.2 Hz, 1H), 7.39 (d, <i>J</i> = 8.1 Hz, 2H), 7.32 (t, <i>J</i> = 7.6 Hz, 2H), 7.24–7.18 (m, 1H), 6.04 (d, <i>J</i> = 4.1 Hz, 1H), 6.02–5.92 (m, 1H), 4.85 (s, 1H), 4.46 (t, <i>J</i> = 4.6 Hz, 1H), 4.17 (t, <i>J</i> = 5.4 Hz, 1H), 3.96 (t, <i>J</i> = 5.5 Hz, 1H), 3.67 (td, <i>J</i> = 13.5, 12.1, 7.3 Hz, 1H), 3.51 (d, <i>J</i> = 8.3 Hz, 2H), 1.52 (d, <i>J</i> = 6.7 Hz, 3H). ESI MS [M + H]<sup>+</sup> for C<sub>20</sub>H<sub>24</sub>ClN<sub>4</sub>O<sub>7</sub>P, calcd 499.9, found 499.8.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-Chloro-4-{[(1<i>S</i>)-1-(2-fluorophenyl)ethyl]amino}-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>5f</b>)</h4><div class="NLM_p last">Compound <b>5f</b> was synthesized in a similar fashion to example <b>4b</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.37 (s, 1H), 8.23 (d, <i>J</i> = 7.1 Hz, 1H), 7.44–7.34 (m, 1H), 7.34–7.26 (m, 1H), 7.26–7.09 (m, 2H), 6.05 (d, <i>J</i> = 4.0 Hz, 1H), 6.00–5.73 (m, 1H), 5.04 (s, 1H), 4.53–4.40 (m, 1H), 4.17 (t, <i>J</i> = 5.2 Hz, 1H), 3.98 (dt, <i>J</i> = 6.4, 4.5 Hz, 1H), 3.69 (dd, <i>J</i> = 10.8, 4.0 Hz, 1H), 3.51 (t, <i>J</i> = 7.4 Hz, 3H), 1.56 (d, <i>J</i> = 6.7 Hz, 3H). ESI MS [M + H]<sup>+</sup> for C<sub>20</sub>H<sub>23</sub>ClFN<sub>4</sub>O<sub>7</sub>P, calcd 517.1, found 517.1.</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-Chloro-4-{[(1<i>S</i>)-1-(3-fluorophenyl)ethyl]amino}-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>5g</b>)</h4><div class="NLM_p last">Compound <b>5g</b> was synthesized in a similar fashion to example <b>4b</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.35 (s, 1H), 8.18 (d, <i>J</i> = 7.3 Hz, 1H), 7.42–7.31 (m, 1H), 7.31–7.18 (m, 2H), 7.10–6.99 (m, 1H), 6.04 (d, <i>J</i> = 4.0 Hz, 1H), 4.91 (s, 1H), 4.51–4.41 (m, 1H), 4.17 (t, <i>J</i> = 5.3 Hz, 1H), 4.04–3.90 (m, 1H), 3.69 (dd, <i>J</i> = 10.8, 4.0 Hz, 1H), 3.51 (d, <i>J</i> = 8.3 Hz, 3H), 1.57–1.46 (m, 3H). ESI MS [M + H]<sup>+</sup> for C<sub>20</sub>H<sub>23</sub>ClFN<sub>4</sub>O<sub>7</sub>P, calcd 517.1, found 517.1.</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-(6-Chloro-4-{[(1<i>S</i>)-1-(4-fluorophenyl)ethyl]amino}-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>5h</b>)</h4><div class="NLM_p last">Compound <b>5h</b> was synthesized in a similar fashion to example <b>4b</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.35 (s, 1H), 8.17 (d, <i>J</i> = 7.2 Hz, 1H), 7.43 (ddd, <i>J</i> = 8.8, 5.5, 1.5 Hz, 2H), 7.14 (td, <i>J</i> = 8.8, 1.4 Hz, 2H), 6.04 (d, <i>J</i> = 4.1 Hz, 2H), 4.89 (s, 1H), 4.52–4.40 (m, 1H), 4.17 (t, <i>J</i> = 5.2 Hz, 1H), 3.97 (dt, <i>J</i> = 6.3, 4.4 Hz, 1H), 3.68 (dd, <i>J</i> = 10.8, 4.0 Hz, 1H), 3.60–3.38 (m, 3H), 1.50 (d, <i>J</i> = 6.5 Hz, 3H). ESI MS [M + H]<sup>+</sup> for C<sub>20</sub>H<sub>23</sub>ClFN<sub>4</sub>O<sub>7</sub>P, calcd 517.1, found 517.1.</div></div><div id="sec4_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> ({[(2<i>R</i>,3<i>S</i>,4<i>R</i>,5<i>R</i>)-5-[5-Chloro-7-(cyclopentylamino)-3H-imidazo[4,5-<i>b</i>]pyridin-3-yl]-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic Acid (<b>4c</b>)</h4><div class="NLM_p">To a solution of 5,7-dichloroimidazo[4,5-<i>b</i>]pyridine <b>34</b> (376 mg, 2 mmol) in MeCN (14 mL) at rt was added <i>N</i>,<i>O</i>-bis(trimethylsilyl)acetamide (0.523 mL, 2.14 mmol) dropwise, and the reaction mixture was heated to 85 °C for 1 h. The mixture was cooled to rt, and a solution of β-<span class="smallcaps smallerCapital">d</span>-ribofuranose 1,2,3,5-tetraacetate (726 mg, 2.28 mmol) in MeCN (7 mL) and trimethylsilyl trifluoromethanesulfonate (0.471 mL, 2.60 mmol) were added sequentially dropwise. The reaction mixture was heated to 85 °C for 4 h. After cooling to rt, aqueous saturated sodium bicarbonate (50 mL) was added, subsequently extracted three times with EtOAc (100 mL), dried over sodium sulfate, and concentrated. The crude material <b>35</b> thus obtained was redissolved in dioxane (2 mL), and cyclopentylamine (0.987 mL, 10 mmol) was added. The mixture was heated to 100 °C for 16 h. The reaction mixture was then directly loaded onto silica gel and purified by silica gel chromatography (0–10% MeOH in DCM) to afford the desired product <b>36</b> as a brown solid (298 mg, 40%, two steps). ESI MS [M + H]<sup>+</sup> for C<sub>16</sub>H<sub>22</sub>ClN<sub>4</sub>O<sub>4</sub>, calcd 369.1, found 369.1.</div><div class="NLM_p">A solution of the compound <b>36</b> (298 mg; 0.808 mmol) and <i>p</i>-toluenesulfonic acid monohydrate (154 mg, 0.808 mmol) in 2,2-dimethoxypropane (1.6 mL) and acetone (1.6 mL) was stirred at rt for 20 h. Triethylamine (0.5 mL) was added, the solvent was removed, and the residue was purified by silica gel chromatography (50–100% EtOAc in hexanes) to afford the desired product <b>37</b> as a white solid (258 mg; 78%). ESI MS [M + H]<sup>+</sup> for C<sub>19</sub>H<sub>26</sub>ClN<sub>4</sub>O<sub>4</sub>, calcd 409.2, found 409.2.</div><div class="NLM_p">Compound <b>37</b> (126 mg, 0.308 mmol) in anhydrous THF (1.5 mL) was cooled to 0 °C, and 1 M NaHMDS in THF (0.43 mL, 0.43 mmol) was added dropwise. The reaction mixture was stirred at 0 °C for 1 h; then, (diethoxyphosphoryl)methyl trifluoromethanesulfonate (139 mg, 0.47 mmol) was added. The cooling bath was removed, and the reaction was stirred at rt overnight. It was quenched with a saturated solution of NH<sub>4</sub>Cl (1.0 mL) and diluted with MTBE (100 mL). The organic layer was separated, dried over MgSO<sub>4</sub>, filtered, and evaporated. The crude product was purified by column chromatography to obtain <b>38</b> as a white solid (107 mg; 62%). ESI MS [M + H]<sup>+</sup> for C<sub>24</sub>H<sub>37</sub>ClN<sub>4</sub>O<sub>7</sub>P, calcd 559.9, found 559.9.</div><div class="NLM_p last">Compound <b>38</b> (107 mg, 0.19 mmol) was dissolved in anhydrous CH<sub>3</sub>CN (0.46 mL), TMS-Br (0.25 mL) was added, and the reaction was stirred at rt overnight. It was quenched with H<sub>2</sub>O (1 mL) and stirred at rt for 4 h or until LCMS analysis showed complete cleavage of the acetonide protecting group. The reaction mixture was evaporated and purified by reverse-phase HPLC (C18 column, 0–30% gradient of acetonitrile and water with 0.1% TFA) to give the product <b>4c</b> as a white solid (14 mg; 15%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.47 (s, 1H), 7.12 (d, <i>J</i> = 7.4 Hz, 1H), 6.41 (s, 1H), 5.90 (d, <i>J</i> = 5.8 Hz, 1H), 4.68–4.45 (m, 1H), 4.16–4.10 (m, 1H), 4.03 (q, <i>J</i> = 3.9 Hz, 1H), 3.78–3.65 (m, 2H), 3.61 (d, <i>J</i> = 8.9 Hz, 2H), 2.05–1.89 (m, 2H), 1.77–1.63 (m, 2H), 1.63–1.47 (m, 4H). ESI MS [M – H]<sup>−</sup> for C<sub>17</sub>H<sub>23</sub>ClN<sub>4</sub>O<sub>7</sub>P, calcd 461.8, found 461.2.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Generation and Expansion of the Human CD73 Stable CHO Cell Line</h3><div class="NLM_p last">Stable cell lines were generated by Lake Pharma (Belmont, CA) using a standard protocol to transform CHO cells with a pcDNA3.1(+) vector carrying the human NT5E (CD73) gene. Antibiotic selection was performed in CD OptiCHO cell media containing 5 μg/mL Puromycin and 200 μg/mL Hygromycin B. Pools of surviving CHO-CD73 were collected and frozen in 7.5% dimethyl sulfoxide (DMSO) in CD OptiCHO cell media. Cryopreserved cells were defrosted in a water bath at 37 °C by agitating the vial until the cells were completely thawed. Cells were then transferred to a 15 mL Falcon tube prior to centrifuging at 225<i>g</i> for 5 min to pellet the cells. The cell pellet was resuspended in a fresh warm CD OptiCHO Growth Medium supplemented with 2 mM Glutamax and transferred to a T175 flask. After two days and on reaching ∼80% confluence (∼20 million cells/flask), cells were split 1:3 into three fresh T175 flasks. After a further three days, cells were transferred to 15 mL Falcon tubes and centrifuged at 250<i>g</i> for 5 min to pellet. Cells were resuspended at a density of 3 million cells/mL in CellBanker2 cryopreservation media and aliquoted into cryogenic vials. Cell aliquots were stored at −80 °C until needed.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> CD73 CHO Cellular Assay</h3><div class="NLM_p last">On the day of the experiment, one vial of CHO-CD73 cells was thawed and cells were resuspended in 10 mL of assay buffer consisting of 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.4, 137 mM NaCl, 5.4 mM KCl, 1.3 mM CaCl<sub>2</sub>, 4.2 mM NaHCO<sub>3</sub>, and 0.1% glucose. A 16-point, 1:3 master serial dilution of the test compound was prepared in 100% DMSO to span a final concentration range of 100–0 μM or 0.1–0 μM. Twenty microliters of assay buffer was added to each well of a 96-well round-bottomed polypropylene plate followed by addition of 10 or 1 μL of the test compound at 10-fold or 100-fold final concentration. Fifty or thirty microliters of cells was added to each well, and the plate was incubated for a further 60 min at 37 °C prior to addition of 20 μL of 125 μM AMP or 49 μL of 51 μM AMP in an assay buffer. Final assay conditions comprised 1500 cells per well in 10 or 2% DMSO and 25 μM AMP substrate. After a further 60 min of incubation at 37 °C and 5% CO<sub>2</sub>, the plate was centrifuged at 225<i>g</i> for 5 min. Eighty microliters of supernatant was transferred to a 96-well Spectra Plate, the wells of which had been preloaded with 20 μL of the PiColorLock Gold colorimetric assay reagent (Cat. No. 30 300 30, Thermo Fisher). The inorganic phosphate reaction product was assessed as a function of color developed by reaction with the PiColorLock Gold reagent and quantitated using an Envision 2102 Multilabel Reader fitted with a 620 nm filter. The CD73 enzymatic activity was evaluated as a correlate of phosphate product levels. Percentage maximum activity in each test well was calculated based on DMSO (maximum activity) and wells not containing cells (baseline activity). The IC<sub>50</sub> values of the test compounds were determined from the compound’s dose–response curve fitted using a standard four-parameter fit equation.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> CD39 CHO Cellular Assay</h3><div class="NLM_p last">CD39 stable cell lines were generated by Lake Pharma (Belmont, CA) using the same protocol as the generation of CD73 stable cells. The CD39 CHO cellular assay was carried out using the same protocol as the CD73 CHO cellular assay but with modification to cell number, substrate concentration, and compound preincubation time. Final assay conditions comprised 500 cells per well in 2% DMSO and 15 μM ATP substrate with 4 h of compound preincubation.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Preparation of Chinese Hamster Ovary (CHO) K1 Cells Transiently Transfected with NTPDase2, NTPDase3, or NTPDase8</h3><div class="NLM_p last">One day prior to the assay, 5 ×10<sup>6</sup> CHO-K1 cells (ATCC, #CCL-61) were seeded in 11 mL of cell media (Hams F-12, (Fisher, 11765047), supplemented with 10% FBS (Gibco, Cat. No. A3160502), and 1% GlutaMax (Invitrogen, Cat. No. 35050-061)) in T75 flasks (Corning, 430641U). Then, 10 μL of 100 ng/μL NTPDase2, NTPDase3, or NTPDase8 plasmid DNA was added to 2 mL of serum-free Opti-MEM media (Fisher, 31985062). The diluted plasmid was combined with 2 mL of serum-free Opti-MEM media containing 100 μL of the Lipofectamine LTX Reagent (Fisher, #15338030). The final DNA/LTX mixture was incubated for 30 min at ∼25 °C and added to the T75 flask containing CHO-K1 cells. The cells were incubated at 37 °C and 5% CO<sub>2</sub> overnight. The following day, media were removed by gentle aspiration and cells were washed with 10 mL of phosphate-buffered saline (PBS, Gibco, 14190250) twice. The cells were harvested by adding 2 mL of Accutase (Fisher, #00-4555-56) to the flask. The flask was then incubated at 37 °C until the cells detached from the flask when lightly tapped by hand. Next, 8 mL of PBS was added to the flask to dislodge cells and then the cells were transferred to a 15 mL conical centrifuge tube (Falcon, 339650) and centrifuged at 225<i>g</i> for 5 min. PBS was removed by aspiration, and the cells were suspended in 5 mL of an assay buffer consisting of 20 mM HEPES, pH 7.4, 137 mM NaCl, 5.4 mM KCl, 1.3 mM CaCl<sub>2</sub>, 4.2 mM NaHCO<sub>3</sub>, and 0.1% glucose. Cell density was determined using ViaCell XR (Becman Coulter). The cells were then diluted to 0.25 × 10<sup>6</sup> cells/mL.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> NTPDase2, NTPDase3, or NTPDase8 Cellular Assays</h3><div class="NLM_p last">A 16-point, 1:3 master serial dilution of the test compound was prepared in 100% DMSO to span a final concentration range of 10–0 μM. Then, 18 μL of an assay buffer was added to each well of a 96-well polypropylene plate (Corning, Cat no. 3365) followed by addition of 2 μL of the test compound at 50-fold final concentration. Then, 40 μL of NTPDase2, 3, or 8 cells in an assay buffer was added to each well and the plate was incubated for a further 1 h at 37 °C prior to addition of 40 μL of 62.5 μM (NTPDase2), 40 μL of 37.5 μM (NTPDase3), 40 μL of 75 μM (NTPdase8), and adenosine-5′-triphosphate monohydrate (ATP) (Sigma, Cat. No. A26209-5G) in the assay buffer. Final assay conditions comprised 10 000 cells per well in 2% DMSO and 25/15/30 μM ATP substrate. After a further 50 min of incubation at 37 °C and 5% CO<sub>2</sub>, the plate was centrifuged at 225<i>g</i> for 5 min. Then, 80 μL of the supernatant was transferred to a 96-well Spectra Plate (Perkin Elmer, Cat. No. 6005640), the wells of which had been preloaded with 20 μL of PiColorLock Gold colorimetric assay reagent (Thermo Fisher, Cat. No. 30 300 30). The inorganic phosphate reaction product was quantitated as a function of color developed by reaction with PiColorLock Gold reagent and determined using an Envision 2102 Multilabel Reader (Perkin Elmer) fitted with a 620 nm filter. NTPDase2, 3, or 8 activity was assessed as a correlate of phosphate product levels. Percentage maximum activity in each of the compound test wells was calculated based on DMSO (maximum activity) and no cell control wells (baseline activity). The IC<sub>50</sub> values of the test compounds were determined using Prism software (Graphpad Software Inc., version 7.02, La Jolla, CA 92037), and the compound’s dose–response curve was fitted using a standard four-parameter fit equation.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> A2<sub>a</sub>R Assay</h3><div class="NLM_p last">The compound inhibition constant (IC<sub>50</sub>) was determined as a function of cellular cAMP levels in NECA-stimulated CHO cells stably transfected with adenosine 2A<sub>a</sub> receptor. Clonal CHO cells stably transfected with <i>ADORA2A</i> and induced with tetracycline were seeded into 384-well OptiPlates at a density of between 2000 cells per well and preincubated with 20-point, 1:2 serial dilution of the compound to span a final concentration range of 10–0 μM. A 30 nM fixed concentration of NECA was prepared and added to the wells to generate a full serial dilution of NECA against each of the five compound concentrations. Cells were incubated for a further 30 min at 37 °C. The reaction was quenched by addition of 5 μL of Ulight-anti-cAMP diluted 1:150 with a conjugate and lysis buffer. Five microliters of Eu-cAMP tracer diluted 1:50 dilution in the conjugate and lysis buffer was then added to each well, and the plate was incubated for an additional 60 min at 37 °C. Cellular cAMP levels were then quantitated as a function of the fluorescence resonance energy transfer (FRET) signal measured using an Envision 2102 Multilabel Reader (Perkin Elmer) fitted with 615 nm excitation and 665 nm emission filters. The IC<sub>50</sub> potency was performed using Prism software (Graphpad Software Inc., version 7.02, La Jolla, CA 92037) to calculate the compound IC<sub>50</sub>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Pharmacokinetic Studies</h3><div class="NLM_p last">All animal procedures were conducted under protocols approved by the Arcus Institutional Animal Care and Use Committee (IACUC). Male rats, weighing between 0.27 and 0.30 kg, were purchased from Charles River Laboratories (Hollister, CA) and were acclimated before use. Test articles were dissolved in 31.6% DMA, 36.8% ethanol, and 31.6% PEG and administered intravenously via the femoral vein at 0.25 or 0.5 mg/kg. Blood was sampled via the jugular vein at predose, 5, 15, and 30 min, 1, 2, 4, 6, 8, and 24 h post dose. Blood samples were placed in polypropylene tubes containing K2-EDTA as the anticoagulant and centrifuged at 8000 rpm and 4 °C for 7 min to obtain plasma, which were stored at −80 °C until analysis. Plasma samples were prepared by protein precipitation and analyzed by LCMS/MS (Shimadzu Nexera X2 UHPLC and API4000 mass spectrometer). Pharmacokinetic analysis was performed using Phoenix WinNonlin v6.4.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01835" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84715" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84715" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01835?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01835</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01835/suppl_file/jm0c01835_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Hepatocyte stability assay, CYP inhibition assay, and crystallographic methods (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01835/suppl_file/jm0c01835_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01835/suppl_file/jm0c01835_si_001.csv">jm0c01835_si_001.csv (3.8 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01835/suppl_file/jm0c01835_si_002.pdf">jm0c01835_si_002.pdf (1.52 MB)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates have been deposited in the Protein Data Bank (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YE1">6YE1</a> for <b>2n</b> and PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YE2">6YE2</a> for <b>4a</b>). Structures will be released upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.0c01835" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51876" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51876" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ehesan U. Sharif</span> - <span class="hlFld-Affiliation affiliation">Arcus
Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2605-6745" title="Orcid link">http://orcid.org/0000-0002-2605-6745</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4a2f39222b38232c0a2b38293f3928232564292527"><span class="__cf_email__" data-cfemail="b0d5c3d8d1c2d9d6f0d1c2d3c5c3d2d9df9ed3dfdd">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jaroslaw Kalisiak</span> - <span class="hlFld-Affiliation affiliation">Arcus
Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth V. Lawson</span> - <span class="hlFld-Affiliation affiliation">Arcus
Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5094-6337" title="Orcid link">http://orcid.org/0000-0001-5094-6337</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dillon H. Miles</span> - <span class="hlFld-Affiliation affiliation">Arcus
Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Newcomb</span> - <span class="hlFld-Affiliation affiliation">Arcus
Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erick A. Lindsey</span> - <span class="hlFld-Affiliation affiliation">Arcus
Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brandon R. Rosen</span> - <span class="hlFld-Affiliation affiliation">Arcus
Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0790-6433" title="Orcid link">http://orcid.org/0000-0002-0790-6433</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurent P. P. Debien</span> - <span class="hlFld-Affiliation affiliation">Arcus
Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ada Chen</span> - <span class="hlFld-Affiliation affiliation">Arcus
Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoning Zhao</span> - <span class="hlFld-Affiliation affiliation">Arcus
Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen W. Young</span> - <span class="hlFld-Affiliation affiliation">Arcus
Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nigel P. Walker</span> - <span class="hlFld-Affiliation affiliation">Arcus
Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Norbert Sträter</span> - <span class="hlFld-Affiliation affiliation">Institute
of Bioanalytical Chemistry, Center for Biotechnology and Biomedicine, Leipzig University, Deutscher Platz 5, D-04103 Leipzig, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2001-0500" title="Orcid link">http://orcid.org/0000-0002-2001-0500</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emma R. Scaletti</span> - <span class="hlFld-Affiliation affiliation">Institute
of Bioanalytical Chemistry, Center for Biotechnology and Biomedicine, Leipzig University, Deutscher Platz 5, D-04103 Leipzig, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lixia Jin</span> - <span class="hlFld-Affiliation affiliation">Arcus
Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guifen Xu</span> - <span class="hlFld-Affiliation affiliation">Arcus
Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manmohan R. Leleti</span> - <span class="hlFld-Affiliation affiliation">Arcus
Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jay P. Powers</span> - <span class="hlFld-Affiliation affiliation">Arcus
Biosciences, Inc., 3928 Point Eden Way, Hayward, California 94545, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">GPI</td><td class="NLM_def"><p class="first last">glycosylphosphatidylinositol</p></td></tr><tr><td class="NLM_term">hCD73</td><td class="NLM_def"><p class="first last">human cluster of differentiation 73</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">protein data bank</p></td></tr><tr><td class="NLM_term">hNTPDases</td><td class="NLM_def"><p class="first last">human nucleoside triphosphate diphosphohydrolases</p></td></tr><tr><td class="NLM_term">POM</td><td class="NLM_def"><p class="first last">pivaloyloxymethyl</p></td></tr><tr><td class="NLM_term">POC</td><td class="NLM_def"><p class="first last">isopropyloxycarbonyloxymethyl</p></td></tr><tr><td class="NLM_term">HDP</td><td class="NLM_def"><p class="first last">hexadecyloxypropyl</p></td></tr><tr><td class="NLM_term">DMA</td><td class="NLM_def"><p class="first last">dimethylacetamide</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">poly(ethylene glycol)</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term"><i>p</i>TsOH</td><td class="NLM_def"><p class="first last">para-toluenesulfonic acid</p></td></tr><tr><td class="NLM_term">HMDS</td><td class="NLM_def"><p class="first last">bis(trimethylsilyl)amine</p></td></tr><tr><td class="NLM_term">BSA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>O</i>-bis(trimethylsilyl)acetamide</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">LCMS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61033" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61033" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 14 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">Ecto-5′-Nucleotidase: Structure Function Relationships</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1007/s11302-006-9000-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1007%2Fs11302-006-9000-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=18404474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A280%3ADC%252BD1c3ktl2iug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=343-350&author=N.+Str%C3%A4ter&title=Ecto-5%E2%80%B2-Nucleotidase%3A+Structure+Function+Relationships&doi=10.1007%2Fs11302-006-9000-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Ecto-5'-nucleotidase: Structure function relationships</span></div><div class="casAuthors">Strater Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic signalling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">343-50</span>
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    </div><div class="casAbstract">Ecto-5'-nucleotidase (ecto-5'-NT) is attached via a GPI anchor to the extracellular membrane, where it hydrolyses AMP to adenosine and phosphate.  Related 5'-nucleotidases exist in bacteria, where they are exported into the periplasmic space.  X-ray structures of the 5'-nucleotidase from E. coli showed that the enzyme consists of two domains.  The N-terminal domain coordinates two catalytic divalent metal ions, whereas the C-terminal domain provides the substrate specificity pocket for the nucleotides.  Thus, the substrate binds at the interface of the two domains.  Here, the currently available structural information on ecto-5'-NT is reviewed in relation to the catalytic properties and enzyme function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThDd9tlAyIrzEC-75aqa5AfW6udTcc2ea-kj39suHNDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3ktl2iug%253D%253D&md5=6b3bf983438fc270d35f8e9cf6d467ed</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs11302-006-9000-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-006-9000-8%26sid%3Dliteratum%253Aachs%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DEcto-5%25E2%2580%25B2-Nucleotidase%253A%2520Structure%2520Function%2520Relationships%26jtitle%3DPurinergic%2520Signalling%26date%3D2006%26volume%3D2%26spage%3D343%26epage%3D350%26doi%3D10.1007%2Fs11302-006-9000-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamin, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braganhol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanin, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edelweiss, M. I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battastini, A. M. O.</span></span> <span> </span><span class="NLM_article-title">Ectonucleotidases in Tumor Cells and Tumor-Associated Immune Cells: An Overview</span>. <i>J. Biomed. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>, <span class="NLM_elocation-id">959848</span> <span class="refDoi"> DOI: 10.1155/2012/959848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1155%2F2012%2F959848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=23118517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A280%3ADC%252BC3s7gtFejtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&author=L.+S.+Bergaminauthor=E.+Braganholauthor=R.+F.+Zaninauthor=M.+I.+A.+Edelweissauthor=A.+M.+O.+Battastini&title=Ectonucleotidases+in+Tumor+Cells+and+Tumor-Associated+Immune+Cells%3A+An+Overview&doi=10.1155%2F2012%2F959848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Ectonucleotidases in tumor cells and tumor-associated immune cells: an overview</span></div><div class="casAuthors">Bergamin Leticia Scussel; Braganhol Elizandra; Zanin Rafael Fernandes; Edelweiss Maria Isabel Albano; Battastini Ana Maria Oliveira</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomedicine & biotechnology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">959848</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Increasing evidence points out that genetic alteration does not guarantee the development of a tumor and indicates that complex interactions of tumor cells with the microenvironment are fundamental to tumorigenesis.  Among the pathological alterations that give tumor cells invasive potential, disruption of inflammatory response and the purinergic signaling are emerging as an important component of cancer progression.  Nucleotide/nucleoside receptor-mediated cell communication is orchestrated by ectonucleotidases, which efficiently hydrolyze ATP, ADP, and AMP to adenosine.  ATP can act as danger signaling whereas adenosine, acts as a negative feedback mechanism to limit inflammation.  Many tumors exhibit alterations in ATP-metabolizing enzymes, which may contribute to the pathological events observed in solid cancer.  In this paper, the main changes occurring in the expression and activity of ectonucleotidases in tumor cells as well as in tumor-associated immune cells are discussed.  Furthermore, we focus on the understanding of the purinergic signaling primarily as exemplified by research done by the group on gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRGVDLyUgDPhPSAs_PE1QvifW6udTcc2eaurg1yX8c91rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7gtFejtQ%253D%253D&md5=5cce519ac9fc74e5754451e1aebcb5f9</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1155%2F2012%2F959848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F959848%26sid%3Dliteratum%253Aachs%26aulast%3DBergamin%26aufirst%3DL.%2BS.%26aulast%3DBraganhol%26aufirst%3DE.%26aulast%3DZanin%26aufirst%3DR.%2BF.%26aulast%3DEdelweiss%26aufirst%3DM.%2BI.%2BA.%26aulast%3DBattastini%26aufirst%3DA.%2BM.%2BO.%26atitle%3DEctonucleotidases%2520in%2520Tumor%2520Cells%2520and%2520Tumor-Associated%2520Immune%2520Cells%253A%2520An%2520Overview%26jtitle%3DJ.%2520Biomed.%2520Biotechnol.%26date%3D2012%26volume%3D2012%26doi%3D10.1155%2F2012%2F959848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span> <span> </span><span class="NLM_article-title">5′-Nucleotidase: Molecular Structure and Functional Aspects</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1042/bj2850345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1042%2Fbj2850345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1637327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADyaK38XkvVGltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1992&pages=345-365&author=H.+Zimmermann&title=5%E2%80%B2-Nucleotidase%3A+Molecular+Structure+and+Functional+Aspects&doi=10.1042%2Fbj2850345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">5'-Nucleotidase:  molecular structure and functional aspects</span></div><div class="casAuthors">Zimmermann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">345-65</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">A review with ∼280 refs. focusing on recent developments in the anal. of the mol. structure and of functional aspects of 5' nucleotide-hydrolyzing enzymes.  A classification system for these enzymes is suggested which divides the vertebrate 5' nucleotidases into 4 distinct groups according to biochem. properties and cellular location.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqGDlEvhu4LbVg90H21EOLACvtfcHk0liXq01lMpB5hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XkvVGltrk%253D&md5=c359900288211b3dce6145df5cafcdba</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1042%2Fbj2850345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2850345%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DH.%26atitle%3D5%25E2%2580%25B2-Nucleotidase%253A%2520Molecular%2520Structure%2520and%2520Functional%2520Aspects%26jtitle%3DBiochem.%2520J.%26date%3D1992%26volume%3D285%26spage%3D345%26epage%3D365%26doi%3D10.1042%2Fbj2850345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Allard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longhi, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span> <span> </span><span class="NLM_article-title">The Ectonucleotidases CD39 and CD73: Novel Checkpoint Inhibitor Targets</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1111/imr.12528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1111%2Fimr.12528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=28258700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1eltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2017&pages=121-144&author=B.+Allardauthor=M.+S.+Longhiauthor=S.+C.+Robsonauthor=J.+Stagg&title=The+Ectonucleotidases+CD39+and+CD73%3A+Novel+Checkpoint+Inhibitor+Targets&doi=10.1111%2Fimr.12528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets</span></div><div class="casAuthors">Allard, Bertrand; Longhi, Maria Serena; Robson, Simon C.; Stagg, John</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">121-144</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Cancers are able to grow by subverting immune suppressive pathways, to prevent the malignant cells as being recognized as dangerous or foreign.  This mechanism prevents the cancer from being eliminated by the immune system and allows disease to progress from a very early stage to a lethal state.  Immunotherapies are newly developing interventions that modify the patient's immune system to fight cancer, by either directly stimulating rejection-type processes or blocking suppressive pathways.  Extracellular adenosine generated by the ectonucleotidases CD39 and CD73 is a newly recognized "immune checkpoint mediator" that interferes with anti-tumor immune responses.  In this review, we focus on CD39 and CD73 ectoenzymes and encompass aspects of the biochem. of these mols. as well as detailing the distribution and function on immune cells.  Effects of CD39 and CD73 inhibition in preclin. and clin. studies are discussed.  Finally, we provide insights into potential clin. application of adenosinergic and other purinergic-targeting therapies and forecast how these might develop in combination with other anti-cancer modalities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiLKxqHb6HnbVg90H21EOLACvtfcHk0liXq01lMpB5hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1eltL8%253D&md5=1f2c1bf632b238d6b7d9d7c46cea77c5</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1111%2Fimr.12528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fimr.12528%26sid%3Dliteratum%253Aachs%26aulast%3DAllard%26aufirst%3DB.%26aulast%3DLonghi%26aufirst%3DM.%2BS.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26aulast%3DStagg%26aufirst%3DJ.%26atitle%3DThe%2520Ectonucleotidases%2520CD39%2520and%2520CD73%253A%2520Novel%2520Checkpoint%2520Inhibitor%2520Targets%26jtitle%3DImmunol.%2520Rev.%26date%3D2017%26volume%3D276%26spage%3D121%26epage%3D144%26doi%3D10.1111%2Fimr.12528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Antonioli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vizi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haskó, G.</span></span> <span> </span><span class="NLM_article-title">CD39 and CD73 in Immunity and Inflamation</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2013.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1016%2Fj.molmed.2013.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=23601906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsFamtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=355-367&author=L.+Antonioliauthor=P.+Pacherauthor=S.+Viziauthor=G.+Hask%C3%B3&title=CD39+and+CD73+in+Immunity+and+Inflamation&doi=10.1016%2Fj.molmed.2013.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">CD39 and CD73 in immunity and inflammation</span></div><div class="casAuthors">Antonioli, Luca; Pacher, Pal; Vizi, E. Sylvester; Hasko, Gyorgy</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The enzymic activities of CD39 and CD73 play strategic roles in calibrating the duration, magnitude, and chem. nature of purinergic signals delivered to immune cells through the conversion of ADP/ATP to AMP and AMP to adenosine, resp.  This drives a shift from an ATP-driven proinflammatory environment to an anti-inflammatory milieu induced by adenosine.  The CD39/CD73 pathway changes dynamically with the pathophysiol. context in which it is embedded.  It is becoming increasingly appreciated that altering this catabolic machinery can change the course or dictate the outcome of several pathophysiol. events, such as AIDS, autoimmune diseases, infections, atherosclerosis, ischemia-reperfusion injury, and cancer, suggesting these ectoenzymes are novel therapeutic targets for managing a variety of disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmWiFFVp_ddbVg90H21EOLACvtfcHk0liXq01lMpB5hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsFamtLg%253D&md5=75d0f7627b3b8a5dd81fd3a76992af2b</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2013.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2013.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DAntonioli%26aufirst%3DL.%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DVizi%26aufirst%3DS.%26aulast%3DHask%25C3%25B3%26aufirst%3DG.%26atitle%3DCD39%2520and%2520CD73%2520in%2520Immunity%2520and%2520Inflamation%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D355%26epage%3D367%26doi%3D10.1016%2Fj.molmed.2013.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainwright, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matei, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span> <span> </span><span class="NLM_article-title">CD73: An Emerging Checkpoint for Cancer Immunotherapy</span>. <i>Immunotherapy</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">983</span>– <span class="NLM_lpage">997</span>, <span class="refDoi"> DOI: 10.2217/imt-2018-0200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.2217%2Fimt-2018-0200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=31223045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVGntbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=983-997&author=S.+Chenauthor=D.+A.+Wainwrightauthor=J.+D.+Wuauthor=Y.+Wanauthor=D.+E.+Mateiauthor=Y.+Zhangauthor=B.+Zhang&title=CD73%3A+An+Emerging+Checkpoint+for+Cancer+Immunotherapy&doi=10.2217%2Fimt-2018-0200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">CD73: an emerging checkpoint for cancer immunotherapy</span></div><div class="casAuthors">Chen, Siqi; Wainwright, Derek A.; Wu, Jennifer D.; Wan, Yong; Matei, Daniela E.; Zhang, Yi; Zhang, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Immunotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">983-997</span>CODEN:
                <span class="NLM_cas:coden">IMMUCO</span>;
        ISSN:<span class="NLM_cas:issn">1750-7448</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  CD73 is a novel immune checkpoint assocd. with adenosine metab. that promotes tumor progression by suppressing antitumor immune response and promoting angiogenesis.  The inhibition of CD73, in combination with immune checkpoint blockade, targeted therapy or conventional therapy, improves antitumor effects in numerous preclin. mouse models of cancer.  Emerging evidence suggests that the combination of anti-CD73 and immune checkpoint blockade has promising clin. activity in patients with advanced solid tumors.  In this review, we will discuss the specific role of CD73 on both tumor cells and nontumor cells in regulating tumor immunity and tumorigenesis and provide an update on the current view of the antitumor activity of targeting CD73 by mAb or small mol. selective inhibitors in preclin. and clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGyU8cLKovBbVg90H21EOLACvtfcHk0ljMmVT4tUYqzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVGntbrN&md5=ea8d2f4f26039a1aff0f2eb2159c8b07</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.2217%2Fimt-2018-0200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fimt-2018-0200%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DWainwright%26aufirst%3DD.%2BA.%26aulast%3DWu%26aufirst%3DJ.%2BD.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DMatei%26aufirst%3DD.%2BE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DB.%26atitle%3DCD73%253A%2520An%2520Emerging%2520Checkpoint%2520for%2520Cancer%2520Immunotherapy%26jtitle%3DImmunotherapy%26date%3D2019%26volume%3D11%26spage%3D983%26epage%3D997%26doi%3D10.2217%2Fimt-2018-0200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span> For a review see<span class="NLM_contrib-group"><span class="NLM_string-name">Corbelini, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueiro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machado
das Neves, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawano, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira
Battastini, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eifler-Lima, V. L.</span></span> <span> </span><span class="NLM_article-title">Insights into Ecto-5′-Nucleotidase as a New Target for Cancer Therapy: A Medicinal Chemistry Study</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1776</span>– <span class="NLM_lpage">1792</span>, <span class="refDoi"> DOI: 10.2174/0929867322666150408112615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.2174%2F0929867322666150408112615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=25850771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVGnuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=1776-1792&author=P.+F.+Corbeliniauthor=F.+Figueiroauthor=G.+Machado%0Adas+Nevesauthor=S.+Andradeauthor=D.+F.+Kawanoauthor=A.+M.+Oliveira%0ABattastiniauthor=V.+L.+Eifler-Lima&title=Insights+into+Ecto-5%E2%80%B2-Nucleotidase+as+a+New+Target+for+Cancer+Therapy%3A+A+Medicinal+Chemistry+Study&doi=10.2174%2F0929867322666150408112615"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into Ecto-5'-Nucleotidase as a New Target for Cancer Therapy: A Medicinal Chemistry Study</span></div><div class="casAuthors">Corbelini, Patricia Frasson; Figueiro, Fabricio; Machado das Neves, Gustavo; Andrade, Saulo; Kawano, Daniel Fabio; Oliveira Battastini, Ana Maria; Eifler-Lima, Vera Lucia</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1776-1792</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Ecto-5'-nucleotidase (ecto-5'-NT, 5'-NT, eN, CD73) is a membrane ectoenzyme that is primarily responsible for the extracellular prodn. of adenosine from AMP.  Ecto-5'-NT is overexpressed in various types of cancer cells, leading to elevated concns. of adenosine in the tumor microenvironment.  Adenosine has also been found to be important in cancer pathogenesis, showing strong immunosuppressive effects over antitumor T cells and macrophages and promoting neovascularization and cell adherence.  These actions support tumor growth and development.  It has been suggested that the inhibition of ecto-5'-NT results in lower extracellular concns. of adenosine within the tumor microenvironment, which would directly affect cancer cells and render malignant cells more susceptible to host defense systems.  Such mechanisms are proposed to represent promising new targets for cancer therapy.  The aim of this review is to explore the biochem. and structural features of ecto-5'-NT, including a brief anal. of its active site by mol. modeling, as a means of evaluating whether the inhibition of this enzyme does indeed represent a feasible strategy for treating cancer.  Known inhibitors and possible prototypes that could be used to target ecto-5'-NT during cancer therapy are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxGNC2_iGAn7Vg90H21EOLACvtfcHk0ljMmVT4tUYqzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVGnuro%253D&md5=29a35d2e469dc2e69823eb0f8a428e28</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F0929867322666150408112615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666150408112615%26sid%3Dliteratum%253Aachs%26aulast%3DCorbelini%26aufirst%3DP.%2BF.%26aulast%3DFigueiro%26aufirst%3DF.%26aulast%3DMachado%2Bdas%2BNeves%26aufirst%3DG.%26aulast%3DAndrade%26aufirst%3DS.%26aulast%3DKawano%26aufirst%3DD.%2BF.%26aulast%3DOliveira%2BBattastini%26aufirst%3DA.%2BM.%26aulast%3DEifler-Lima%26aufirst%3DV.%2BL.%26atitle%3DInsights%2520into%2520Ecto-5%25E2%2580%25B2-Nucleotidase%2520as%2520a%2520New%2520Target%2520for%2520Cancer%2520Therapy%253A%2520A%2520Medicinal%2520Chemistry%2520Study%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26spage%3D1776%26epage%3D1792%26doi%3D10.2174%2F0929867322666150408112615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Divisekera, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharkey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denoyer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, M. J.</span></span> <span> </span><span class="NLM_article-title">Anti-CD73 Antibody Therapy Inhibits Breast Tumor Growth and Metastasis</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">1547</span>– <span class="NLM_lpage">1552</span>, <span class="refDoi"> DOI: 10.1073/pnas.0908801107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1073%2Fpnas.0908801107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=20080644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslOrs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=1547-1552&author=J.+Staggauthor=U.+Divisekeraauthor=N.+McLaughlinauthor=J.+Sharkeyauthor=S.+Pommeyauthor=D.+Denoyerauthor=K.+M.+Dwyerauthor=M.+J.+Smyth&title=Anti-CD73+Antibody+Therapy+Inhibits+Breast+Tumor+Growth+and+Metastasis&doi=10.1073%2Fpnas.0908801107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis</span></div><div class="casAuthors">Stagg, John; Divisekera, Upulie; McLaughlin, Nicole; Sharkey, Janelle; Pommey, Sandra; Denoyer, Delphine; Dwyer, Karen M.; Smyth, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1547-1552, S1547/1-S1547/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Extracellular adenosine is a potent immunosuppressor that accumulates during tumor growth.  We performed proof-of-concept studies investigating the therapeutic potential and mechanism of action of monoclonal antibody (mAb)-based therapy against CD73, an ecto-enzyme overexpressed on breast-cancer cells that catalyzes the dephosphorylation of adenosine monophosphates into adenosine.  We showed that anti-CD73 mAb therapy significantly delayed primary 4T1.2 and E0771 tumor growth in immune-competent mice and significantly inhibited the development of spontaneous 4T1.2 lung metastases.  Notably, anti-CD73 mAb therapy was essentially dependent on the induction of adaptive anti-tumor immune responses.  Knockdown of CD73 in 4T1.2 tumor cells confirmed the tumor-promoting effects of CD73.  In addn. to its immunosuppressive effect, CD73 enhanced tumor cell chemotaxis, suggesting a role for CD73-derived adenosine in tumor metastasis.  Accordingly, administration of adenosine-5'-N-ethylcarboxamide to tumor-bearing mice significantly enhanced spontaneous 4T1.2 lung metastasis.  Using selective adenosine-receptor antagonists, we showed that activation of A2B adenosine receptors promoted 4T1.2 tumor cell chemotaxis in vitro and metastasis in vivo.  In conclusion, our study identified tumor-derived CD73 as a mechanism of tumor immune escape and tumor metastasis, and it also established the proof of concept that targeted therapy against CD73 can trigger adaptive anti-tumor immunity and inhibit metastasis of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT2etrhOGG3bVg90H21EOLACvtfcHk0lgQanATQ4t4Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslOrs7o%253D&md5=7bafdf788526df932910865c2e291959</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0908801107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0908801107%26sid%3Dliteratum%253Aachs%26aulast%3DStagg%26aufirst%3DJ.%26aulast%3DDivisekera%26aufirst%3DU.%26aulast%3DMcLaughlin%26aufirst%3DN.%26aulast%3DSharkey%26aufirst%3DJ.%26aulast%3DPommey%26aufirst%3DS.%26aulast%3DDenoyer%26aufirst%3DD.%26aulast%3DDwyer%26aufirst%3DK.%2BM.%26aulast%3DSmyth%26aufirst%3DM.%2BJ.%26atitle%3DAnti-CD73%2520Antibody%2520Therapy%2520Inhibits%2520Breast%2520Tumor%2520Growth%2520and%2520Metastasis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D1547%26epage%3D1552%26doi%3D10.1073%2Fpnas.0908801107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattarai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freundlieb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pippel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yegutkin, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Tayeb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selectve <i>ecto</i>-5′-Nucleotidase (CD73) Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6248</span>– <span class="NLM_lpage">6263</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00802</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00802" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFejt7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6248-6263&author=S.+Bhattaraiauthor=M.+Freundliebauthor=J.+Pippelauthor=A.+Meyerauthor=A.+Abdelrahmanauthor=A.+Fieneauthor=S.-Y.+Leeauthor=H.+Zimmermanauthor=G.+G.+Yegutkinauthor=N.+Str%C3%A4terauthor=A.+El-Tayebauthor=C.+E.+M%C3%BCller&title=%CE%B1%2C%CE%B2-Methylene-ADP+%28AOPCP%29+Derivatives+and+Analogues%3A+Development+of+Potent+and+Selectve+ecto-5%E2%80%B2-Nucleotidase+%28CD73%29+Inhibitors&doi=10.1021%2Facs.jmedchem.5b00802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selective ecto-5'-Nucleotidase (CD73) Inhibitors</span></div><div class="casAuthors">Bhattarai, Sanjay; Freundlieb, Marianne; Pippel, Jan; Meyer, Anne; Abdelrahman, Aliaa; Fiene, Amelie; Lee, Sang-Yong; Zimmermann, Herbert; Yegutkin, Gennady G.; Straeter, Norbert; El-Tayeb, Ali; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6248-6263</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ecto-5'-Nucleotidase (eN, CD73) catalyzes the hydrolysis of extracellular AMP to adenosine. eN inhibitors have potential for use as cancer therapeutics.  The eN inhibitor α,β-methylene-ADP (AOPCP, adenosine-5'-O-[(phosphonomethyl)phosphonic acid]) was used as a lead structure, and derivs. modified in various positions were prepd.  Products were tested at rat recombinant eN.  6-(Ar)alkylamino substitution led to the largest improvement in potency.  N6-Monosubstitution was superior to sym. N6,N6-disubstitution.  The most potent inhibitors were N6-(4-chlorobenzyl)- (PSB-12441, Ki 7.23 nM), N6-phenylethyl- (PSB-12425, Ki 8.04 nM), and N6-benzyl-adenosine-5'-O-[(phosphonomethyl)phosphonic acid] I (PSB-12379, Ki 9.03 nM).  Replacement of the 6-NH group in I by O (PSB-12431) or S (PSB-12553) yielded equally potent inhibitors (9.20 nM and 9.50 nM, resp.).  Selected compds. investigated at the human enzyme did not show species differences; they displayed high selectivity vs. other ecto-nucleotidases and ADP-activated P2Y receptors.  Moreover, high metabolic stability was obsd.  These compds. represent the most potent eN inhibitors described to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTmxberqVtKLVg90H21EOLACvtfcHk0lgQanATQ4t4Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFejt7fF&md5=5f1231a662dd86345b9d3803f1c4e716</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00802%26sid%3Dliteratum%253Aachs%26aulast%3DBhattarai%26aufirst%3DS.%26aulast%3DFreundlieb%26aufirst%3DM.%26aulast%3DPippel%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DAbdelrahman%26aufirst%3DA.%26aulast%3DFiene%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DS.-Y.%26aulast%3DZimmerman%26aufirst%3DH.%26aulast%3DYegutkin%26aufirst%3DG.%2BG.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26aulast%3DEl-Tayeb%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3D%25CE%25B1%252C%25CE%25B2-Methylene-ADP%2520%2528AOPCP%2529%2520Derivatives%2520and%2520Analogues%253A%2520Development%2520of%2520Potent%2520and%2520Selectve%2520ecto-5%25E2%2580%25B2-Nucleotidase%2520%2528CD73%2529%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6248%26epage%3D6263%26doi%3D10.1021%2Facs.jmedchem.5b00802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Debien, L. P. P.</span>; <span class="NLM_string-name">Jaen, J. C.</span>; <span class="NLM_string-name">Kalisiak, J.</span>; <span class="NLM_string-name">Lawson, K. V.</span>; <span class="NLM_string-name">Leleti, M. R.</span>; <span class="NLM_string-name">Lindsey, E. A.</span>; <span class="NLM_string-name">Miles, D. H.</span>; <span class="NLM_string-name">Newcomb, E.</span>; <span class="NLM_string-name">Powers, J. P.</span>; <span class="NLM_string-name">Rosen, B. R.</span>; <span class="NLM_string-name">Sharif, E. U.</span></span> <span> </span><span class="NLM_article-title">Modulators of 5′-Nucleotidase, Ecto and The Use Thereof</span>. <span class="NLM_patent">US2017/0267710 A1</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=L.+P.+P.+Debien&author=J.+C.+Jaen&author=J.+Kalisiak&author=K.+V.+Lawson&author=M.+R.+Leleti&author=E.+A.+Lindsey&author=D.+H.+Miles&author=E.+Newcomb&author=J.+P.+Powers&author=B.+R.+Rosen&author=E.+U.+Sharif&title=Modulators+of+5%E2%80%B2-Nucleotidase%2C+Ecto+and+The+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDebien%26aufirst%3DL.%2BP.%2BP.%26atitle%3DModulators%2520of%25205%25E2%2580%25B2-Nucleotidase%252C%2520Ecto%2520and%2520The%2520Use%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharif, E. U.</span>; <span class="NLM_string-name">Lawson, K. V.</span>; <span class="NLM_string-name">Kalisiak, J.</span>; <span class="NLM_string-name">Lindsey, E. A.</span>; <span class="NLM_string-name">Newcomb, E.</span>; <span class="NLM_string-name">Rosen, B. R.</span>; <span class="NLM_string-name">Walker, N.</span>; <span class="NLM_string-name">Jin, L.</span>; <span class="NLM_string-name">Scaletti, E. R.</span>; <span class="NLM_string-name">Sträter, N.</span>; <span class="NLM_string-name">Chen, A.</span>; <span class="NLM_string-name">Leleti, M. R.</span>; <span class="NLM_string-name">Powers, J. P.</span></span> <span> </span><span class="NLM_article-title">Discovery and Characterization of Potent and Selective Small-Molecule Inhibitors of Ecto-Nucleotidase CD73 for Cancer Immunotherapy</span>,  <i>ACS National Meeting and Exposition</i>, <span class="NLM_publisher-loc">Orlando, FL</span>, March 31–April 4, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=E.+U.+Sharif&author=K.+V.+Lawson&author=J.+Kalisiak&author=E.+A.+Lindsey&author=E.+Newcomb&author=B.+R.+Rosen&author=N.+Walker&author=L.+Jin&author=E.+R.+Scaletti&author=N.+Str%C3%A4ter&author=A.+Chen&author=M.+R.+Leleti&author=J.+P.+Powers&title=Discovery+and+Characterization+of+Potent+and+Selective+Small-Molecule+Inhibitors+of+Ecto-Nucleotidase+CD73+for+Cancer+Immunotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DSharif%26aufirst%3DE.%2BU.%26atitle%3DDiscovery%2520and%2520Characterization%2520of%2520Potent%2520and%2520Selective%2520Small-Molecule%2520Inhibitors%2520of%2520Ecto-Nucleotidase%2520CD73%2520for%2520Cancer%2520Immunotherapy%26jtitle%3DACS%2520National%2520Meeting%2520and%2520Exposition%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalisiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomb, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leleti, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debien, L. P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharif, E. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moschütz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaletti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schindler, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of AB680–A Potent and Selective Inhibitor of CD73</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">11448</span>– <span class="NLM_lpage">11468</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00525</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00525" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlWqs7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=11448-11468&author=K.+V.+Lawsonauthor=J.+Kalisiakauthor=E.+A.+Lindseyauthor=E.+Newcombauthor=M.+R.+Leletiauthor=L.+P.+P.+Debienauthor=B.+R.+Rosenauthor=D.+H.+Milesauthor=E.+U.+Sharifauthor=J.+Jeffreyauthor=J.+Tanauthor=A.+Chenauthor=S.+Zhaoauthor=G.+Xuauthor=L.+Fuauthor=L.+Jinauthor=T.+Parkauthor=W.+Berryauthor=S.+Mosch%C3%BCtzauthor=E.+Scalettiauthor=N.+Str%C3%A4terauthor=N.+Walkerauthor=S.+Youngauthor=M.+Waltersauthor=U.+Schindlerauthor=J.+P.+Powers&title=Discovery+of+AB680%E2%80%93A+Potent+and+Selective+Inhibitor+of+CD73&doi=10.1021%2Facs.jmedchem.0c00525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of AB680: A Potent and Selective Inhibitor of CD73</span></div><div class="casAuthors">Lawson, Kenneth V.; Kalisiak, Jaroslaw; Lindsey, Erick A.; Newcomb, Eric T.; Leleti, Manmohan Reddy; Debien, Laurent; Rosen, Brandon R.; Miles, Dillon H.; Sharif, Ehesan U.; Jeffrey, Jenna L.; Tan, Joanne B. L.; Chen, Ada; Zhao, Sharon; Xu, Guifen; Fu, Lijuan; Jin, Lixia; Park, Tim W.; Berry, Wade; Moschutz, Susanne; Scaletti, Emma; Strater, Norbert; Walker, Nigel P.; Young, Stephen W.; Walters, Matthew J.; Schindler, Uli; Powers, Jay P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">11448-11468</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Extracellular adenosine (ADO), present in high concns. in the tumor microenvironment (TME), suppresses immune function via inhibition of T cell and NK cell activation.  Intratumoral generation of ADO depends on the sequential catabolism of ATP by two ecto-nucleotidases, CD39 (ATP → AMP) and CD73 (AMP → ADO).  Inhibition of CD73 eliminates a major pathway of ADO prodn. in the TME and can reverse ADO-mediated immune suppression.  Extensive interrogation of structure-activity relationships (SARs), structure-based drug design, and optimization of pharmacokinetic properties culminated in the discovery of AB680, a highly potent (Ki = 5 pM), reversible, and selective inhibitor of CD73.  AB680 is further characterized by very low clearance and long half-lives across preclin. species, resulting in a PK profile suitable for long-acting parenteral administration.  AB680 is currently being evaluated in phase 1 clin. trials.  Initial data show AB680 is well tolerated and exhibits a pharmacokinetic profile suitable for biweekly (Q2W) iv-administration in human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIAhGPLddUtrVg90H21EOLACvtfcHk0lirNBn0wdjNQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlWqs7fO&md5=6e4fcbc045e56d2ecb3807ffc9050649</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00525%26sid%3Dliteratum%253Aachs%26aulast%3DLawson%26aufirst%3DK.%2BV.%26aulast%3DKalisiak%26aufirst%3DJ.%26aulast%3DLindsey%26aufirst%3DE.%2BA.%26aulast%3DNewcomb%26aufirst%3DE.%26aulast%3DLeleti%26aufirst%3DM.%2BR.%26aulast%3DDebien%26aufirst%3DL.%2BP.%2BP.%26aulast%3DRosen%26aufirst%3DB.%2BR.%26aulast%3DMiles%26aufirst%3DD.%2BH.%26aulast%3DSharif%26aufirst%3DE.%2BU.%26aulast%3DJeffrey%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DPark%26aufirst%3DT.%26aulast%3DBerry%26aufirst%3DW.%26aulast%3DMosch%25C3%25BCtz%26aufirst%3DS.%26aulast%3DScaletti%26aufirst%3DE.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26aulast%3DWalker%26aufirst%3DN.%26aulast%3DYoung%26aufirst%3DS.%26aulast%3DWalters%26aufirst%3DM.%26aulast%3DSchindler%26aufirst%3DU.%26aulast%3DPowers%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520of%2520AB680%25E2%2580%2593A%2520Potent%2520and%2520Selective%2520Inhibitor%2520of%2520CD73%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D11448%26epage%3D11468%26doi%3D10.1021%2Facs.jmedchem.0c00525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalisiak, J.</span>; <span class="NLM_string-name">Lawson, K. V.</span>; <span class="NLM_string-name">Leleti, M. R.</span>; <span class="NLM_string-name">Lindsey, E. A.</span>; <span class="NLM_string-name">Miles, D. H.</span>; <span class="NLM_string-name">Newcomb, E.</span>; <span class="NLM_string-name">Powers, J. P.</span>; <span class="NLM_string-name">Sharif, E. U.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of CD73-Mediated Immunosuppression</span>. <span class="NLM_patent">WO2018/094148 A1</span><span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+Kalisiak&author=K.+V.+Lawson&author=M.+R.+Leleti&author=E.+A.+Lindsey&author=D.+H.+Miles&author=E.+Newcomb&author=J.+P.+Powers&author=E.+U.+Sharif&title=Inhibitors+of+CD73-Mediated+Immunosuppression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKalisiak%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520CD73-Mediated%2520Immunosuppression%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. W.</span></span> <span> </span><span class="NLM_article-title">An Exceptionally Potent Inhibitor of Human CD73</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3331</span>– <span class="NLM_lpage">3334</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.9b00448</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.9b00448" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVWjur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=3331-3334&author=C.+E.+Bowmanauthor=R.+G.+da+Silvaauthor=A.+Phamauthor=S.+W.+Young&title=An+Exceptionally+Potent+Inhibitor+of+Human+CD73&doi=10.1021%2Facs.biochem.9b00448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7eR"><div class="casContent"><span class="casTitleNuber">7e</span><div class="casTitle"><span class="NLM_cas:atitle">An Exceptionally Potent Inhibitor of Human CD73</span></div><div class="casAuthors">Bowman, Christine E.; da Silva, Rafael G.; Pham, Amber; Young, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">3331-3334</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We recently reported the initiation of a Phase I clin. trial with AB680, a potent human CD73 inhibitor, being developed for the treatment of solid tumors (NCT03677973).  We undertook a detailed kinetic anal. of the interaction between human CD73 and AB680 to det. the mode of inhibition.  We found AB680 to be a reversible, slow-onset competitive inhibitor of human CD73 with a Ki of 5 pM.  Clin. candidates of this potency are uncommon and deserve special consideration during lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYGag3hdjGb7Vg90H21EOLACvtfcHk0lirNBn0wdjNQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVWjur3O&md5=ad600cb74b603c4daa3c5f002e1c5f4a</span></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.9b00448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.9b00448%26sid%3Dliteratum%253Aachs%26aulast%3DBowman%26aufirst%3DC.%2BE.%26aulast%3Dda%2BSilva%26aufirst%3DR.%2BG.%26aulast%3DPham%26aufirst%3DA.%26aulast%3DYoung%26aufirst%3DS.%2BW.%26atitle%3DAn%2520Exceptionally%2520Potent%2520Inhibitor%2520of%2520Human%2520CD73%26jtitle%3DBiochemistry%26date%3D2019%26volume%3D58%26spage%3D3331%26epage%3D3334%26doi%3D10.1021%2Facs.biochem.9b00448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Cacatian, S.</span>; <span class="NLM_string-name">Claremon, S. A.</span>; <span class="NLM_string-name">Jia, L.</span>; <span class="NLM_string-name">Morales-Ramos, A.</span>; <span class="NLM_string-name">Singh, S. B.</span>; <span class="NLM_string-name">Venkatraman, S.</span>; <span class="NLM_string-name">Xu, Z.</span>; <span class="NLM_string-name">Zheng, Y.</span></span> <span> </span><span class="NLM_article-title">Purine Derivatives as CD73 Inhibitors for the Treatment of Cancer</span>. <span class="NLM_patent">WO2015164573</span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+Cacatian&author=S.+A.+Claremon&author=L.+Jia&author=A.+Morales-Ramos&author=S.+B.+Singh&author=S.+Venkatraman&author=Z.+Xu&author=Y.+Zheng&title=Purine+Derivatives+as+CD73+Inhibitors+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCacatian%26aufirst%3DS.%26atitle%3DPurine%2520Derivatives%2520as%2520CD73%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Cancer%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span>; <span class="NLM_string-name">Ll, J.</span>; <span class="NLM_string-name">Sjogren, E. B.</span>; <span class="NLM_string-name">Billedeau, R. J.</span></span> <span> </span><span class="NLM_article-title">Ectonucleotidase Inhibitors and Methods of Use Thereof</span>. <span class="NLM_patent">WO2018049145</span><span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=L.+Chen&author=J.+Ll&author=E.+B.+Sjogren&author=R.+J.+Billedeau&title=Ectonucleotidase+Inhibitors+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26atitle%3DEctonucleotidase%2520Inhibitors%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Billedeau, R. J.</span>; <span class="NLM_string-name">Ll, J.</span>; <span class="NLM_string-name">Chen, L.</span></span> <span> </span><span class="NLM_article-title">Ectonucleotidase Inhibitors and Methods of Use Thereof</span>. <span class="NLM_patent">WO2018119284</span><span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=R.+J.+Billedeau&author=J.+Ll&author=L.+Chen&title=Ectonucleotidase+Inhibitors+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBilledeau%26aufirst%3DR.%2BJ.%26atitle%3DEctonucleotidase%2520Inhibitors%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span>; <span class="NLM_string-name">Yang, H.</span>; <span class="NLM_string-name">Bedke, K.</span>; <span class="NLM_string-name">Wehn, P.</span>; <span class="NLM_string-name">Rizzi, J. P.</span></span> <span> </span><span class="NLM_article-title">CD73 Inhibitors and Uses Thereof</span>. <span class="NLM_patent">WO2018183635</span><span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=B.+Wang&author=H.+Yang&author=K.+Bedke&author=P.+Wehn&author=J.+P.+Rizzi&title=CD73+Inhibitors+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DB.%26atitle%3DCD73%2520Inhibitors%2520and%2520Uses%2520Thereof%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span>; <span class="NLM_string-name">Zhuang, L.</span>; <span class="NLM_string-name">Wu, H.</span>; <span class="NLM_string-name">Liu, S.</span>; <span class="NLM_string-name">Zhang, R.</span></span> <span> </span><span class="NLM_article-title">Nucleoside and Nucleotide Analogues as CD73 Inhibitors and Therapeutic Uses Thereof</span>. <span class="NLM_patent">WO2018208727</span><span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+Liu&author=L.+Zhuang&author=H.+Wu&author=S.+Liu&author=R.+Zhang&title=Nucleoside+and+Nucleotide+Analogues+as+CD73+Inhibitors+and+Therapeutic+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DNucleoside%2520and%2520Nucleotide%2520Analogues%2520as%2520CD73%2520Inhibitors%2520and%2520Therapeutic%2520Uses%2520Thereof%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Eksterowicz, J.</span>; <span class="NLM_string-name">Fantin, V. R.</span>; <span class="NLM_string-name">Jackson, E. L.</span>; <span class="NLM_string-name">Sun, D.</span>; <span class="NLM_string-name">Ye, Q.</span>; <span class="NLM_string-name">Moore, J.</span>; <span class="NLM_string-name">Zavorotinskaya, T.</span></span> <span> </span><span class="NLM_article-title">CD73 Inhibitors</span>. <span class="NLM_patent">WO2019090111</span><span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=X.+Du&author=J.+Eksterowicz&author=V.+R.+Fantin&author=E.+L.+Jackson&author=D.+Sun&author=Q.+Ye&author=J.+Moore&author=T.+Zavorotinskaya&title=CD73+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7k&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DX.%26atitle%3DCD73%2520Inhibitors%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, H.</span>; <span class="NLM_string-name">Zhao, B.</span>; <span class="NLM_string-name">Yu, H.</span>; <span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">Phosphonic Acid Derivative Having CD73 Inhibitory Activity, and Preparation Method and Use thereof</span>. <span class="NLM_patent">WO2019129059A1</span><span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=H.+Deng&author=B.+Zhao&author=H.+Yu&author=Z.+Chen&author=Y.+Xu&title=Phosphonic+Acid+Derivative+Having+CD73+Inhibitory+Activity%2C+and+Preparation+Method+and+Use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DH.%26atitle%3DPhosphonic%2520Acid%2520Derivative%2520Having%2520CD73%2520Inhibitory%2520Activity%252C%2520and%2520Preparation%2520Method%2520and%2520Use%2520thereof%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. L.</span>; <span class="NLM_string-name">Ator, L. E.</span>; <span class="NLM_string-name">Duffy, K. J.</span>; <span class="NLM_string-name">Graybill, T. L.</span>; <span class="NLM_string-name">Kiesow, T. J.</span>; <span class="NLM_string-name">Lian, Y.</span>; <span class="NLM_string-name">Moore, M. L.</span>; <span class="NLM_string-name">Ralph, J. M.</span>; <span class="NLM_string-name">Ridgers, L. H.</span></span> <span> </span><span class="NLM_article-title">Benzothiadiazine Compounds</span>. <span class="NLM_patent">WO2017098421</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+L.+Adams&author=L.+E.+Ator&author=K.+J.+Duffy&author=T.+L.+Graybill&author=T.+J.+Kiesow&author=Y.+Lian&author=M.+L.+Moore&author=J.+M.+Ralph&author=L.+H.+Ridgers&title=Benzothiadiazine+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26atitle%3DBenzothiadiazine%2520Compounds%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. L.</span>; <span class="NLM_string-name">Duffy, K. J.</span>; <span class="NLM_string-name">Graybill, T. L.</span>; <span class="NLM_string-name">Moore, M. L.</span>; <span class="NLM_string-name">Neipp, C. E.</span>; <span class="NLM_string-name">Ralph, J. M.</span>; <span class="NLM_string-name">Squire, M. D.</span></span> <span> </span><span class="NLM_article-title">5-Sulfamoyl-2-Hydroxybenzamide Derivatives</span>. <span class="NLM_patent">WO2017153952A1</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+L.+Adams&author=K.+J.+Duffy&author=T.+L.+Graybill&author=M.+L.+Moore&author=C.+E.+Neipp&author=J.+M.+Ralph&author=M.+D.+Squire&title=5-Sulfamoyl-2-Hydroxybenzamide+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26atitle%3D5-Sulfamoyl-2-Hydroxybenzamide%2520Derivatives%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, K. J.</span>; <span class="NLM_string-name">Parrish, C. A.</span>; <span class="NLM_string-name">Ator, L. E.</span>; <span class="NLM_string-name">Baskaran, S.</span>; <span class="NLM_string-name">Darcy, M. G.</span>; <span class="NLM_string-name">Oplinger, J. A.</span>; <span class="NLM_string-name">Ralph, J. M.</span>; <span class="NLM_string-name">Ridgers, L. H.</span>; <span class="NLM_string-name">Tian, X.</span>; <span class="NLM_string-name">Zhang, C.</span></span> <span> </span><span class="NLM_article-title">Chemical Compounds</span>. <span class="NLM_patent">WO2019053617</span><span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=K.+J.+Duffy&author=C.+A.+Parrish&author=L.+E.+Ator&author=S.+Baskaran&author=M.+G.+Darcy&author=J.+A.+Oplinger&author=J.+M.+Ralph&author=L.+H.+Ridgers&author=X.+Tian&author=C.+Zhang&title=Chemical+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDuffy%26aufirst%3DK.%2BJ.%26atitle%3DChemical%2520Compounds%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Beatty, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas-Tran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debien, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drew, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leleti, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moschütz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, K. V.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">3935</span>– <span class="NLM_lpage">3955</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01713</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01713" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslCgsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=3935-3955&author=J.+W.+Beattyauthor=E.+A.+Lindseyauthor=R.+Thomas-Tranauthor=L.+Debienauthor=D.+Mandalauthor=J.+L.+Jeffreyauthor=A.+T.+Tranauthor=J.+Fournierauthor=S.+D.+Jacobauthor=X.+Yanauthor=S.+L.+Drewauthor=E.+Ginnauthor=A.+Chenauthor=S.+Zhaoauthor=L.+Jinauthor=S.+W.+Youngauthor=N.+Walkerauthor=M.+R.+Leletiauthor=S.+Mosch%C3%BCtzauthor=N.+Str%C3%A4terauthor=J.+P.+Powersauthor=K.+V.+Lawson&title=Discovery+of+Potent+and+Selective+Non-Nucleotide+Small+Molecule+Inhibitors+of+CD73&doi=10.1021%2Facs.jmedchem.9b01713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73</span></div><div class="casAuthors">Beatty, Joel W.; Lindsey, Erick A.; Thomas-Tran, Rhiannon; Debien, Laurent; Mandal, Debashis; Jeffrey, Jenna L.; Tran, Anh T.; Fournier, Jeremy; Jacob, Steven D.; Yan, Xuelei; Drew, Samuel L.; Ginn, Elaine; Chen, Ada; Pham, Amber T.; Zhao, Sharon; Jin, Lixia; Young, Stephen W.; Walker, Nigel P.; Leleti, Manmohan Reddy; Moschutz, Susanne; Strater, Norbert; Powers, Jay P.; Lawson, Kenneth V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3935-3955</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CD73 is an extracellular mediator of purinergic signaling.  When upregulated in the tumor microenvironment, CD73 has been implicated in the inhibition of immune function through overprodn. of adenosine.  Traditional efforts to inhibit CD73 have involved antibody therapy or the development of small mols., the most potent of which mimic the acidic and ionizable structure of the enzyme's natural substrate, AMP (AMP).  Here, we report the systematic discovery of a novel class of non-nucleotide CD73 inhibitors that are more potent than all other nonphosphonate inhibitor classes reported to date.  These efforts have culminated in the discovery of 4-({5-[4-fluoro-1-(2H-indazol-6-yl)-1H-1,2,3-benzotriazol-6-yl]-1H-pyrazol-1-yl}methyl)benzonitrile (73, IC50 = 12 nM) and 4-({5-[4-chloro-1-(2H-indazol-6-yl)-1H-1,2,3-benzotriazol-6-yl]-1H-pyrazol-1-yl}methyl)benzonitrile (74, IC50 = 19 nM).  Cocrystn. of 74 with human CD73 demonstrates a competitive binding mode.  These compds. show promise for the improvement of drug-like character via the attenuation of the acidity and low membrane permeability inherent to known nucleoside inhibitors of CD73.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxjIt23HCPD7Vg90H21EOLACvtfcHk0ljQ9B6HNPWNHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslCgsb8%253D&md5=52f39aa24bfc4e36a2e8218404ab2079</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01713%26sid%3Dliteratum%253Aachs%26aulast%3DBeatty%26aufirst%3DJ.%2BW.%26aulast%3DLindsey%26aufirst%3DE.%2BA.%26aulast%3DThomas-Tran%26aufirst%3DR.%26aulast%3DDebien%26aufirst%3DL.%26aulast%3DMandal%26aufirst%3DD.%26aulast%3DJeffrey%26aufirst%3DJ.%2BL.%26aulast%3DTran%26aufirst%3DA.%2BT.%26aulast%3DFournier%26aufirst%3DJ.%26aulast%3DJacob%26aufirst%3DS.%2BD.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DDrew%26aufirst%3DS.%2BL.%26aulast%3DGinn%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DYoung%26aufirst%3DS.%2BW.%26aulast%3DWalker%26aufirst%3DN.%26aulast%3DLeleti%26aufirst%3DM.%2BR.%26aulast%3DMosch%25C3%25BCtz%26aufirst%3DS.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26aulast%3DPowers%26aufirst%3DJ.%2BP.%26aulast%3DLawson%26aufirst%3DK.%2BV.%26atitle%3DDiscovery%2520of%2520Potent%2520and%2520Selective%2520Non-Nucleotide%2520Small%2520Molecule%2520Inhibitors%2520of%2520CD73%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D3935%26epage%3D3955%26doi%3D10.1021%2Facs.jmedchem.9b01713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pippel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Tayeb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of the Human Ecto-5′-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2161</span>– <span class="NLM_lpage">2173</span>, <span class="refDoi"> DOI: 10.1016/j.str.2012.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1016%2Fj.str.2012.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=23142347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqu7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=2161-2173&author=K.+Knappauthor=M.+Zebischauthor=J.+Pippelauthor=A.+El-Tayebauthor=C.+E.+M%C3%BCllerauthor=N.+Str%C3%A4ter&title=Crystal+Structure+of+the+Human+Ecto-5%E2%80%B2-Nucleotidase+%28CD73%29%3A+Insights+into+the+Regulation+of+Purinergic+Signaling&doi=10.1016%2Fj.str.2012.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Human Ecto-5'-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling</span></div><div class="casAuthors">Knapp, Karen; Zebisch, Matthias; Pippel, Jan; El-Tayeb, Ali; Mueller, Christa E.; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2161-2173</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In vertebrates ecto-5'-nucleotidase (e5NT) catalyzes the hydrolysis of extracellular AMP to adenosine and represents the major control point for extracellular adenosine levels.  Due to its pivotal role for activation of P1 adenosine receptors, e5NT has emerged as an appealing drug target for treatment of inflammation, chronic pain, hypoxia, and cancer.  Crystal structures of the dimeric human e5NT reveal an extensive 114° conformational switch between the open and closed forms of the enzyme.  The dimerization interface is formed by the C-terminal domains and exhibits interchain motions of up to 13°.  Complex structures with adenosine and AMPCP indicate that structural control of the domain movement dets. the selectivity for monophosphate nucleotides.  Binding modes of nucleotide-derived and flavonoid-based compds. complexed to the C-terminal domain in the open form reveal an addnl. binding pocket of ∼210 Å3 that might be explored to design more potent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8MOj4dwx2J7Vg90H21EOLACvtfcHk0ljQ9B6HNPWNHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqu7jK&md5=e108171e8079cca4dd11483dfacb909e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2012.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2012.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DKnapp%26aufirst%3DK.%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DPippel%26aufirst%3DJ.%26aulast%3DEl-Tayeb%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Human%2520Ecto-5%25E2%2580%25B2-Nucleotidase%2520%2528CD73%2529%253A%2520Insights%2520into%2520the%2520Regulation%2520of%2520Purinergic%2520Signaling%26jtitle%3DStructure%26date%3D2012%26volume%3D20%26spage%3D2161%26epage%3D2173%26doi%3D10.1016%2Fj.str.2012.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattarai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pippel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaletti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freundlieb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolshoven, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Tayeb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5′-Nucleotidase (CD73) Inhibitors with Variable Binding Modes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2941</span>– <span class="NLM_lpage">2957</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01611</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01611" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BB3cXivVarsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=2941-2957&author=S.+Bhattaraiauthor=J.+Pippelauthor=E.+Scalettiauthor=R.+Idrisauthor=M.+Freundliebauthor=G.+Rolshovenauthor=C.+Rennauthor=S-Y.+Leeauthor=A.+Abdelrahmanauthor=H.+Zimmermanauthor=A.+El-Tayebauthor=C.+M%C3%BCllerauthor=N.+Str%C3%A4ter&title=2-Substituted+%CE%B1%2C%CE%B2-Methylene-ADP+Derivatives%3A+Potent+Competitive+Ecto-5%E2%80%B2-Nucleotidase+%28CD73%29+Inhibitors+with+Variable+Binding+Modes&doi=10.1021%2Facs.jmedchem.9b01611"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes</span></div><div class="casAuthors">Bhattarai, Sanjay; Pippel, Jan; Scaletti, Emma; Idris, Riham; Freundlieb, Marianne; Rolshoven, Georg; Renn, Christian; Lee, Sang-Yong; Abdelrahman, Aliaa; Zimmermann, Herbert; El-Tayeb, Ali; Mueller, Christa E.; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2941-2957</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CD73 inhibitors are promising drugs for the (immuno)therapy of cancer.  Here, we present the synthesis, structure-activity relationships, and co-crystal structures of novel derivs. of the competitive CD73 inhibitor α,β-methylene-ADP (AOPCP) substituted in the 2-position.  Small polar or lipophilic residues increased potency, 2-iodo- and 2-chloro-adenosine-5'-O-[(phosphonomethyl)phosphonic acid] (15, 16) being the most potent inhibitors with Ki values towards human CD73 of 3-6 nM.  Subject to the size and nature of the 2-substituent, variable binding modes were obsd. by X-ray crystallog.  Depending on the binding mode, large species differences were found, e.g. 2-piperazinyl-AOPCP (21) was >12-fold less potent against rat CD73 compared to human CD73.  This study shows that high CD73-inhibitory potency can be achieved by simply introducing a small substituent into the 2-position of AOPCP without the necessity of addnl. bulky N6-substituents.  Moreover, it provides valuable insights into the binding modes of competitive CD73 inhibitors, representing an excellent basis for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK0OpQBzKNX7Vg90H21EOLACvtfcHk0ljQ9B6HNPWNHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXivVarsbg%253D&md5=453dcd3d41f20b380c951ddf6e05fe3a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01611%26sid%3Dliteratum%253Aachs%26aulast%3DBhattarai%26aufirst%3DS.%26aulast%3DPippel%26aufirst%3DJ.%26aulast%3DScaletti%26aufirst%3DE.%26aulast%3DIdris%26aufirst%3DR.%26aulast%3DFreundlieb%26aufirst%3DM.%26aulast%3DRolshoven%26aufirst%3DG.%26aulast%3DRenn%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DS-Y.%26aulast%3DAbdelrahman%26aufirst%3DA.%26aulast%3DZimmerman%26aufirst%3DH.%26aulast%3DEl-Tayeb%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3D2-Substituted%2520%25CE%25B1%252C%25CE%25B2-Methylene-ADP%2520Derivatives%253A%2520Potent%2520Competitive%2520Ecto-5%25E2%2580%25B2-Nucleotidase%2520%2528CD73%2529%2520Inhibitors%2520with%2520Variable%2520Binding%2520Modes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D2941%26epage%3D2957%26doi%3D10.1021%2Facs.jmedchem.9b01611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cholongitasa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papatheodoridisb, G. V.</span></span> <span> </span><span class="NLM_article-title">Sofosbuvir: A Novel Oral Agent for Chronic Hepatitis C</span>. <i>Ann. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">337</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=25332066" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=331-337&author=E.+Cholongitasaauthor=G.+V.+Papatheodoridisb&title=Sofosbuvir%3A+A+Novel+Oral+Agent+for+Chronic+Hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCholongitasa%26aufirst%3DE.%26aulast%3DPapatheodoridisb%26aufirst%3DG.%2BV.%26atitle%3DSofosbuvir%253A%2520A%2520Novel%2520Oral%2520Agent%2520for%2520Chronic%2520Hepatitis%2520C%26jtitle%3DAnn.%2520Gastroenterol.%26date%3D2014%26volume%3D27%26spage%3D331%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Arimilli, M. N.</span>; <span class="NLM_string-name">Cundy, K. C.</span>; <span class="NLM_string-name">Dougherty, J. P.</span>; <span class="NLM_string-name">Kim, C. U.</span>; <span class="NLM_string-name">Reza, O.</span>; <span class="NLM_string-name">Stella, V. J.</span></span> <span> </span><span class="NLM_article-title">Antiviral Phosphonomethoxy Nucleotide Analogs Having Incrased Oral Bioavailability</span>. <span class="NLM_patent">US5977089A</span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=M.+N.+Arimilli&author=K.+C.+Cundy&author=J.+P.+Dougherty&author=C.+U.+Kim&author=O.+Reza&author=V.+J.+Stella&title=Antiviral+Phosphonomethoxy+Nucleotide+Analogs+Having+Incrased+Oral+Bioavailability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArimilli%26aufirst%3DM.%2BN.%26atitle%3DAntiviral%2520Phosphonomethoxy%2520Nucleotide%2520Analogs%2520Having%2520Incrased%2520Oral%2520Bioavailability%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Heidel, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowd, C.</span></span> <span> </span><span class="NLM_article-title">Phosphonate Prodrugs: An Overview and Recent Advances</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1625</span>– <span class="NLM_lpage">1643</span>, <span class="refDoi"> DOI: 10.4155/fmc-2018-0591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.4155%2Ffmc-2018-0591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=31469328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1yhtr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=1625-1643&author=K.+M.+Heidelauthor=C.+Dowd&title=Phosphonate+Prodrugs%3A+An+Overview+and+Recent+Advances&doi=10.4155%2Ffmc-2018-0591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphonate prodrugs: an overview and recent advances</span></div><div class="casAuthors">Heidel, Kenneth M.; Dowd, Cynthia S.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1625-1643</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Phosphonates, often used as isosteric replacements for phosphates, can provide important interactions with an enzyme.  Due to their high charge at physiol. pH, however, permeation into cells can be a challenge.  Protecting phosphonates as prodrugs has shown promise in drug delivery.  Thus, a variety of structures and cleavage/activation mechanisms exist, enabling release of the active compd.  This review describes the structural diversity of these pro-moieties, relevant cleavage mechanisms and recent advances in the design of phosphonate prodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8GcyRrVN8-rVg90H21EOLACvtfcHk0ljzinIfbxo3-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1yhtr3M&md5=461d5aa771bebc20ebdc78dc662e2467</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2018-0591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2018-0591%26sid%3Dliteratum%253Aachs%26aulast%3DHeidel%26aufirst%3DK.%2BM.%26aulast%3DDowd%26aufirst%3DC.%26atitle%3DPhosphonate%2520Prodrugs%253A%2520An%2520Overview%2520and%2520Recent%2520Advances%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2019%26volume%3D11%26spage%3D1625%26epage%3D1643%26doi%3D10.4155%2Ffmc-2018-0591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrew, J. W.</span>; <span class="NLM_string-name">David, F. W.</span></span> <span> </span><span class="NLM_article-title">Prodrugs of Phosphonates and Phosphates: Crossing the Membrane Barrier</span>.  <i>Topics in Current Chemistry</i>; <span class="NLM_publisher-name">Springer</span>, <span class="NLM_year">2015</span>; Vol  <span class="NLM_volume">360</span>, pp  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">160</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=115-160&author=J.+W.+Andrew&author=F.+W.+David&title=Topics+in+Current+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAndrew%26aufirst%3DJ.%2BW.%26atitle%3DProdrugs%2520of%2520Phosphonates%2520and%2520Phosphates%253A%2520Crossing%2520the%2520Membrane%2520Barrier%26btitle%3DTopics%2520in%2520Current%2520Chemistry%26pub%3DSpringer%26date%3D2015%26volume%3D360%26spage%3D115%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Stella, V. J.</span></span> <span> </span><span class="NLM_article-title">Prodrug Approaches to Enhancing the Oral Delivery of Poorly Permeable Drugs</span>.  <i>Prodrugs. Biotechnology: Pharmaceutical Aspects</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stella, V. J.</span>; <span class="NLM_string-name">Borchardt, R. T.</span>; <span class="NLM_string-name">Hageman, M. J.</span>; <span class="NLM_string-name">Oliyai, R.</span>; <span class="NLM_string-name">Maag, H.</span>; <span class="NLM_string-name">Tilley, J. W.</span></span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2007</span>; Vol.  <span class="NLM_volume">V</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1007%2F978-0-387-49785-3_2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=V.+J.+Stellaauthor=V.+J.+Stella&author=R.+T.+Borchardt&author=M.+J.+Hageman&author=R.+Oliyai&author=H.+Maag&author=J.+W.+Tilley&title=Prodrugs.+Biotechnology%3A+Pharmaceutical+Aspects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11e&amp;dbid=16384&amp;doi=10.1007%2F978-0-387-49785-3_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-0-387-49785-3_2%26sid%3Dliteratum%253Aachs%26aulast%3DStella%26aufirst%3DV.%2BJ.%26atitle%3DProdrug%2520Approaches%2520to%2520Enhancing%2520the%2520Oral%2520Delivery%2520of%2520Poorly%2520Permeable%2520Drugs%26btitle%3DProdrugs.%2520Biotechnology%253A%2520Pharmaceutical%2520Aspects%26aulast%3DStella%26aufirst%3DV.%2BJ.%26pub%3DSpringer%26date%3D2007%26volume%3DV" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Debien, L. P. P.</span>; <span class="NLM_string-name">Kalisiak, J.</span>; <span class="NLM_string-name">Lawson, K. V.</span>; <span class="NLM_string-name">Leleti, M. R.</span>; <span class="NLM_string-name">Lindsey, E. A.</span>; <span class="NLM_string-name">Miles, D. H.</span>; <span class="NLM_string-name">Newcomb, E.</span>; <span class="NLM_string-name">Powers, J. P.</span>; <span class="NLM_string-name">Rosen, B. R.</span>; <span class="NLM_string-name">Sharif, E. U.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Adenosine 5′-Nucleotidase</span>. <span class="NLM_patent">WO2018067424 A1</span><span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=L.+P.+P.+Debien&author=J.+Kalisiak&author=K.+V.+Lawson&author=M.+R.+Leleti&author=E.+A.+Lindsey&author=D.+H.+Miles&author=E.+Newcomb&author=J.+P.+Powers&author=B.+R.+Rosen&author=E.+U.+Sharif&title=Inhibitors+of+Adenosine+5%E2%80%B2-Nucleotidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDebien%26aufirst%3DL.%2BP.%2BP.%26atitle%3DInhibitors%2520of%2520Adenosine%25205%25E2%2580%25B2-Nucleotidase%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Holý, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, I.</span></span> <span> </span><span class="NLM_article-title">Preparation of 5′-O-Phosphonylmethyl Analogues of Nucleoside-5′-Phosphates, 5′-Diphosphates and 5′-Triphosphates</span>. <i>Collect. czech. Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">3447</span>– <span class="NLM_lpage">3463</span>, <span class="refDoi"> DOI: 10.1135/cccc19823447</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1135%2Fcccc19823447" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADyaL3sXhvFylsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1982&pages=3447-3463&author=A.+Hol%C3%BDauthor=I.+Rosenberg&title=Preparation+of+5%E2%80%B2-O-Phosphonylmethyl+Analogues+of+Nucleoside-5%E2%80%B2-Phosphates%2C+5%E2%80%B2-Diphosphates+and+5%E2%80%B2-Triphosphates&doi=10.1135%2Fcccc19823447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of 5'-O-phosphonylmethyl analogs of nucleoside-5'-phosphates, 5'-diphosphates and 5'-triphosphates</span></div><div class="casAuthors">Holy, Antonin; Rosenberg, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Collection of Czechoslovak Chemical Communications</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3447-63</span>CODEN:
                <span class="NLM_cas:coden">CCCCAK</span>;
        ISSN:<span class="NLM_cas:issn">0366-547X</span>.
    </div><div class="casAbstract">Reaction of 2',3'-O-protected nucleosides with p-MeC6H4SO3CH2P(O)(OR2)2 (R2 = Me, Et) in the presence of NaH, followed by acid hydrolysis gave (phosphonylmethyl)nucleosides I (R = MeO, EtO; R1 = uracil-1-yl, cytosin-1-yl, adenin-9-yl, guanin-9-yl, hypoxanthin-9-yl, 6-azauracil-1-yl), which on treatment with Me3SiI gave I (R = HO).  I (R = OH) on reaction with morpholine gave I (R = morpholino), which on phosphorylation gave I [R = (HO)2P(O)O, (HO)2P(O)OP(O)(OH)O].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDacPk849RBrVg90H21EOLACvtfcHk0lgm2WkUu2fOgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhvFylsbc%253D&md5=48346b1b8095d6b58f052503d27ffd59</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1135%2Fcccc19823447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1135%252Fcccc19823447%26sid%3Dliteratum%253Aachs%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26aulast%3DRosenberg%26aufirst%3DI.%26atitle%3DPreparation%2520of%25205%25E2%2580%25B2-O-Phosphonylmethyl%2520Analogues%2520of%2520Nucleoside-5%25E2%2580%25B2-Phosphates%252C%25205%25E2%2580%25B2-Diphosphates%2520and%25205%25E2%2580%25B2-Triphosphates%26jtitle%3DCollect.%2520czech.%2520Chem.%2520Commun.%26date%3D1982%26volume%3D47%26spage%3D3447%26epage%3D3463%26doi%3D10.1135%2Fcccc19823447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Malnuit, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smoleń, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tichý, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slavětínská, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocek, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Cyclic and Acyclic Nucleoside Phosphonates and Sulfonamides Derived from 6-(Thiophen-2-yl)-7-fluoro-7-deazapurine</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2019</i></span>,  <span class="NLM_fpage">5409</span>– <span class="NLM_lpage">5423</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201900509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1002%2Fejoc.201900509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVOjs7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2019&publication_year=2019&pages=5409-5423&author=V.+Malnuitauthor=S.+Smole%C5%84author=M.+Tich%C3%BDauthor=L.+P.+Slav%C4%9Bt%C3%ADnsk%C3%A1author=M.+Hocek&title=Synthesis+of+Cyclic+and+Acyclic+Nucleoside+Phosphonates+and+Sulfonamides+Derived+from+6-%28Thiophen-2-yl%29-7-fluoro-7-deazapurine&doi=10.1002%2Fejoc.201900509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Cyclic and Acyclic Nucleoside Phosphonates and Sulfonamides Derived from 6-(Thiophen-2-yl)-7-fluoro-7-deazapurine</span></div><div class="casAuthors">Malnuit, Vincent; Smolen, Sabina; Tichy, Michal; Postova Slavetinska, Lenka; Hocek, Michal</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">2019</span>
        (<span class="NLM_cas:issue">31-32</span>),
    <span class="NLM_cas:pages">5409-5423</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Ribonuclosides derived from 6-heteroaryl-7-deazapurines are potent cytostatics, but their mechanism of action is unknown.  Here we designed and synthesized a series of cyclic and acyclic nucleoside phosphonates, as well as carboxy, cyano, sulfo, and sulfonamide acyclic analogs derived from 6-thiophen-2-yl-7-deazapurine and 7-fluoro-6-thiophen-2-yl-7-deazapurine as ribonucleoside monophosphate mimics.  None of these analogs exerted significant cytotoxic and antiviral activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2G6ZyPh8rtrVg90H21EOLACvtfcHk0lgm2WkUu2fOgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVOjs7rE&md5=cf95d2f5e00644ac479e68c19880ef53</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201900509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201900509%26sid%3Dliteratum%253Aachs%26aulast%3DMalnuit%26aufirst%3DV.%26aulast%3DSmole%25C5%2584%26aufirst%3DS.%26aulast%3DTich%25C3%25BD%26aufirst%3DM.%26aulast%3DSlav%25C4%259Bt%25C3%25ADnsk%25C3%25A1%26aufirst%3DL.%2BP.%26aulast%3DHocek%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520Cyclic%2520and%2520Acyclic%2520Nucleoside%2520Phosphonates%2520and%2520Sulfonamides%2520Derived%2520from%25206-%2528Thiophen-2-yl%2529-7-fluoro-7-deazapurine%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2019%26volume%3D2019%26spage%3D5409%26epage%3D5423%26doi%3D10.1002%2Fejoc.201900509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Šilhár, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohl, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votruba, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klepetářová, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocek, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of similar 2-(hydroxymethyl)purine nucleosides has been reported previously Synthesis of 6-Amino-, 6-Methyl- and 6-Aryl-2-(hydroxymethyl)purine Bases and Nucleosides</span>. <i>Collect. Czech. Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">788</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1135/cccc20060788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1135%2Fcccc20060788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmt1artbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=788-803&author=P.+%C5%A0ilh%C3%A1rauthor=R.+Pohlauthor=I.+Votrubaauthor=B.+Klepet%C3%A1%C5%99ov%C3%A1author=M.+Hocek&title=Synthesis+of+similar+2-%28hydroxymethyl%29purine+nucleosides+has+been+reported+previously+Synthesis+of+6-Amino-%2C+6-Methyl-+and+6-Aryl-2-%28hydroxymethyl%29purine+Bases+and+Nucleosides&doi=10.1135%2Fcccc20060788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 6-amino-, 6-methyl- and 6-aryl-2-(hydroxymethyl)purine bases and nucleosides</span></div><div class="casAuthors">Silhar, Peter; Pohl, Radek; Votruba, Ivan; Klepetarova, Blanka; Hocek, Michal</div><div class="citationInfo"><span class="NLM_cas:title">Collection of Czechoslovak Chemical Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">788-803</span>CODEN:
                <span class="NLM_cas:coden">CCCCAK</span>;
        ISSN:<span class="NLM_cas:issn">0010-0765</span>.
    
            (<span class="NLM_cas:orgname">Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic</span>)
        </div><div class="casAbstract">An efficient methodol. of the synthesis of 6-substituted 2-(hydroxymethyl)purine derivs. (bases and nucleosides) was developed.  Regioselective Pd-catalyzed cross-coupling reactions of 6-chloro-2-iodo-purines with [(benzoyl-oxy)methyl]zinc iodide gave 2-[(benzoyl-oxy)methyl]-6-chloro-purines that were converted to 2-(hydroxymethyl)adenine by reactions with ammonia and to 6-methyl- or 6-aryl-2-(hydroxymethyl)purines by cross-coupling reactions with trimethyl-aluminum or aryl-boronic acids followed by deprotection.  The title 6-substituted 2-(hydroxymethyl)purine bases and nucleosides did not exhibit significant cytostatic or anti-HCV activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT-rklJ1o4wrVg90H21EOLACvtfcHk0ljRc3sqRZYUsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmt1artbk%253D&md5=d6b69e912da9208833c4059e89bd8b55</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1135%2Fcccc20060788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1135%252Fcccc20060788%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0ilh%25C3%25A1r%26aufirst%3DP.%26aulast%3DPohl%26aufirst%3DR.%26aulast%3DVotruba%26aufirst%3DI.%26aulast%3DKlepet%25C3%25A1%25C5%2599ov%25C3%25A1%26aufirst%3DB.%26aulast%3DHocek%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520similar%25202-%2528hydroxymethyl%2529purine%2520nucleosides%2520has%2520been%2520reported%2520previously%2520Synthesis%2520of%25206-Amino-%252C%25206-Methyl-%2520and%25206-Aryl-2-%2528hydroxymethyl%2529purine%2520Bases%2520and%2520Nucleosides%26jtitle%3DCollect.%2520Czech.%2520Chem.%2520Commun.%26date%3D2006%26volume%3D71%26spage%3D788%26epage%3D803%26doi%3D10.1135%2Fcccc20060788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b'],'ref3':['cit3a','cit3b','cit3c'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b','cit7c','cit7d','cit7e','cit7f','cit7g','cit7h','cit7i','cit7j','cit7k','cit7l'],'ref8':['cit8a','cit8b','cit8c','cit8d'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11a','cit11b','cit11c','cit11d','cit11e'],'ref12':['cit12'],'ref13':['cit13a','cit13b'],'ref14':['cit14']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 2 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessio  Nocentini</span>, <span class="hlFld-ContribAuthor ">Clemente  Capasso</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule CD73 inhibitors for the immunotherapy of cancer: a patent and literature review (2017–present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>22 </em>, 1-10. <a href="https://doi.org/10.1080/13543776.2021.1923694" title="DOI URL">https://doi.org/10.1080/13543776.2021.1923694</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1923694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1923694%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSmall-molecule%252BCD73%252Binhibitors%252Bfor%252Bthe%252Bimmunotherapy%252Bof%252Bcancer%25253A%252Ba%252Bpatent%252Band%252Bliterature%252Breview%252B%2525282017%2525E2%252580%252593present%252529%26aulast%3DNocentini%26aufirst%3DAlessio%26date%3D2021%26date%3D2021%26volume%3D22%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Veronica  Salmaso</span>, <span class="hlFld-ContribAuthor ">R. Rama  Suresh</span>, <span class="hlFld-ContribAuthor ">Dilip K.  Tosh</span>. </span><span class="cited-content_cbyCitation_article-title">Expanding the repertoire of methanocarba nucleosides from purinergic signaling to diverse targets. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.1039/D1MD00167A" title="DOI URL">https://doi.org/10.1039/D1MD00167A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1MD00167A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1MD00167A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DExpanding%252Bthe%252Brepertoire%252Bof%252Bmethanocarba%252Bnucleosides%252Bfrom%252Bpurinergic%252Bsignaling%252Bto%252Bdiverse%252Btargets%26aulast%3DJacobson%26aufirst%3DKenneth%2BA.%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/medium/jm0c01835_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01835&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/medium/jm0c01835_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Key Interactions of AMPCP with hCD73</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01835&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/medium/jm0c01835_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. SAR Study of AMPCP-Based CD73 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01835&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/medium/jm0c01835_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Superposition of AMPCP (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4H2I">4H2I</a>) in gray with <b>2n</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YE1">6YE1</a>) in yellow. (B) Lateral view of superposition of AMPCP and <b>2n</b>. (C) X-ray structure of <b>2n</b> bound to CD73, represented by a water-accessible surface in gray for selected residues within 10 Å of the ligand, reveals a narrow hydrophobic pocket around the C2 chlorine. (D) Molecular interactions of <b>2n</b> in the cocrystal structure with hCD73.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01835&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/medium/jm0c01835_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) X-ray structure of <b>4a</b> cocrystallized with hCD73 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YE2">6YE2</a>) showing molecular interactions. (B) Overlay of X-ray crystals of <b>2n</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YE1">6YE1</a>) in green and <b>4a</b> in yellow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01835&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3a" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3a</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/medium/jm0c01835_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3a. Replacement of Bisphosphonic Acid<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01835&amp;id=sch3a"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Rh<sub>2</sub>(OAc)<sub>4</sub>, dimethyl 2-diazomalonate for <b>7</b> or ethyl 2-diazo-2-(diethoxyphosphoryl)acetate for <b>8</b>, toluene, reflux, yield = 60% for <b>7</b> and 64% for <b>8</b>; (b) benzylamine, Et<sub>3</sub>N, EtOH, room temperature (rt), yield = quantitative; (c) TMS-Br, CH<sub>3</sub>CN, rt and then H<sub>2</sub>O, yield = 38% for <b>11</b> and 23% for <b>12</b>; (d) LiOH, tetrahydrofuran (THF)/H<sub>2</sub>O, rt, yield = 89% for <b>1a</b>, 15% for <b>1b</b>; (e) benzylamine, Et<sub>3</sub>N, EtOH, rt and then 7 N NH<sub>3</sub> in MeOH, yield = 55%; (f) 2,2-dimethoxypropane, <i>p-</i>TSA, acetone, rt; (g) diethyl <i>p</i>-toluenesulfonyloxy methylphosphonate for <b>1c</b> or diethyl 2-bromoethylphosphonate for <b>1d</b> or diethyl 2-bromopropylphosphonate for <b>1e</b>, NaH, DMF, 0 °C–rt; (h) TMS-Br, CH<sub>3</sub>CN, rt and then H<sub>2</sub>O, yield = 20% for <b>1c</b>, 6% for <b>1d</b>, 23% for <b>1e</b> (three steps).</p></p></figure><figure data-id="sch3b" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3b</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/medium/jm0c01835_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0006.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3b. Synthesis of C2-Modified Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01835&amp;id=sch3b"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) two steps: (1) phenylboronic acid or tolylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>3</sub>CO<sub>3</sub>, THF/H<sub>2</sub>O, reflux; (2) TMS-Br, CH<sub>3</sub>CN, rt and then H<sub>2</sub>O, yields = 20% for <b>3a</b> and 10% for <b>3b</b>; (b) cinnamylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>3</sub>CO<sub>3</sub>, THF/H<sub>2</sub>O, reflux; (c) K<sub>2</sub>OsO<sub>4</sub>·<sub>2</sub>H<sub>2</sub>O, NaIO<sub>4</sub>, 2,6-lutidine, THF, H<sub>2</sub>O, rt; (d) NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, yield = 60% (three steps); (e) SOCl<sub>2</sub>, pyridine, CH<sub>3</sub>CN, 0 °C, yield = 40%; (f) two steps: (1) K<sub>2</sub>CO<sub>3</sub>, MeOH or phenol, rt–40 °C; (2) TMS-Br, CH<sub>3</sub>CN, rt and then H<sub>2</sub>O, yields = 13% for <b>3c</b> and 37% for <b>3d</b>; (g) <i>N</i>-Boc-3-pyrrolidinol, NaH, DMF; (h) TMS-Br, CH<sub>3</sub>CN, rt and then H<sub>2</sub>O, yield = 15% (two steps).</p></p></figure><figure data-id="sch3c" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3c</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/medium/jm0c01835_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0007.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3c. Synthesis of Analogs with Modified Purine Base<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01835/20210107/images/large/jm0c01835_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01835&amp;id=sch3c"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HMDS, (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, reflux and then β-<span class="smallcaps smallerCapital">d</span>-ribofuranose 1,2,3,5-tetraacetate, TMSOTf, CH<sub>3</sub>CN, rt, yield = 25% for <b>27</b> and 32% for <b>28</b>; (b) cyclopentylamine, Et<sub>3</sub>N, MeOH, rt and then 7 N NH<sub>3</sub> in MeOH; (c) 2,2-dimethoxypropane, <i>p-</i>TSA, acetone, rt; (d) NaHMDS, diethyl <i>p</i>-toluenesulfonyloxy methylphosphonate THF, 0 °C–rt; yield = 73% (three steps); (e) TMS-Br, CH<sub>3</sub>CN, rt and then MeOH/HCl, yield = 93%; (f) two steps: (1) 7 N NH<sub>3</sub> in MeOH, rt; (2) 2,2-dimethoxypropane, <i>p</i>-TSA, acetone, rt, yield = 80%; (g) diethyl <i>p</i>-toluenesulfonyloxy methylphosphonate, LiHMDS, THF, −78 °C–rt, yield = 59%; (h) two steps: (1) cyclopentylamine, Et<sub>3</sub>N, EtOH, reflux; (2) TMS-Br, CH<sub>3</sub>CN, rt and then H<sub>2</sub>O, yield = 48%; (i) BSA, CH<sub>3</sub>CN, reflux then β-<span class="smallcaps smallerCapital">d</span>-ribofuranose 1,2,3,5-tetraacetate, TMSOTf, CH<sub>3</sub>CN, reflux; (j) cyclopentylamine, dioxane, reflux, yield = 40%, two steps; (k) 2,2-dimethoxypropane, <i>p-</i>TSA, acetone, rt, yield = 78%; (l) NaHMDS, diethyl <i>p</i>-toluenesulfonyloxy methylphosphonate THF, 0 °C–rt; yield = 62%; (m) TMS-Br, CH<sub>3</sub>CN, rt and then H<sub>2</sub>O, yield = 15%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i70">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71471" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71471" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 14 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">Ecto-5′-Nucleotidase: Structure Function Relationships</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1007/s11302-006-9000-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1007%2Fs11302-006-9000-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=18404474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A280%3ADC%252BD1c3ktl2iug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=343-350&author=N.+Str%C3%A4ter&title=Ecto-5%E2%80%B2-Nucleotidase%3A+Structure+Function+Relationships&doi=10.1007%2Fs11302-006-9000-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Ecto-5'-nucleotidase: Structure function relationships</span></div><div class="casAuthors">Strater Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic signalling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">343-50</span>
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    </div><div class="casAbstract">Ecto-5'-nucleotidase (ecto-5'-NT) is attached via a GPI anchor to the extracellular membrane, where it hydrolyses AMP to adenosine and phosphate.  Related 5'-nucleotidases exist in bacteria, where they are exported into the periplasmic space.  X-ray structures of the 5'-nucleotidase from E. coli showed that the enzyme consists of two domains.  The N-terminal domain coordinates two catalytic divalent metal ions, whereas the C-terminal domain provides the substrate specificity pocket for the nucleotides.  Thus, the substrate binds at the interface of the two domains.  Here, the currently available structural information on ecto-5'-NT is reviewed in relation to the catalytic properties and enzyme function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThDd9tlAyIrzEC-75aqa5AfW6udTcc2eYIlNu-BnV2qLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3ktl2iug%253D%253D&md5=6b3bf983438fc270d35f8e9cf6d467ed</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs11302-006-9000-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-006-9000-8%26sid%3Dliteratum%253Aachs%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DEcto-5%25E2%2580%25B2-Nucleotidase%253A%2520Structure%2520Function%2520Relationships%26jtitle%3DPurinergic%2520Signalling%26date%3D2006%26volume%3D2%26spage%3D343%26epage%3D350%26doi%3D10.1007%2Fs11302-006-9000-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamin, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braganhol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanin, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edelweiss, M. I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battastini, A. M. O.</span></span> <span> </span><span class="NLM_article-title">Ectonucleotidases in Tumor Cells and Tumor-Associated Immune Cells: An Overview</span>. <i>J. Biomed. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>, <span class="NLM_elocation-id">959848</span> <span class="refDoi"> DOI: 10.1155/2012/959848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1155%2F2012%2F959848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=23118517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A280%3ADC%252BC3s7gtFejtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&author=L.+S.+Bergaminauthor=E.+Braganholauthor=R.+F.+Zaninauthor=M.+I.+A.+Edelweissauthor=A.+M.+O.+Battastini&title=Ectonucleotidases+in+Tumor+Cells+and+Tumor-Associated+Immune+Cells%3A+An+Overview&doi=10.1155%2F2012%2F959848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Ectonucleotidases in tumor cells and tumor-associated immune cells: an overview</span></div><div class="casAuthors">Bergamin Leticia Scussel; Braganhol Elizandra; Zanin Rafael Fernandes; Edelweiss Maria Isabel Albano; Battastini Ana Maria Oliveira</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomedicine & biotechnology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">959848</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Increasing evidence points out that genetic alteration does not guarantee the development of a tumor and indicates that complex interactions of tumor cells with the microenvironment are fundamental to tumorigenesis.  Among the pathological alterations that give tumor cells invasive potential, disruption of inflammatory response and the purinergic signaling are emerging as an important component of cancer progression.  Nucleotide/nucleoside receptor-mediated cell communication is orchestrated by ectonucleotidases, which efficiently hydrolyze ATP, ADP, and AMP to adenosine.  ATP can act as danger signaling whereas adenosine, acts as a negative feedback mechanism to limit inflammation.  Many tumors exhibit alterations in ATP-metabolizing enzymes, which may contribute to the pathological events observed in solid cancer.  In this paper, the main changes occurring in the expression and activity of ectonucleotidases in tumor cells as well as in tumor-associated immune cells are discussed.  Furthermore, we focus on the understanding of the purinergic signaling primarily as exemplified by research done by the group on gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRGVDLyUgDPhPSAs_PE1QvifW6udTcc2eY9_Jot9IHCH7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7gtFejtQ%253D%253D&md5=5cce519ac9fc74e5754451e1aebcb5f9</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1155%2F2012%2F959848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F959848%26sid%3Dliteratum%253Aachs%26aulast%3DBergamin%26aufirst%3DL.%2BS.%26aulast%3DBraganhol%26aufirst%3DE.%26aulast%3DZanin%26aufirst%3DR.%2BF.%26aulast%3DEdelweiss%26aufirst%3DM.%2BI.%2BA.%26aulast%3DBattastini%26aufirst%3DA.%2BM.%2BO.%26atitle%3DEctonucleotidases%2520in%2520Tumor%2520Cells%2520and%2520Tumor-Associated%2520Immune%2520Cells%253A%2520An%2520Overview%26jtitle%3DJ.%2520Biomed.%2520Biotechnol.%26date%3D2012%26volume%3D2012%26doi%3D10.1155%2F2012%2F959848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, H.</span></span> <span> </span><span class="NLM_article-title">5′-Nucleotidase: Molecular Structure and Functional Aspects</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1042/bj2850345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1042%2Fbj2850345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1637327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADyaK38XkvVGltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1992&pages=345-365&author=H.+Zimmermann&title=5%E2%80%B2-Nucleotidase%3A+Molecular+Structure+and+Functional+Aspects&doi=10.1042%2Fbj2850345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">5'-Nucleotidase:  molecular structure and functional aspects</span></div><div class="casAuthors">Zimmermann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">345-65</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">A review with ∼280 refs. focusing on recent developments in the anal. of the mol. structure and of functional aspects of 5' nucleotide-hydrolyzing enzymes.  A classification system for these enzymes is suggested which divides the vertebrate 5' nucleotidases into 4 distinct groups according to biochem. properties and cellular location.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqGDlEvhu4LbVg90H21EOLACvtfcHk0lhlPKCTCOcRnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XkvVGltrk%253D&md5=c359900288211b3dce6145df5cafcdba</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1042%2Fbj2850345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2850345%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DH.%26atitle%3D5%25E2%2580%25B2-Nucleotidase%253A%2520Molecular%2520Structure%2520and%2520Functional%2520Aspects%26jtitle%3DBiochem.%2520J.%26date%3D1992%26volume%3D285%26spage%3D345%26epage%3D365%26doi%3D10.1042%2Fbj2850345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Allard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longhi, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span> <span> </span><span class="NLM_article-title">The Ectonucleotidases CD39 and CD73: Novel Checkpoint Inhibitor Targets</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1111/imr.12528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1111%2Fimr.12528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=28258700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1eltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2017&pages=121-144&author=B.+Allardauthor=M.+S.+Longhiauthor=S.+C.+Robsonauthor=J.+Stagg&title=The+Ectonucleotidases+CD39+and+CD73%3A+Novel+Checkpoint+Inhibitor+Targets&doi=10.1111%2Fimr.12528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets</span></div><div class="casAuthors">Allard, Bertrand; Longhi, Maria Serena; Robson, Simon C.; Stagg, John</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">121-144</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Cancers are able to grow by subverting immune suppressive pathways, to prevent the malignant cells as being recognized as dangerous or foreign.  This mechanism prevents the cancer from being eliminated by the immune system and allows disease to progress from a very early stage to a lethal state.  Immunotherapies are newly developing interventions that modify the patient's immune system to fight cancer, by either directly stimulating rejection-type processes or blocking suppressive pathways.  Extracellular adenosine generated by the ectonucleotidases CD39 and CD73 is a newly recognized "immune checkpoint mediator" that interferes with anti-tumor immune responses.  In this review, we focus on CD39 and CD73 ectoenzymes and encompass aspects of the biochem. of these mols. as well as detailing the distribution and function on immune cells.  Effects of CD39 and CD73 inhibition in preclin. and clin. studies are discussed.  Finally, we provide insights into potential clin. application of adenosinergic and other purinergic-targeting therapies and forecast how these might develop in combination with other anti-cancer modalities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiLKxqHb6HnbVg90H21EOLACvtfcHk0lhlPKCTCOcRnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1eltL8%253D&md5=1f2c1bf632b238d6b7d9d7c46cea77c5</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1111%2Fimr.12528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fimr.12528%26sid%3Dliteratum%253Aachs%26aulast%3DAllard%26aufirst%3DB.%26aulast%3DLonghi%26aufirst%3DM.%2BS.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26aulast%3DStagg%26aufirst%3DJ.%26atitle%3DThe%2520Ectonucleotidases%2520CD39%2520and%2520CD73%253A%2520Novel%2520Checkpoint%2520Inhibitor%2520Targets%26jtitle%3DImmunol.%2520Rev.%26date%3D2017%26volume%3D276%26spage%3D121%26epage%3D144%26doi%3D10.1111%2Fimr.12528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Antonioli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vizi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haskó, G.</span></span> <span> </span><span class="NLM_article-title">CD39 and CD73 in Immunity and Inflamation</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2013.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1016%2Fj.molmed.2013.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=23601906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsFamtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=355-367&author=L.+Antonioliauthor=P.+Pacherauthor=S.+Viziauthor=G.+Hask%C3%B3&title=CD39+and+CD73+in+Immunity+and+Inflamation&doi=10.1016%2Fj.molmed.2013.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">CD39 and CD73 in immunity and inflammation</span></div><div class="casAuthors">Antonioli, Luca; Pacher, Pal; Vizi, E. Sylvester; Hasko, Gyorgy</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The enzymic activities of CD39 and CD73 play strategic roles in calibrating the duration, magnitude, and chem. nature of purinergic signals delivered to immune cells through the conversion of ADP/ATP to AMP and AMP to adenosine, resp.  This drives a shift from an ATP-driven proinflammatory environment to an anti-inflammatory milieu induced by adenosine.  The CD39/CD73 pathway changes dynamically with the pathophysiol. context in which it is embedded.  It is becoming increasingly appreciated that altering this catabolic machinery can change the course or dictate the outcome of several pathophysiol. events, such as AIDS, autoimmune diseases, infections, atherosclerosis, ischemia-reperfusion injury, and cancer, suggesting these ectoenzymes are novel therapeutic targets for managing a variety of disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmWiFFVp_ddbVg90H21EOLACvtfcHk0lg2cbVrMXcWBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsFamtLg%253D&md5=75d0f7627b3b8a5dd81fd3a76992af2b</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2013.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2013.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DAntonioli%26aufirst%3DL.%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DVizi%26aufirst%3DS.%26aulast%3DHask%25C3%25B3%26aufirst%3DG.%26atitle%3DCD39%2520and%2520CD73%2520in%2520Immunity%2520and%2520Inflamation%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D355%26epage%3D367%26doi%3D10.1016%2Fj.molmed.2013.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainwright, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matei, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span> <span> </span><span class="NLM_article-title">CD73: An Emerging Checkpoint for Cancer Immunotherapy</span>. <i>Immunotherapy</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">983</span>– <span class="NLM_lpage">997</span>, <span class="refDoi"> DOI: 10.2217/imt-2018-0200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.2217%2Fimt-2018-0200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=31223045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVGntbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=983-997&author=S.+Chenauthor=D.+A.+Wainwrightauthor=J.+D.+Wuauthor=Y.+Wanauthor=D.+E.+Mateiauthor=Y.+Zhangauthor=B.+Zhang&title=CD73%3A+An+Emerging+Checkpoint+for+Cancer+Immunotherapy&doi=10.2217%2Fimt-2018-0200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">CD73: an emerging checkpoint for cancer immunotherapy</span></div><div class="casAuthors">Chen, Siqi; Wainwright, Derek A.; Wu, Jennifer D.; Wan, Yong; Matei, Daniela E.; Zhang, Yi; Zhang, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Immunotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">983-997</span>CODEN:
                <span class="NLM_cas:coden">IMMUCO</span>;
        ISSN:<span class="NLM_cas:issn">1750-7448</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  CD73 is a novel immune checkpoint assocd. with adenosine metab. that promotes tumor progression by suppressing antitumor immune response and promoting angiogenesis.  The inhibition of CD73, in combination with immune checkpoint blockade, targeted therapy or conventional therapy, improves antitumor effects in numerous preclin. mouse models of cancer.  Emerging evidence suggests that the combination of anti-CD73 and immune checkpoint blockade has promising clin. activity in patients with advanced solid tumors.  In this review, we will discuss the specific role of CD73 on both tumor cells and nontumor cells in regulating tumor immunity and tumorigenesis and provide an update on the current view of the antitumor activity of targeting CD73 by mAb or small mol. selective inhibitors in preclin. and clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGyU8cLKovBbVg90H21EOLACvtfcHk0lg2cbVrMXcWBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVGntbrN&md5=ea8d2f4f26039a1aff0f2eb2159c8b07</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.2217%2Fimt-2018-0200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fimt-2018-0200%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DWainwright%26aufirst%3DD.%2BA.%26aulast%3DWu%26aufirst%3DJ.%2BD.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DMatei%26aufirst%3DD.%2BE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DB.%26atitle%3DCD73%253A%2520An%2520Emerging%2520Checkpoint%2520for%2520Cancer%2520Immunotherapy%26jtitle%3DImmunotherapy%26date%3D2019%26volume%3D11%26spage%3D983%26epage%3D997%26doi%3D10.2217%2Fimt-2018-0200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span> For a review see<span class="NLM_contrib-group"><span class="NLM_string-name">Corbelini, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueiro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machado
das Neves, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawano, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira
Battastini, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eifler-Lima, V. L.</span></span> <span> </span><span class="NLM_article-title">Insights into Ecto-5′-Nucleotidase as a New Target for Cancer Therapy: A Medicinal Chemistry Study</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1776</span>– <span class="NLM_lpage">1792</span>, <span class="refDoi"> DOI: 10.2174/0929867322666150408112615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.2174%2F0929867322666150408112615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=25850771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVGnuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=1776-1792&author=P.+F.+Corbeliniauthor=F.+Figueiroauthor=G.+Machado%0Adas+Nevesauthor=S.+Andradeauthor=D.+F.+Kawanoauthor=A.+M.+Oliveira%0ABattastiniauthor=V.+L.+Eifler-Lima&title=Insights+into+Ecto-5%E2%80%B2-Nucleotidase+as+a+New+Target+for+Cancer+Therapy%3A+A+Medicinal+Chemistry+Study&doi=10.2174%2F0929867322666150408112615"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into Ecto-5'-Nucleotidase as a New Target for Cancer Therapy: A Medicinal Chemistry Study</span></div><div class="casAuthors">Corbelini, Patricia Frasson; Figueiro, Fabricio; Machado das Neves, Gustavo; Andrade, Saulo; Kawano, Daniel Fabio; Oliveira Battastini, Ana Maria; Eifler-Lima, Vera Lucia</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1776-1792</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Ecto-5'-nucleotidase (ecto-5'-NT, 5'-NT, eN, CD73) is a membrane ectoenzyme that is primarily responsible for the extracellular prodn. of adenosine from AMP.  Ecto-5'-NT is overexpressed in various types of cancer cells, leading to elevated concns. of adenosine in the tumor microenvironment.  Adenosine has also been found to be important in cancer pathogenesis, showing strong immunosuppressive effects over antitumor T cells and macrophages and promoting neovascularization and cell adherence.  These actions support tumor growth and development.  It has been suggested that the inhibition of ecto-5'-NT results in lower extracellular concns. of adenosine within the tumor microenvironment, which would directly affect cancer cells and render malignant cells more susceptible to host defense systems.  Such mechanisms are proposed to represent promising new targets for cancer therapy.  The aim of this review is to explore the biochem. and structural features of ecto-5'-NT, including a brief anal. of its active site by mol. modeling, as a means of evaluating whether the inhibition of this enzyme does indeed represent a feasible strategy for treating cancer.  Known inhibitors and possible prototypes that could be used to target ecto-5'-NT during cancer therapy are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxGNC2_iGAn7Vg90H21EOLACvtfcHk0lg2cbVrMXcWBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVGnuro%253D&md5=29a35d2e469dc2e69823eb0f8a428e28</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F0929867322666150408112615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666150408112615%26sid%3Dliteratum%253Aachs%26aulast%3DCorbelini%26aufirst%3DP.%2BF.%26aulast%3DFigueiro%26aufirst%3DF.%26aulast%3DMachado%2Bdas%2BNeves%26aufirst%3DG.%26aulast%3DAndrade%26aufirst%3DS.%26aulast%3DKawano%26aufirst%3DD.%2BF.%26aulast%3DOliveira%2BBattastini%26aufirst%3DA.%2BM.%26aulast%3DEifler-Lima%26aufirst%3DV.%2BL.%26atitle%3DInsights%2520into%2520Ecto-5%25E2%2580%25B2-Nucleotidase%2520as%2520a%2520New%2520Target%2520for%2520Cancer%2520Therapy%253A%2520A%2520Medicinal%2520Chemistry%2520Study%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26spage%3D1776%26epage%3D1792%26doi%3D10.2174%2F0929867322666150408112615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Divisekera, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharkey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denoyer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, M. J.</span></span> <span> </span><span class="NLM_article-title">Anti-CD73 Antibody Therapy Inhibits Breast Tumor Growth and Metastasis</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">1547</span>– <span class="NLM_lpage">1552</span>, <span class="refDoi"> DOI: 10.1073/pnas.0908801107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1073%2Fpnas.0908801107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=20080644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslOrs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=1547-1552&author=J.+Staggauthor=U.+Divisekeraauthor=N.+McLaughlinauthor=J.+Sharkeyauthor=S.+Pommeyauthor=D.+Denoyerauthor=K.+M.+Dwyerauthor=M.+J.+Smyth&title=Anti-CD73+Antibody+Therapy+Inhibits+Breast+Tumor+Growth+and+Metastasis&doi=10.1073%2Fpnas.0908801107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis</span></div><div class="casAuthors">Stagg, John; Divisekera, Upulie; McLaughlin, Nicole; Sharkey, Janelle; Pommey, Sandra; Denoyer, Delphine; Dwyer, Karen M.; Smyth, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1547-1552, S1547/1-S1547/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Extracellular adenosine is a potent immunosuppressor that accumulates during tumor growth.  We performed proof-of-concept studies investigating the therapeutic potential and mechanism of action of monoclonal antibody (mAb)-based therapy against CD73, an ecto-enzyme overexpressed on breast-cancer cells that catalyzes the dephosphorylation of adenosine monophosphates into adenosine.  We showed that anti-CD73 mAb therapy significantly delayed primary 4T1.2 and E0771 tumor growth in immune-competent mice and significantly inhibited the development of spontaneous 4T1.2 lung metastases.  Notably, anti-CD73 mAb therapy was essentially dependent on the induction of adaptive anti-tumor immune responses.  Knockdown of CD73 in 4T1.2 tumor cells confirmed the tumor-promoting effects of CD73.  In addn. to its immunosuppressive effect, CD73 enhanced tumor cell chemotaxis, suggesting a role for CD73-derived adenosine in tumor metastasis.  Accordingly, administration of adenosine-5'-N-ethylcarboxamide to tumor-bearing mice significantly enhanced spontaneous 4T1.2 lung metastasis.  Using selective adenosine-receptor antagonists, we showed that activation of A2B adenosine receptors promoted 4T1.2 tumor cell chemotaxis in vitro and metastasis in vivo.  In conclusion, our study identified tumor-derived CD73 as a mechanism of tumor immune escape and tumor metastasis, and it also established the proof of concept that targeted therapy against CD73 can trigger adaptive anti-tumor immunity and inhibit metastasis of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT2etrhOGG3bVg90H21EOLACvtfcHk0linpWqdS6r98Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslOrs7o%253D&md5=7bafdf788526df932910865c2e291959</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0908801107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0908801107%26sid%3Dliteratum%253Aachs%26aulast%3DStagg%26aufirst%3DJ.%26aulast%3DDivisekera%26aufirst%3DU.%26aulast%3DMcLaughlin%26aufirst%3DN.%26aulast%3DSharkey%26aufirst%3DJ.%26aulast%3DPommey%26aufirst%3DS.%26aulast%3DDenoyer%26aufirst%3DD.%26aulast%3DDwyer%26aufirst%3DK.%2BM.%26aulast%3DSmyth%26aufirst%3DM.%2BJ.%26atitle%3DAnti-CD73%2520Antibody%2520Therapy%2520Inhibits%2520Breast%2520Tumor%2520Growth%2520and%2520Metastasis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D1547%26epage%3D1552%26doi%3D10.1073%2Fpnas.0908801107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattarai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freundlieb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pippel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiene, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yegutkin, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Tayeb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selectve <i>ecto</i>-5′-Nucleotidase (CD73) Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6248</span>– <span class="NLM_lpage">6263</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00802</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00802" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFejt7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6248-6263&author=S.+Bhattaraiauthor=M.+Freundliebauthor=J.+Pippelauthor=A.+Meyerauthor=A.+Abdelrahmanauthor=A.+Fieneauthor=S.-Y.+Leeauthor=H.+Zimmermanauthor=G.+G.+Yegutkinauthor=N.+Str%C3%A4terauthor=A.+El-Tayebauthor=C.+E.+M%C3%BCller&title=%CE%B1%2C%CE%B2-Methylene-ADP+%28AOPCP%29+Derivatives+and+Analogues%3A+Development+of+Potent+and+Selectve+ecto-5%E2%80%B2-Nucleotidase+%28CD73%29+Inhibitors&doi=10.1021%2Facs.jmedchem.5b00802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selective ecto-5'-Nucleotidase (CD73) Inhibitors</span></div><div class="casAuthors">Bhattarai, Sanjay; Freundlieb, Marianne; Pippel, Jan; Meyer, Anne; Abdelrahman, Aliaa; Fiene, Amelie; Lee, Sang-Yong; Zimmermann, Herbert; Yegutkin, Gennady G.; Straeter, Norbert; El-Tayeb, Ali; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6248-6263</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ecto-5'-Nucleotidase (eN, CD73) catalyzes the hydrolysis of extracellular AMP to adenosine. eN inhibitors have potential for use as cancer therapeutics.  The eN inhibitor α,β-methylene-ADP (AOPCP, adenosine-5'-O-[(phosphonomethyl)phosphonic acid]) was used as a lead structure, and derivs. modified in various positions were prepd.  Products were tested at rat recombinant eN.  6-(Ar)alkylamino substitution led to the largest improvement in potency.  N6-Monosubstitution was superior to sym. N6,N6-disubstitution.  The most potent inhibitors were N6-(4-chlorobenzyl)- (PSB-12441, Ki 7.23 nM), N6-phenylethyl- (PSB-12425, Ki 8.04 nM), and N6-benzyl-adenosine-5'-O-[(phosphonomethyl)phosphonic acid] I (PSB-12379, Ki 9.03 nM).  Replacement of the 6-NH group in I by O (PSB-12431) or S (PSB-12553) yielded equally potent inhibitors (9.20 nM and 9.50 nM, resp.).  Selected compds. investigated at the human enzyme did not show species differences; they displayed high selectivity vs. other ecto-nucleotidases and ADP-activated P2Y receptors.  Moreover, high metabolic stability was obsd.  These compds. represent the most potent eN inhibitors described to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTmxberqVtKLVg90H21EOLACvtfcHk0linpWqdS6r98Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFejt7fF&md5=5f1231a662dd86345b9d3803f1c4e716</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00802%26sid%3Dliteratum%253Aachs%26aulast%3DBhattarai%26aufirst%3DS.%26aulast%3DFreundlieb%26aufirst%3DM.%26aulast%3DPippel%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DAbdelrahman%26aufirst%3DA.%26aulast%3DFiene%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DS.-Y.%26aulast%3DZimmerman%26aufirst%3DH.%26aulast%3DYegutkin%26aufirst%3DG.%2BG.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26aulast%3DEl-Tayeb%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3D%25CE%25B1%252C%25CE%25B2-Methylene-ADP%2520%2528AOPCP%2529%2520Derivatives%2520and%2520Analogues%253A%2520Development%2520of%2520Potent%2520and%2520Selectve%2520ecto-5%25E2%2580%25B2-Nucleotidase%2520%2528CD73%2529%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6248%26epage%3D6263%26doi%3D10.1021%2Facs.jmedchem.5b00802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Debien, L. P. P.</span>; <span class="NLM_string-name">Jaen, J. C.</span>; <span class="NLM_string-name">Kalisiak, J.</span>; <span class="NLM_string-name">Lawson, K. V.</span>; <span class="NLM_string-name">Leleti, M. R.</span>; <span class="NLM_string-name">Lindsey, E. A.</span>; <span class="NLM_string-name">Miles, D. H.</span>; <span class="NLM_string-name">Newcomb, E.</span>; <span class="NLM_string-name">Powers, J. P.</span>; <span class="NLM_string-name">Rosen, B. R.</span>; <span class="NLM_string-name">Sharif, E. U.</span></span> <span> </span><span class="NLM_article-title">Modulators of 5′-Nucleotidase, Ecto and The Use Thereof</span>. <span class="NLM_patent">US2017/0267710 A1</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=L.+P.+P.+Debien&author=J.+C.+Jaen&author=J.+Kalisiak&author=K.+V.+Lawson&author=M.+R.+Leleti&author=E.+A.+Lindsey&author=D.+H.+Miles&author=E.+Newcomb&author=J.+P.+Powers&author=B.+R.+Rosen&author=E.+U.+Sharif&title=Modulators+of+5%E2%80%B2-Nucleotidase%2C+Ecto+and+The+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDebien%26aufirst%3DL.%2BP.%2BP.%26atitle%3DModulators%2520of%25205%25E2%2580%25B2-Nucleotidase%252C%2520Ecto%2520and%2520The%2520Use%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharif, E. U.</span>; <span class="NLM_string-name">Lawson, K. V.</span>; <span class="NLM_string-name">Kalisiak, J.</span>; <span class="NLM_string-name">Lindsey, E. A.</span>; <span class="NLM_string-name">Newcomb, E.</span>; <span class="NLM_string-name">Rosen, B. R.</span>; <span class="NLM_string-name">Walker, N.</span>; <span class="NLM_string-name">Jin, L.</span>; <span class="NLM_string-name">Scaletti, E. R.</span>; <span class="NLM_string-name">Sträter, N.</span>; <span class="NLM_string-name">Chen, A.</span>; <span class="NLM_string-name">Leleti, M. R.</span>; <span class="NLM_string-name">Powers, J. P.</span></span> <span> </span><span class="NLM_article-title">Discovery and Characterization of Potent and Selective Small-Molecule Inhibitors of Ecto-Nucleotidase CD73 for Cancer Immunotherapy</span>,  <i>ACS National Meeting and Exposition</i>, <span class="NLM_publisher-loc">Orlando, FL</span>, March 31–April 4, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=E.+U.+Sharif&author=K.+V.+Lawson&author=J.+Kalisiak&author=E.+A.+Lindsey&author=E.+Newcomb&author=B.+R.+Rosen&author=N.+Walker&author=L.+Jin&author=E.+R.+Scaletti&author=N.+Str%C3%A4ter&author=A.+Chen&author=M.+R.+Leleti&author=J.+P.+Powers&title=Discovery+and+Characterization+of+Potent+and+Selective+Small-Molecule+Inhibitors+of+Ecto-Nucleotidase+CD73+for+Cancer+Immunotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DSharif%26aufirst%3DE.%2BU.%26atitle%3DDiscovery%2520and%2520Characterization%2520of%2520Potent%2520and%2520Selective%2520Small-Molecule%2520Inhibitors%2520of%2520Ecto-Nucleotidase%2520CD73%2520for%2520Cancer%2520Immunotherapy%26jtitle%3DACS%2520National%2520Meeting%2520and%2520Exposition%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalisiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomb, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leleti, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debien, L. P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharif, E. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moschütz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaletti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schindler, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of AB680–A Potent and Selective Inhibitor of CD73</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">11448</span>– <span class="NLM_lpage">11468</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00525</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00525" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlWqs7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=11448-11468&author=K.+V.+Lawsonauthor=J.+Kalisiakauthor=E.+A.+Lindseyauthor=E.+Newcombauthor=M.+R.+Leletiauthor=L.+P.+P.+Debienauthor=B.+R.+Rosenauthor=D.+H.+Milesauthor=E.+U.+Sharifauthor=J.+Jeffreyauthor=J.+Tanauthor=A.+Chenauthor=S.+Zhaoauthor=G.+Xuauthor=L.+Fuauthor=L.+Jinauthor=T.+Parkauthor=W.+Berryauthor=S.+Mosch%C3%BCtzauthor=E.+Scalettiauthor=N.+Str%C3%A4terauthor=N.+Walkerauthor=S.+Youngauthor=M.+Waltersauthor=U.+Schindlerauthor=J.+P.+Powers&title=Discovery+of+AB680%E2%80%93A+Potent+and+Selective+Inhibitor+of+CD73&doi=10.1021%2Facs.jmedchem.0c00525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of AB680: A Potent and Selective Inhibitor of CD73</span></div><div class="casAuthors">Lawson, Kenneth V.; Kalisiak, Jaroslaw; Lindsey, Erick A.; Newcomb, Eric T.; Leleti, Manmohan Reddy; Debien, Laurent; Rosen, Brandon R.; Miles, Dillon H.; Sharif, Ehesan U.; Jeffrey, Jenna L.; Tan, Joanne B. L.; Chen, Ada; Zhao, Sharon; Xu, Guifen; Fu, Lijuan; Jin, Lixia; Park, Tim W.; Berry, Wade; Moschutz, Susanne; Scaletti, Emma; Strater, Norbert; Walker, Nigel P.; Young, Stephen W.; Walters, Matthew J.; Schindler, Uli; Powers, Jay P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">11448-11468</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Extracellular adenosine (ADO), present in high concns. in the tumor microenvironment (TME), suppresses immune function via inhibition of T cell and NK cell activation.  Intratumoral generation of ADO depends on the sequential catabolism of ATP by two ecto-nucleotidases, CD39 (ATP → AMP) and CD73 (AMP → ADO).  Inhibition of CD73 eliminates a major pathway of ADO prodn. in the TME and can reverse ADO-mediated immune suppression.  Extensive interrogation of structure-activity relationships (SARs), structure-based drug design, and optimization of pharmacokinetic properties culminated in the discovery of AB680, a highly potent (Ki = 5 pM), reversible, and selective inhibitor of CD73.  AB680 is further characterized by very low clearance and long half-lives across preclin. species, resulting in a PK profile suitable for long-acting parenteral administration.  AB680 is currently being evaluated in phase 1 clin. trials.  Initial data show AB680 is well tolerated and exhibits a pharmacokinetic profile suitable for biweekly (Q2W) iv-administration in human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIAhGPLddUtrVg90H21EOLACvtfcHk0lgfECW3uqKyIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlWqs7fO&md5=6e4fcbc045e56d2ecb3807ffc9050649</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00525%26sid%3Dliteratum%253Aachs%26aulast%3DLawson%26aufirst%3DK.%2BV.%26aulast%3DKalisiak%26aufirst%3DJ.%26aulast%3DLindsey%26aufirst%3DE.%2BA.%26aulast%3DNewcomb%26aufirst%3DE.%26aulast%3DLeleti%26aufirst%3DM.%2BR.%26aulast%3DDebien%26aufirst%3DL.%2BP.%2BP.%26aulast%3DRosen%26aufirst%3DB.%2BR.%26aulast%3DMiles%26aufirst%3DD.%2BH.%26aulast%3DSharif%26aufirst%3DE.%2BU.%26aulast%3DJeffrey%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DPark%26aufirst%3DT.%26aulast%3DBerry%26aufirst%3DW.%26aulast%3DMosch%25C3%25BCtz%26aufirst%3DS.%26aulast%3DScaletti%26aufirst%3DE.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26aulast%3DWalker%26aufirst%3DN.%26aulast%3DYoung%26aufirst%3DS.%26aulast%3DWalters%26aufirst%3DM.%26aulast%3DSchindler%26aufirst%3DU.%26aulast%3DPowers%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520of%2520AB680%25E2%2580%2593A%2520Potent%2520and%2520Selective%2520Inhibitor%2520of%2520CD73%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D11448%26epage%3D11468%26doi%3D10.1021%2Facs.jmedchem.0c00525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalisiak, J.</span>; <span class="NLM_string-name">Lawson, K. V.</span>; <span class="NLM_string-name">Leleti, M. R.</span>; <span class="NLM_string-name">Lindsey, E. A.</span>; <span class="NLM_string-name">Miles, D. H.</span>; <span class="NLM_string-name">Newcomb, E.</span>; <span class="NLM_string-name">Powers, J. P.</span>; <span class="NLM_string-name">Sharif, E. U.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of CD73-Mediated Immunosuppression</span>. <span class="NLM_patent">WO2018/094148 A1</span><span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+Kalisiak&author=K.+V.+Lawson&author=M.+R.+Leleti&author=E.+A.+Lindsey&author=D.+H.+Miles&author=E.+Newcomb&author=J.+P.+Powers&author=E.+U.+Sharif&title=Inhibitors+of+CD73-Mediated+Immunosuppression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKalisiak%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520CD73-Mediated%2520Immunosuppression%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. W.</span></span> <span> </span><span class="NLM_article-title">An Exceptionally Potent Inhibitor of Human CD73</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3331</span>– <span class="NLM_lpage">3334</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.9b00448</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.9b00448" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVWjur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=3331-3334&author=C.+E.+Bowmanauthor=R.+G.+da+Silvaauthor=A.+Phamauthor=S.+W.+Young&title=An+Exceptionally+Potent+Inhibitor+of+Human+CD73&doi=10.1021%2Facs.biochem.9b00448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7eR"><div class="casContent"><span class="casTitleNuber">7e</span><div class="casTitle"><span class="NLM_cas:atitle">An Exceptionally Potent Inhibitor of Human CD73</span></div><div class="casAuthors">Bowman, Christine E.; da Silva, Rafael G.; Pham, Amber; Young, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">3331-3334</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We recently reported the initiation of a Phase I clin. trial with AB680, a potent human CD73 inhibitor, being developed for the treatment of solid tumors (NCT03677973).  We undertook a detailed kinetic anal. of the interaction between human CD73 and AB680 to det. the mode of inhibition.  We found AB680 to be a reversible, slow-onset competitive inhibitor of human CD73 with a Ki of 5 pM.  Clin. candidates of this potency are uncommon and deserve special consideration during lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYGag3hdjGb7Vg90H21EOLACvtfcHk0lgfECW3uqKyIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVWjur3O&md5=ad600cb74b603c4daa3c5f002e1c5f4a</span></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.9b00448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.9b00448%26sid%3Dliteratum%253Aachs%26aulast%3DBowman%26aufirst%3DC.%2BE.%26aulast%3Dda%2BSilva%26aufirst%3DR.%2BG.%26aulast%3DPham%26aufirst%3DA.%26aulast%3DYoung%26aufirst%3DS.%2BW.%26atitle%3DAn%2520Exceptionally%2520Potent%2520Inhibitor%2520of%2520Human%2520CD73%26jtitle%3DBiochemistry%26date%3D2019%26volume%3D58%26spage%3D3331%26epage%3D3334%26doi%3D10.1021%2Facs.biochem.9b00448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Cacatian, S.</span>; <span class="NLM_string-name">Claremon, S. A.</span>; <span class="NLM_string-name">Jia, L.</span>; <span class="NLM_string-name">Morales-Ramos, A.</span>; <span class="NLM_string-name">Singh, S. B.</span>; <span class="NLM_string-name">Venkatraman, S.</span>; <span class="NLM_string-name">Xu, Z.</span>; <span class="NLM_string-name">Zheng, Y.</span></span> <span> </span><span class="NLM_article-title">Purine Derivatives as CD73 Inhibitors for the Treatment of Cancer</span>. <span class="NLM_patent">WO2015164573</span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+Cacatian&author=S.+A.+Claremon&author=L.+Jia&author=A.+Morales-Ramos&author=S.+B.+Singh&author=S.+Venkatraman&author=Z.+Xu&author=Y.+Zheng&title=Purine+Derivatives+as+CD73+Inhibitors+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCacatian%26aufirst%3DS.%26atitle%3DPurine%2520Derivatives%2520as%2520CD73%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Cancer%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span>; <span class="NLM_string-name">Ll, J.</span>; <span class="NLM_string-name">Sjogren, E. B.</span>; <span class="NLM_string-name">Billedeau, R. J.</span></span> <span> </span><span class="NLM_article-title">Ectonucleotidase Inhibitors and Methods of Use Thereof</span>. <span class="NLM_patent">WO2018049145</span><span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=L.+Chen&author=J.+Ll&author=E.+B.+Sjogren&author=R.+J.+Billedeau&title=Ectonucleotidase+Inhibitors+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26atitle%3DEctonucleotidase%2520Inhibitors%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Billedeau, R. J.</span>; <span class="NLM_string-name">Ll, J.</span>; <span class="NLM_string-name">Chen, L.</span></span> <span> </span><span class="NLM_article-title">Ectonucleotidase Inhibitors and Methods of Use Thereof</span>. <span class="NLM_patent">WO2018119284</span><span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=R.+J.+Billedeau&author=J.+Ll&author=L.+Chen&title=Ectonucleotidase+Inhibitors+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBilledeau%26aufirst%3DR.%2BJ.%26atitle%3DEctonucleotidase%2520Inhibitors%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span>; <span class="NLM_string-name">Yang, H.</span>; <span class="NLM_string-name">Bedke, K.</span>; <span class="NLM_string-name">Wehn, P.</span>; <span class="NLM_string-name">Rizzi, J. P.</span></span> <span> </span><span class="NLM_article-title">CD73 Inhibitors and Uses Thereof</span>. <span class="NLM_patent">WO2018183635</span><span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=B.+Wang&author=H.+Yang&author=K.+Bedke&author=P.+Wehn&author=J.+P.+Rizzi&title=CD73+Inhibitors+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DB.%26atitle%3DCD73%2520Inhibitors%2520and%2520Uses%2520Thereof%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span>; <span class="NLM_string-name">Zhuang, L.</span>; <span class="NLM_string-name">Wu, H.</span>; <span class="NLM_string-name">Liu, S.</span>; <span class="NLM_string-name">Zhang, R.</span></span> <span> </span><span class="NLM_article-title">Nucleoside and Nucleotide Analogues as CD73 Inhibitors and Therapeutic Uses Thereof</span>. <span class="NLM_patent">WO2018208727</span><span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+Liu&author=L.+Zhuang&author=H.+Wu&author=S.+Liu&author=R.+Zhang&title=Nucleoside+and+Nucleotide+Analogues+as+CD73+Inhibitors+and+Therapeutic+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DNucleoside%2520and%2520Nucleotide%2520Analogues%2520as%2520CD73%2520Inhibitors%2520and%2520Therapeutic%2520Uses%2520Thereof%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Eksterowicz, J.</span>; <span class="NLM_string-name">Fantin, V. R.</span>; <span class="NLM_string-name">Jackson, E. L.</span>; <span class="NLM_string-name">Sun, D.</span>; <span class="NLM_string-name">Ye, Q.</span>; <span class="NLM_string-name">Moore, J.</span>; <span class="NLM_string-name">Zavorotinskaya, T.</span></span> <span> </span><span class="NLM_article-title">CD73 Inhibitors</span>. <span class="NLM_patent">WO2019090111</span><span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=X.+Du&author=J.+Eksterowicz&author=V.+R.+Fantin&author=E.+L.+Jackson&author=D.+Sun&author=Q.+Ye&author=J.+Moore&author=T.+Zavorotinskaya&title=CD73+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7k&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DX.%26atitle%3DCD73%2520Inhibitors%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, H.</span>; <span class="NLM_string-name">Zhao, B.</span>; <span class="NLM_string-name">Yu, H.</span>; <span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">Phosphonic Acid Derivative Having CD73 Inhibitory Activity, and Preparation Method and Use thereof</span>. <span class="NLM_patent">WO2019129059A1</span><span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=H.+Deng&author=B.+Zhao&author=H.+Yu&author=Z.+Chen&author=Y.+Xu&title=Phosphonic+Acid+Derivative+Having+CD73+Inhibitory+Activity%2C+and+Preparation+Method+and+Use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DH.%26atitle%3DPhosphonic%2520Acid%2520Derivative%2520Having%2520CD73%2520Inhibitory%2520Activity%252C%2520and%2520Preparation%2520Method%2520and%2520Use%2520thereof%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. L.</span>; <span class="NLM_string-name">Ator, L. E.</span>; <span class="NLM_string-name">Duffy, K. J.</span>; <span class="NLM_string-name">Graybill, T. L.</span>; <span class="NLM_string-name">Kiesow, T. J.</span>; <span class="NLM_string-name">Lian, Y.</span>; <span class="NLM_string-name">Moore, M. L.</span>; <span class="NLM_string-name">Ralph, J. M.</span>; <span class="NLM_string-name">Ridgers, L. H.</span></span> <span> </span><span class="NLM_article-title">Benzothiadiazine Compounds</span>. <span class="NLM_patent">WO2017098421</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+L.+Adams&author=L.+E.+Ator&author=K.+J.+Duffy&author=T.+L.+Graybill&author=T.+J.+Kiesow&author=Y.+Lian&author=M.+L.+Moore&author=J.+M.+Ralph&author=L.+H.+Ridgers&title=Benzothiadiazine+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26atitle%3DBenzothiadiazine%2520Compounds%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. L.</span>; <span class="NLM_string-name">Duffy, K. J.</span>; <span class="NLM_string-name">Graybill, T. L.</span>; <span class="NLM_string-name">Moore, M. L.</span>; <span class="NLM_string-name">Neipp, C. E.</span>; <span class="NLM_string-name">Ralph, J. M.</span>; <span class="NLM_string-name">Squire, M. D.</span></span> <span> </span><span class="NLM_article-title">5-Sulfamoyl-2-Hydroxybenzamide Derivatives</span>. <span class="NLM_patent">WO2017153952A1</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+L.+Adams&author=K.+J.+Duffy&author=T.+L.+Graybill&author=M.+L.+Moore&author=C.+E.+Neipp&author=J.+M.+Ralph&author=M.+D.+Squire&title=5-Sulfamoyl-2-Hydroxybenzamide+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26atitle%3D5-Sulfamoyl-2-Hydroxybenzamide%2520Derivatives%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, K. J.</span>; <span class="NLM_string-name">Parrish, C. A.</span>; <span class="NLM_string-name">Ator, L. E.</span>; <span class="NLM_string-name">Baskaran, S.</span>; <span class="NLM_string-name">Darcy, M. G.</span>; <span class="NLM_string-name">Oplinger, J. A.</span>; <span class="NLM_string-name">Ralph, J. M.</span>; <span class="NLM_string-name">Ridgers, L. H.</span>; <span class="NLM_string-name">Tian, X.</span>; <span class="NLM_string-name">Zhang, C.</span></span> <span> </span><span class="NLM_article-title">Chemical Compounds</span>. <span class="NLM_patent">WO2019053617</span><span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=K.+J.+Duffy&author=C.+A.+Parrish&author=L.+E.+Ator&author=S.+Baskaran&author=M.+G.+Darcy&author=J.+A.+Oplinger&author=J.+M.+Ralph&author=L.+H.+Ridgers&author=X.+Tian&author=C.+Zhang&title=Chemical+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDuffy%26aufirst%3DK.%2BJ.%26atitle%3DChemical%2520Compounds%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Beatty, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas-Tran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debien, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drew, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leleti, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moschütz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, K. V.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">3935</span>– <span class="NLM_lpage">3955</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01713</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01713" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslCgsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=3935-3955&author=J.+W.+Beattyauthor=E.+A.+Lindseyauthor=R.+Thomas-Tranauthor=L.+Debienauthor=D.+Mandalauthor=J.+L.+Jeffreyauthor=A.+T.+Tranauthor=J.+Fournierauthor=S.+D.+Jacobauthor=X.+Yanauthor=S.+L.+Drewauthor=E.+Ginnauthor=A.+Chenauthor=S.+Zhaoauthor=L.+Jinauthor=S.+W.+Youngauthor=N.+Walkerauthor=M.+R.+Leletiauthor=S.+Mosch%C3%BCtzauthor=N.+Str%C3%A4terauthor=J.+P.+Powersauthor=K.+V.+Lawson&title=Discovery+of+Potent+and+Selective+Non-Nucleotide+Small+Molecule+Inhibitors+of+CD73&doi=10.1021%2Facs.jmedchem.9b01713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73</span></div><div class="casAuthors">Beatty, Joel W.; Lindsey, Erick A.; Thomas-Tran, Rhiannon; Debien, Laurent; Mandal, Debashis; Jeffrey, Jenna L.; Tran, Anh T.; Fournier, Jeremy; Jacob, Steven D.; Yan, Xuelei; Drew, Samuel L.; Ginn, Elaine; Chen, Ada; Pham, Amber T.; Zhao, Sharon; Jin, Lixia; Young, Stephen W.; Walker, Nigel P.; Leleti, Manmohan Reddy; Moschutz, Susanne; Strater, Norbert; Powers, Jay P.; Lawson, Kenneth V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3935-3955</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CD73 is an extracellular mediator of purinergic signaling.  When upregulated in the tumor microenvironment, CD73 has been implicated in the inhibition of immune function through overprodn. of adenosine.  Traditional efforts to inhibit CD73 have involved antibody therapy or the development of small mols., the most potent of which mimic the acidic and ionizable structure of the enzyme's natural substrate, AMP (AMP).  Here, we report the systematic discovery of a novel class of non-nucleotide CD73 inhibitors that are more potent than all other nonphosphonate inhibitor classes reported to date.  These efforts have culminated in the discovery of 4-({5-[4-fluoro-1-(2H-indazol-6-yl)-1H-1,2,3-benzotriazol-6-yl]-1H-pyrazol-1-yl}methyl)benzonitrile (73, IC50 = 12 nM) and 4-({5-[4-chloro-1-(2H-indazol-6-yl)-1H-1,2,3-benzotriazol-6-yl]-1H-pyrazol-1-yl}methyl)benzonitrile (74, IC50 = 19 nM).  Cocrystn. of 74 with human CD73 demonstrates a competitive binding mode.  These compds. show promise for the improvement of drug-like character via the attenuation of the acidity and low membrane permeability inherent to known nucleoside inhibitors of CD73.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxjIt23HCPD7Vg90H21EOLACvtfcHk0liKcnzwgEwrgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslCgsb8%253D&md5=52f39aa24bfc4e36a2e8218404ab2079</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01713%26sid%3Dliteratum%253Aachs%26aulast%3DBeatty%26aufirst%3DJ.%2BW.%26aulast%3DLindsey%26aufirst%3DE.%2BA.%26aulast%3DThomas-Tran%26aufirst%3DR.%26aulast%3DDebien%26aufirst%3DL.%26aulast%3DMandal%26aufirst%3DD.%26aulast%3DJeffrey%26aufirst%3DJ.%2BL.%26aulast%3DTran%26aufirst%3DA.%2BT.%26aulast%3DFournier%26aufirst%3DJ.%26aulast%3DJacob%26aufirst%3DS.%2BD.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DDrew%26aufirst%3DS.%2BL.%26aulast%3DGinn%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DYoung%26aufirst%3DS.%2BW.%26aulast%3DWalker%26aufirst%3DN.%26aulast%3DLeleti%26aufirst%3DM.%2BR.%26aulast%3DMosch%25C3%25BCtz%26aufirst%3DS.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26aulast%3DPowers%26aufirst%3DJ.%2BP.%26aulast%3DLawson%26aufirst%3DK.%2BV.%26atitle%3DDiscovery%2520of%2520Potent%2520and%2520Selective%2520Non-Nucleotide%2520Small%2520Molecule%2520Inhibitors%2520of%2520CD73%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D3935%26epage%3D3955%26doi%3D10.1021%2Facs.jmedchem.9b01713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zebisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pippel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Tayeb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of the Human Ecto-5′-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2161</span>– <span class="NLM_lpage">2173</span>, <span class="refDoi"> DOI: 10.1016/j.str.2012.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1016%2Fj.str.2012.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=23142347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqu7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=2161-2173&author=K.+Knappauthor=M.+Zebischauthor=J.+Pippelauthor=A.+El-Tayebauthor=C.+E.+M%C3%BCllerauthor=N.+Str%C3%A4ter&title=Crystal+Structure+of+the+Human+Ecto-5%E2%80%B2-Nucleotidase+%28CD73%29%3A+Insights+into+the+Regulation+of+Purinergic+Signaling&doi=10.1016%2Fj.str.2012.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Human Ecto-5'-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling</span></div><div class="casAuthors">Knapp, Karen; Zebisch, Matthias; Pippel, Jan; El-Tayeb, Ali; Mueller, Christa E.; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2161-2173</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In vertebrates ecto-5'-nucleotidase (e5NT) catalyzes the hydrolysis of extracellular AMP to adenosine and represents the major control point for extracellular adenosine levels.  Due to its pivotal role for activation of P1 adenosine receptors, e5NT has emerged as an appealing drug target for treatment of inflammation, chronic pain, hypoxia, and cancer.  Crystal structures of the dimeric human e5NT reveal an extensive 114° conformational switch between the open and closed forms of the enzyme.  The dimerization interface is formed by the C-terminal domains and exhibits interchain motions of up to 13°.  Complex structures with adenosine and AMPCP indicate that structural control of the domain movement dets. the selectivity for monophosphate nucleotides.  Binding modes of nucleotide-derived and flavonoid-based compds. complexed to the C-terminal domain in the open form reveal an addnl. binding pocket of ∼210 Å3 that might be explored to design more potent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8MOj4dwx2J7Vg90H21EOLACvtfcHk0liKcnzwgEwrgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqu7jK&md5=e108171e8079cca4dd11483dfacb909e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2012.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2012.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DKnapp%26aufirst%3DK.%26aulast%3DZebisch%26aufirst%3DM.%26aulast%3DPippel%26aufirst%3DJ.%26aulast%3DEl-Tayeb%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Human%2520Ecto-5%25E2%2580%25B2-Nucleotidase%2520%2528CD73%2529%253A%2520Insights%2520into%2520the%2520Regulation%2520of%2520Purinergic%2520Signaling%26jtitle%3DStructure%26date%3D2012%26volume%3D20%26spage%3D2161%26epage%3D2173%26doi%3D10.1016%2Fj.str.2012.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattarai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pippel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaletti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freundlieb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolshoven, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Tayeb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sträter, N.</span></span> <span> </span><span class="NLM_article-title">2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5′-Nucleotidase (CD73) Inhibitors with Variable Binding Modes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2941</span>– <span class="NLM_lpage">2957</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01611</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01611" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BB3cXivVarsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=2941-2957&author=S.+Bhattaraiauthor=J.+Pippelauthor=E.+Scalettiauthor=R.+Idrisauthor=M.+Freundliebauthor=G.+Rolshovenauthor=C.+Rennauthor=S-Y.+Leeauthor=A.+Abdelrahmanauthor=H.+Zimmermanauthor=A.+El-Tayebauthor=C.+M%C3%BCllerauthor=N.+Str%C3%A4ter&title=2-Substituted+%CE%B1%2C%CE%B2-Methylene-ADP+Derivatives%3A+Potent+Competitive+Ecto-5%E2%80%B2-Nucleotidase+%28CD73%29+Inhibitors+with+Variable+Binding+Modes&doi=10.1021%2Facs.jmedchem.9b01611"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes</span></div><div class="casAuthors">Bhattarai, Sanjay; Pippel, Jan; Scaletti, Emma; Idris, Riham; Freundlieb, Marianne; Rolshoven, Georg; Renn, Christian; Lee, Sang-Yong; Abdelrahman, Aliaa; Zimmermann, Herbert; El-Tayeb, Ali; Mueller, Christa E.; Straeter, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2941-2957</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CD73 inhibitors are promising drugs for the (immuno)therapy of cancer.  Here, we present the synthesis, structure-activity relationships, and co-crystal structures of novel derivs. of the competitive CD73 inhibitor α,β-methylene-ADP (AOPCP) substituted in the 2-position.  Small polar or lipophilic residues increased potency, 2-iodo- and 2-chloro-adenosine-5'-O-[(phosphonomethyl)phosphonic acid] (15, 16) being the most potent inhibitors with Ki values towards human CD73 of 3-6 nM.  Subject to the size and nature of the 2-substituent, variable binding modes were obsd. by X-ray crystallog.  Depending on the binding mode, large species differences were found, e.g. 2-piperazinyl-AOPCP (21) was >12-fold less potent against rat CD73 compared to human CD73.  This study shows that high CD73-inhibitory potency can be achieved by simply introducing a small substituent into the 2-position of AOPCP without the necessity of addnl. bulky N6-substituents.  Moreover, it provides valuable insights into the binding modes of competitive CD73 inhibitors, representing an excellent basis for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK0OpQBzKNX7Vg90H21EOLACvtfcHk0liKcnzwgEwrgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXivVarsbg%253D&md5=453dcd3d41f20b380c951ddf6e05fe3a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01611%26sid%3Dliteratum%253Aachs%26aulast%3DBhattarai%26aufirst%3DS.%26aulast%3DPippel%26aufirst%3DJ.%26aulast%3DScaletti%26aufirst%3DE.%26aulast%3DIdris%26aufirst%3DR.%26aulast%3DFreundlieb%26aufirst%3DM.%26aulast%3DRolshoven%26aufirst%3DG.%26aulast%3DRenn%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DS-Y.%26aulast%3DAbdelrahman%26aufirst%3DA.%26aulast%3DZimmerman%26aufirst%3DH.%26aulast%3DEl-Tayeb%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DStr%25C3%25A4ter%26aufirst%3DN.%26atitle%3D2-Substituted%2520%25CE%25B1%252C%25CE%25B2-Methylene-ADP%2520Derivatives%253A%2520Potent%2520Competitive%2520Ecto-5%25E2%2580%25B2-Nucleotidase%2520%2528CD73%2529%2520Inhibitors%2520with%2520Variable%2520Binding%2520Modes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D2941%26epage%3D2957%26doi%3D10.1021%2Facs.jmedchem.9b01611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cholongitasa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papatheodoridisb, G. V.</span></span> <span> </span><span class="NLM_article-title">Sofosbuvir: A Novel Oral Agent for Chronic Hepatitis C</span>. <i>Ann. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">337</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=25332066" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=331-337&author=E.+Cholongitasaauthor=G.+V.+Papatheodoridisb&title=Sofosbuvir%3A+A+Novel+Oral+Agent+for+Chronic+Hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCholongitasa%26aufirst%3DE.%26aulast%3DPapatheodoridisb%26aufirst%3DG.%2BV.%26atitle%3DSofosbuvir%253A%2520A%2520Novel%2520Oral%2520Agent%2520for%2520Chronic%2520Hepatitis%2520C%26jtitle%3DAnn.%2520Gastroenterol.%26date%3D2014%26volume%3D27%26spage%3D331%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Arimilli, M. N.</span>; <span class="NLM_string-name">Cundy, K. C.</span>; <span class="NLM_string-name">Dougherty, J. P.</span>; <span class="NLM_string-name">Kim, C. U.</span>; <span class="NLM_string-name">Reza, O.</span>; <span class="NLM_string-name">Stella, V. J.</span></span> <span> </span><span class="NLM_article-title">Antiviral Phosphonomethoxy Nucleotide Analogs Having Incrased Oral Bioavailability</span>. <span class="NLM_patent">US5977089A</span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=M.+N.+Arimilli&author=K.+C.+Cundy&author=J.+P.+Dougherty&author=C.+U.+Kim&author=O.+Reza&author=V.+J.+Stella&title=Antiviral+Phosphonomethoxy+Nucleotide+Analogs+Having+Incrased+Oral+Bioavailability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArimilli%26aufirst%3DM.%2BN.%26atitle%3DAntiviral%2520Phosphonomethoxy%2520Nucleotide%2520Analogs%2520Having%2520Incrased%2520Oral%2520Bioavailability%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Heidel, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowd, C.</span></span> <span> </span><span class="NLM_article-title">Phosphonate Prodrugs: An Overview and Recent Advances</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1625</span>– <span class="NLM_lpage">1643</span>, <span class="refDoi"> DOI: 10.4155/fmc-2018-0591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.4155%2Ffmc-2018-0591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=31469328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1yhtr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=1625-1643&author=K.+M.+Heidelauthor=C.+Dowd&title=Phosphonate+Prodrugs%3A+An+Overview+and+Recent+Advances&doi=10.4155%2Ffmc-2018-0591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphonate prodrugs: an overview and recent advances</span></div><div class="casAuthors">Heidel, Kenneth M.; Dowd, Cynthia S.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1625-1643</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Phosphonates, often used as isosteric replacements for phosphates, can provide important interactions with an enzyme.  Due to their high charge at physiol. pH, however, permeation into cells can be a challenge.  Protecting phosphonates as prodrugs has shown promise in drug delivery.  Thus, a variety of structures and cleavage/activation mechanisms exist, enabling release of the active compd.  This review describes the structural diversity of these pro-moieties, relevant cleavage mechanisms and recent advances in the design of phosphonate prodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8GcyRrVN8-rVg90H21EOLACvtfcHk0li2bkhF4NlCNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1yhtr3M&md5=461d5aa771bebc20ebdc78dc662e2467</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2018-0591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2018-0591%26sid%3Dliteratum%253Aachs%26aulast%3DHeidel%26aufirst%3DK.%2BM.%26aulast%3DDowd%26aufirst%3DC.%26atitle%3DPhosphonate%2520Prodrugs%253A%2520An%2520Overview%2520and%2520Recent%2520Advances%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2019%26volume%3D11%26spage%3D1625%26epage%3D1643%26doi%3D10.4155%2Ffmc-2018-0591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrew, J. W.</span>; <span class="NLM_string-name">David, F. W.</span></span> <span> </span><span class="NLM_article-title">Prodrugs of Phosphonates and Phosphates: Crossing the Membrane Barrier</span>.  <i>Topics in Current Chemistry</i>; <span class="NLM_publisher-name">Springer</span>, <span class="NLM_year">2015</span>; Vol  <span class="NLM_volume">360</span>, pp  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">160</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=115-160&author=J.+W.+Andrew&author=F.+W.+David&title=Topics+in+Current+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAndrew%26aufirst%3DJ.%2BW.%26atitle%3DProdrugs%2520of%2520Phosphonates%2520and%2520Phosphates%253A%2520Crossing%2520the%2520Membrane%2520Barrier%26btitle%3DTopics%2520in%2520Current%2520Chemistry%26pub%3DSpringer%26date%3D2015%26volume%3D360%26spage%3D115%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Stella, V. J.</span></span> <span> </span><span class="NLM_article-title">Prodrug Approaches to Enhancing the Oral Delivery of Poorly Permeable Drugs</span>.  <i>Prodrugs. Biotechnology: Pharmaceutical Aspects</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stella, V. J.</span>; <span class="NLM_string-name">Borchardt, R. T.</span>; <span class="NLM_string-name">Hageman, M. J.</span>; <span class="NLM_string-name">Oliyai, R.</span>; <span class="NLM_string-name">Maag, H.</span>; <span class="NLM_string-name">Tilley, J. W.</span></span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2007</span>; Vol.  <span class="NLM_volume">V</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1007%2F978-0-387-49785-3_2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=V.+J.+Stellaauthor=V.+J.+Stella&author=R.+T.+Borchardt&author=M.+J.+Hageman&author=R.+Oliyai&author=H.+Maag&author=J.+W.+Tilley&title=Prodrugs.+Biotechnology%3A+Pharmaceutical+Aspects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11e&amp;dbid=16384&amp;doi=10.1007%2F978-0-387-49785-3_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-0-387-49785-3_2%26sid%3Dliteratum%253Aachs%26aulast%3DStella%26aufirst%3DV.%2BJ.%26atitle%3DProdrug%2520Approaches%2520to%2520Enhancing%2520the%2520Oral%2520Delivery%2520of%2520Poorly%2520Permeable%2520Drugs%26btitle%3DProdrugs.%2520Biotechnology%253A%2520Pharmaceutical%2520Aspects%26aulast%3DStella%26aufirst%3DV.%2BJ.%26pub%3DSpringer%26date%3D2007%26volume%3DV" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Debien, L. P. P.</span>; <span class="NLM_string-name">Kalisiak, J.</span>; <span class="NLM_string-name">Lawson, K. V.</span>; <span class="NLM_string-name">Leleti, M. R.</span>; <span class="NLM_string-name">Lindsey, E. A.</span>; <span class="NLM_string-name">Miles, D. H.</span>; <span class="NLM_string-name">Newcomb, E.</span>; <span class="NLM_string-name">Powers, J. P.</span>; <span class="NLM_string-name">Rosen, B. R.</span>; <span class="NLM_string-name">Sharif, E. U.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Adenosine 5′-Nucleotidase</span>. <span class="NLM_patent">WO2018067424 A1</span><span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=L.+P.+P.+Debien&author=J.+Kalisiak&author=K.+V.+Lawson&author=M.+R.+Leleti&author=E.+A.+Lindsey&author=D.+H.+Miles&author=E.+Newcomb&author=J.+P.+Powers&author=B.+R.+Rosen&author=E.+U.+Sharif&title=Inhibitors+of+Adenosine+5%E2%80%B2-Nucleotidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDebien%26aufirst%3DL.%2BP.%2BP.%26atitle%3DInhibitors%2520of%2520Adenosine%25205%25E2%2580%25B2-Nucleotidase%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Holý, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, I.</span></span> <span> </span><span class="NLM_article-title">Preparation of 5′-O-Phosphonylmethyl Analogues of Nucleoside-5′-Phosphates, 5′-Diphosphates and 5′-Triphosphates</span>. <i>Collect. czech. Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">3447</span>– <span class="NLM_lpage">3463</span>, <span class="refDoi"> DOI: 10.1135/cccc19823447</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1135%2Fcccc19823447" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADyaL3sXhvFylsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1982&pages=3447-3463&author=A.+Hol%C3%BDauthor=I.+Rosenberg&title=Preparation+of+5%E2%80%B2-O-Phosphonylmethyl+Analogues+of+Nucleoside-5%E2%80%B2-Phosphates%2C+5%E2%80%B2-Diphosphates+and+5%E2%80%B2-Triphosphates&doi=10.1135%2Fcccc19823447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of 5'-O-phosphonylmethyl analogs of nucleoside-5'-phosphates, 5'-diphosphates and 5'-triphosphates</span></div><div class="casAuthors">Holy, Antonin; Rosenberg, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Collection of Czechoslovak Chemical Communications</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3447-63</span>CODEN:
                <span class="NLM_cas:coden">CCCCAK</span>;
        ISSN:<span class="NLM_cas:issn">0366-547X</span>.
    </div><div class="casAbstract">Reaction of 2',3'-O-protected nucleosides with p-MeC6H4SO3CH2P(O)(OR2)2 (R2 = Me, Et) in the presence of NaH, followed by acid hydrolysis gave (phosphonylmethyl)nucleosides I (R = MeO, EtO; R1 = uracil-1-yl, cytosin-1-yl, adenin-9-yl, guanin-9-yl, hypoxanthin-9-yl, 6-azauracil-1-yl), which on treatment with Me3SiI gave I (R = HO).  I (R = OH) on reaction with morpholine gave I (R = morpholino), which on phosphorylation gave I [R = (HO)2P(O)O, (HO)2P(O)OP(O)(OH)O].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDacPk849RBrVg90H21EOLACvtfcHk0lgxF9TK8U2ANg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhvFylsbc%253D&md5=48346b1b8095d6b58f052503d27ffd59</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1135%2Fcccc19823447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1135%252Fcccc19823447%26sid%3Dliteratum%253Aachs%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26aulast%3DRosenberg%26aufirst%3DI.%26atitle%3DPreparation%2520of%25205%25E2%2580%25B2-O-Phosphonylmethyl%2520Analogues%2520of%2520Nucleoside-5%25E2%2580%25B2-Phosphates%252C%25205%25E2%2580%25B2-Diphosphates%2520and%25205%25E2%2580%25B2-Triphosphates%26jtitle%3DCollect.%2520czech.%2520Chem.%2520Commun.%26date%3D1982%26volume%3D47%26spage%3D3447%26epage%3D3463%26doi%3D10.1135%2Fcccc19823447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Malnuit, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smoleń, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tichý, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slavětínská, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocek, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Cyclic and Acyclic Nucleoside Phosphonates and Sulfonamides Derived from 6-(Thiophen-2-yl)-7-fluoro-7-deazapurine</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2019</i></span>,  <span class="NLM_fpage">5409</span>– <span class="NLM_lpage">5423</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201900509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1002%2Fejoc.201900509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVOjs7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2019&publication_year=2019&pages=5409-5423&author=V.+Malnuitauthor=S.+Smole%C5%84author=M.+Tich%C3%BDauthor=L.+P.+Slav%C4%9Bt%C3%ADnsk%C3%A1author=M.+Hocek&title=Synthesis+of+Cyclic+and+Acyclic+Nucleoside+Phosphonates+and+Sulfonamides+Derived+from+6-%28Thiophen-2-yl%29-7-fluoro-7-deazapurine&doi=10.1002%2Fejoc.201900509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Cyclic and Acyclic Nucleoside Phosphonates and Sulfonamides Derived from 6-(Thiophen-2-yl)-7-fluoro-7-deazapurine</span></div><div class="casAuthors">Malnuit, Vincent; Smolen, Sabina; Tichy, Michal; Postova Slavetinska, Lenka; Hocek, Michal</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">2019</span>
        (<span class="NLM_cas:issue">31-32</span>),
    <span class="NLM_cas:pages">5409-5423</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Ribonuclosides derived from 6-heteroaryl-7-deazapurines are potent cytostatics, but their mechanism of action is unknown.  Here we designed and synthesized a series of cyclic and acyclic nucleoside phosphonates, as well as carboxy, cyano, sulfo, and sulfonamide acyclic analogs derived from 6-thiophen-2-yl-7-deazapurine and 7-fluoro-6-thiophen-2-yl-7-deazapurine as ribonucleoside monophosphate mimics.  None of these analogs exerted significant cytotoxic and antiviral activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2G6ZyPh8rtrVg90H21EOLACvtfcHk0lgxF9TK8U2ANg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVOjs7rE&md5=cf95d2f5e00644ac479e68c19880ef53</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201900509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201900509%26sid%3Dliteratum%253Aachs%26aulast%3DMalnuit%26aufirst%3DV.%26aulast%3DSmole%25C5%2584%26aufirst%3DS.%26aulast%3DTich%25C3%25BD%26aufirst%3DM.%26aulast%3DSlav%25C4%259Bt%25C3%25ADnsk%25C3%25A1%26aufirst%3DL.%2BP.%26aulast%3DHocek%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520Cyclic%2520and%2520Acyclic%2520Nucleoside%2520Phosphonates%2520and%2520Sulfonamides%2520Derived%2520from%25206-%2528Thiophen-2-yl%2529-7-fluoro-7-deazapurine%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2019%26volume%3D2019%26spage%3D5409%26epage%3D5423%26doi%3D10.1002%2Fejoc.201900509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Šilhár, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohl, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votruba, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klepetářová, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocek, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of similar 2-(hydroxymethyl)purine nucleosides has been reported previously Synthesis of 6-Amino-, 6-Methyl- and 6-Aryl-2-(hydroxymethyl)purine Bases and Nucleosides</span>. <i>Collect. Czech. Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">788</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1135/cccc20060788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=10.1135%2Fcccc20060788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmt1artbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=788-803&author=P.+%C5%A0ilh%C3%A1rauthor=R.+Pohlauthor=I.+Votrubaauthor=B.+Klepet%C3%A1%C5%99ov%C3%A1author=M.+Hocek&title=Synthesis+of+similar+2-%28hydroxymethyl%29purine+nucleosides+has+been+reported+previously+Synthesis+of+6-Amino-%2C+6-Methyl-+and+6-Aryl-2-%28hydroxymethyl%29purine+Bases+and+Nucleosides&doi=10.1135%2Fcccc20060788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 6-amino-, 6-methyl- and 6-aryl-2-(hydroxymethyl)purine bases and nucleosides</span></div><div class="casAuthors">Silhar, Peter; Pohl, Radek; Votruba, Ivan; Klepetarova, Blanka; Hocek, Michal</div><div class="citationInfo"><span class="NLM_cas:title">Collection of Czechoslovak Chemical Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">788-803</span>CODEN:
                <span class="NLM_cas:coden">CCCCAK</span>;
        ISSN:<span class="NLM_cas:issn">0010-0765</span>.
    
            (<span class="NLM_cas:orgname">Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic</span>)
        </div><div class="casAbstract">An efficient methodol. of the synthesis of 6-substituted 2-(hydroxymethyl)purine derivs. (bases and nucleosides) was developed.  Regioselective Pd-catalyzed cross-coupling reactions of 6-chloro-2-iodo-purines with [(benzoyl-oxy)methyl]zinc iodide gave 2-[(benzoyl-oxy)methyl]-6-chloro-purines that were converted to 2-(hydroxymethyl)adenine by reactions with ammonia and to 6-methyl- or 6-aryl-2-(hydroxymethyl)purines by cross-coupling reactions with trimethyl-aluminum or aryl-boronic acids followed by deprotection.  The title 6-substituted 2-(hydroxymethyl)purine bases and nucleosides did not exhibit significant cytostatic or anti-HCV activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT-rklJ1o4wrVg90H21EOLACvtfcHk0lgxF9TK8U2ANg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmt1artbk%253D&md5=d6b69e912da9208833c4059e89bd8b55</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1135%2Fcccc20060788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1135%252Fcccc20060788%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0ilh%25C3%25A1r%26aufirst%3DP.%26aulast%3DPohl%26aufirst%3DR.%26aulast%3DVotruba%26aufirst%3DI.%26aulast%3DKlepet%25C3%25A1%25C5%2599ov%25C3%25A1%26aufirst%3DB.%26aulast%3DHocek%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520similar%25202-%2528hydroxymethyl%2529purine%2520nucleosides%2520has%2520been%2520reported%2520previously%2520Synthesis%2520of%25206-Amino-%252C%25206-Methyl-%2520and%25206-Aryl-2-%2528hydroxymethyl%2529purine%2520Bases%2520and%2520Nucleosides%26jtitle%3DCollect.%2520Czech.%2520Chem.%2520Commun.%26date%3D2006%26volume%3D71%26spage%3D788%26epage%3D803%26doi%3D10.1135%2Fcccc20060788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4H2I" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4H2I','PDB','4H2I'); return false;">PDB: 4H2I</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YE1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YE1','PDB','6YE1'); return false;">PDB: 6YE1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YE2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YE2','PDB','6YE2'); return false;">PDB: 6YE2</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i65"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01835">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_83447"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01835?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01835</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01835/suppl_file/jm0c01835_si_001.csv">CSV</a>)</p></li><li><p class="inline">Hepatocyte stability assay, CYP inhibition assay, and crystallographic methods (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01835/suppl_file/jm0c01835_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01835/suppl_file/jm0c01835_si_001.csv">jm0c01835_si_001.csv (3.8 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01835/suppl_file/jm0c01835_si_002.pdf">jm0c01835_si_002.pdf (1.52 MB)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates have been deposited in the Protein Data Bank (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YE1">6YE1</a> for <b>2n</b> and PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YE2">6YE2</a> for <b>4a</b>). Structures will be released upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01835&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01835%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-1%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01835" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997991e8033d54","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
